Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,A1BG,Alpha-1B-glycoprotein,18873,98,2.44 [0.75-7.92],0.1369792297336956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AAMDC,Mth938 domain-containing protein,18378,94,1.07 [0.73-1.57],0.7207218468990717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AARSD1,Alanyl-tRNA editing protein Aarsd1,21446,131,1.11 [0.85-1.46],0.4426245835211255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABCA2,ATP-binding cassette sub-family A member 2,18209,92,1.15 [0.66-2.02],0.6270324899401003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABHD14B,Protein ABHD14B,21310,132,1.24 [0.95-1.63],0.1178899430614555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABL1,Tyrosine-protein kinase ABL1,21446,131,1.19 [0.95-1.49],0.1285538207588605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABO,Histo-blood group ABO system transferase,18856,97,0.97 [0.85-1.11],0.7048501922412089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABRAXAS2,BRISC complex subunit Abraxas 2,18209,92,0.98 [0.72-1.34],0.9052457114546576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",21052,127,1.13 [0.93-1.36],0.2219377878176393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",18501,97,1.00 [0.76-1.33],0.9874020396186756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",18843,97,0.91 [0.73-1.14],0.4084675510619543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAN,Aggrecan core protein,21349,131,0.96 [0.55-1.68],0.8792866452454253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE,Angiotensin-converting enzyme,18856,97,1.13 [0.56-2.30],0.7297888353103907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,21144,129,1.41 [1.09-1.81],0.0083891731667579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACHE,Acetylcholinesterase,18442,92,1.12 [0.62-2.04],0.7055615199349754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOT13,Acyl-coenzyme A thioesterase 13,18745,97,0.96 [0.81-1.14],0.6374609306449709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,21557,132,1.32 [1.02-1.71],0.0331934948077501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP1,Low molecular weight phosphotyrosine protein phosphatase,18284,95,0.61 [0.38-0.99],0.0440506439888051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP5,Tartrate-resistant acid phosphatase type 5,21678,133,1.20 [0.76-1.91],0.4343001499638631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP6,Lysophosphatidic acid phosphatase type 6,21686,133,0.93 [0.75-1.15],0.483330328659308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRBP,Acrosin-binding protein,18757,97,1.02 [0.62-1.68],0.934996327274977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRV1,Acrosomal protein SP-10,18284,95,0.90 [0.72-1.13],0.3531694365703659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACSL1,Long-chain-fatty-acid--CoA ligase 1,18209,92,1.15 [0.69-1.90],0.5892453013947776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",21144,129,1.47 [1.11-1.94],0.0067062121042977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN2,Alpha-actinin-2,18209,92,1.48 [1.12-1.96],0.0061806639597827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN4,Alpha-actinin-4,21136,129,0.65 [0.36-1.18],0.1570666956550444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,21332,132,2.08 [1.21-3.58],0.0083492145384217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY1,Aminoacylase-1,21557,132,0.97 [0.75-1.25],0.8088304606977544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,18209,92,1.06 [0.74-1.52],0.7304757717802264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACYP1,Acylphosphatase-1,18377,92,0.79 [0.57-1.08],0.1328702356202562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA,Adenosine deaminase,21768,132,1.34 [0.90-1.99],0.1480738016615061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA2,Adenosine deaminase 2,21446,131,1.39 [0.99-1.96],0.0564114970948849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,18284,95,1.85 [1.07-3.18],0.026370784705239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,21144,129,1.32 [0.80-2.18],0.2824666980424476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,21365,132,0.95 [0.62-1.45],0.8111245021073694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,21768,132,0.90 [0.59-1.38],0.62348772694702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,21693,134,1.21 [0.72-2.04],0.4650313363697351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,18745,97,1.89 [1.04-3.44],0.0378345002519526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,18284,95,1.73 [1.08-2.78],0.022625126887672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,21821,134,1.22 [0.64-2.33],0.5456049865138174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,21446,131,1.10 [0.75-1.59],0.6302996073541922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,21144,129,1.23 [0.81-1.87],0.3210609209606404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,18284,95,1.14 [0.65-2.01],0.6398457310483932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,21637,130,1.18 [0.83-1.67],0.3610844704282409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,18852,99,2.08 [1.27-3.41],0.0035452771441175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL4,ADAMTS-like protein 4,18378,94,2.14 [0.93-4.95],0.0736542947762366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL5,ADAMTS-like protein 5,18843,97,0.77 [0.47-1.27],0.3020380454498697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,21052,127,1.03 [0.67-1.57],0.9070455735123708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADD1,Alpha-adducin,18442,92,0.82 [0.61-1.09],0.163167048496134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRB3,Adhesion G protein-coupled receptor B3,21332,132,1.19 [0.76-1.88],0.4441843733391442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRD1,Adhesion G-protein coupled receptor D1,18442,92,1.04 [0.62-1.76],0.8780235463142864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE1,Adhesion G protein-coupled receptor E1,18745,97,0.76 [0.53-1.09],0.1362327535439332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE2,Adhesion G protein-coupled receptor E2,21644,130,1.28 [0.74-2.21],0.3699282795433698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE5,Adhesion G protein-coupled receptor E5,21732,134,1.19 [0.74-1.93],0.4709940041461482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRF5,Adhesion G protein-coupled receptor F5,18843,97,1.26 [0.62-2.56],0.5286629858179348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG1,Adhesion G-protein coupled receptor G1,21446,131,1.12 [0.96-1.32],0.1589668516597432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG2,Adhesion G-protein coupled receptor G2,21557,132,0.64 [0.36-1.13],0.1265835828750953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRV1,Adhesion G-protein coupled receptor V1,18213,94,1.12 [0.87-1.45],0.373198735284454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH1B,All-trans-retinol dehydrogenase,18442,92,1.03 [0.79-1.34],0.8529525318635951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,21144,129,1.02 [0.84-1.24],0.8268034731632428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,18873,98,1.56 [1.18-2.05],0.001725668055794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,21724,133,2.47 [1.36-4.48],0.0029880731066873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADRA2A,Alpha-2A adrenergic receptor,18209,92,0.97 [0.72-1.31],0.8559209600650133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFAP1,Actin filament-associated protein 1,18442,92,0.96 [0.74-1.23],0.7369266252226535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFM,Afamin,18873,98,0.53 [0.20-1.37],0.1886093706418852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFP,Alpha-fetoprotein,21292,132,1.11 [0.88-1.41],0.3758834135458491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGBL2,Cytosolic carboxypeptidase 2,18213,94,0.94 [0.76-1.17],0.5993817017751342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGER,Advanced glycosylation end product-specific receptor,21518,130,1.16 [0.80-1.67],0.4347578774608616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR2,Anterior gradient protein 2 homolog,20886,130,1.13 [0.97-1.32],0.1058983594538346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR3,Anterior gradient protein 3,21007,126,0.92 [0.70-1.21],0.5562460672030516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,21644,130,1.74 [1.19-2.54],0.0041444365268007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRP,Agouti-related protein,21768,132,1.25 [0.93-1.68],0.1467649817769085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGT,Angiotensinogen,18856,97,0.97 [0.39-2.40],0.9463427062393824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGXT,Serine--pyruvate aminotransferase,21557,132,1.10 [0.90-1.35],0.3411578902489586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHCY,Adenosylhomocysteinase,21557,132,1.11 [0.89-1.40],0.3524209407854007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK,Neuroblast differentiation-associated protein AHNAK,18378,94,1.12 [0.60-2.09],0.71256037917487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK2,Protein AHNAK2,18378,94,1.00 [0.52-1.94],0.9997880978325232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,18757,97,0.94 [0.69-1.28],0.6839166868844808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSG,Alpha-2-HS-glycoprotein,18856,97,0.81 [0.40-1.65],0.5643211814715037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSP,Alpha-hemoglobin-stabilizing protein,21537,130,0.90 [0.75-1.09],0.2783812573066714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIDA,"Axin interactor, dorsalization-associated protein",18334,92,0.71 [0.52-0.98],0.0378950678304224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1,Allograft inflammatory factor 1,21052,127,1.29 [0.96-1.73],0.0906985421821135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1L,Allograft inflammatory factor 1-like,18378,94,0.84 [0.55-1.27],0.4058458552343503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",21416,131,1.08 [0.93-1.24],0.3250435850393997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK1,Adenylate kinase isoenzyme 1,21557,132,0.98 [0.77-1.24],0.850356690318379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK2,"Adenylate kinase 2, mitochondrial",18809,98,0.93 [0.78-1.12],0.4571247377542655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKAP12,A-kinase anchor protein 12,18442,92,0.52 [0.19-1.46],0.2125798915112538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B1,Aldo-keto reductase family 1 member B1,21052,127,1.11 [0.90-1.37],0.3477530731217962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B10,Aldo-keto reductase family 1 member B10,18334,92,1.18 [0.89-1.57],0.2452628443358838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1C4,Aldo-keto reductase family 1 member C4,21144,129,0.96 [0.71-1.30],0.7842720088383368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR7L,Aflatoxin B1 aldehyde reductase member 4,18284,95,1.32 [1.03-1.67],0.0252928970331443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT1S1,Proline-rich AKT1 substrate 1,21055,131,1.01 [0.80-1.28],0.9406972710930236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT2,RAC-beta serine/threonine-protein kinase,18806,96,0.98 [0.84-1.14],0.7959860618410067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT3,RAC-gamma serine/threonine-protein kinase,20963,127,1.17 [0.89-1.55],0.2692516596667599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALCAM,CD166 antigen,21821,134,2.28 [1.07-4.85],0.0327375578781969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH1A1,Retinal dehydrogenase 1,21578,131,1.02 [0.77-1.35],0.8868420870788618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH2,"Aldehyde dehydrogenase, mitochondrial",18757,97,0.87 [0.57-1.34],0.5328596680072136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",21464,131,1.07 [0.87-1.32],0.508914797819038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",18806,96,1.06 [0.70-1.61],0.7872712942772091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALMS1,Alstrom syndrome protein 1,18501,97,0.84 [0.53-1.34],0.4724896326570282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPI,Intestinal-type alkaline phosphatase,18284,95,1.04 [0.89-1.21],0.6398618659720183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPP,"Alkaline phosphatase, placental type",21446,131,1.05 [0.90-1.22],0.5246524565195412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBN,Ameloblastin,21136,129,1.35 [0.90-2.03],0.1499568045590021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,21690,133,2.77 [1.35-5.68],0.0052980589504428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,18852,99,0.96 [0.46-2.01],0.9100669798840272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMFR,E3 ubiquitin-protein ligase AMFR,21055,131,0.91 [0.70-1.18],0.4853565524407879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO1,Amphoterin-induced protein 1,18334,92,0.92 [0.60-1.41],0.6997218598631478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO2,Amphoterin-induced protein 2,21446,131,2.21 [1.15-4.22],0.0170425055015584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMN,Protein amnionless,21136,129,1.04 [0.75-1.45],0.8095118710432527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOT,Angiomotin,18442,92,0.61 [0.35-1.05],0.0756016010871056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOTL2,Angiomotin-like protein 2,18673,97,0.97 [0.63-1.48],0.870587102065051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMPD3,AMP deaminase 3,18809,98,0.88 [0.67-1.15],0.3421340550118422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,17664,92,0.78 [0.51-1.18],0.2357980613049362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2A,Pancreatic alpha-amylase,20707,124,0.94 [0.68-1.30],0.7211985045410065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2B,Alpha-amylase 2B,20089,122,0.95 [0.69-1.32],0.7625003403172294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANG,Angiogenin,21526,132,1.10 [0.70-1.72],0.6920763763506509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT1,Angiopoietin-1,21460,129,0.99 [0.82-1.19],0.9237400891468756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,21724,133,2.25 [1.57-3.22],8.88511116608786e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,21255,128,2.44 [1.43-4.17],0.0010304236797313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL2,Angiopoietin-related protein 2,21574,130,1.35 [0.92-1.98],0.1256932509055651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL3,Angiopoietin-related protein 3,21589,132,1.20 [0.78-1.84],0.4094132516779372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,21610,130,2.00 [1.42-2.82],8.09892287236508e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL7,Angiopoietin-related protein 7,21724,133,1.35 [0.88-2.06],0.1641910904204765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANK2,Ankyrin-2,18209,92,1.11 [0.87-1.43],0.4035835554258857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,18284,95,1.06 [0.83-1.36],0.6482108683024248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRA2,Ankyrin repeat family A protein 2,18165,95,0.87 [0.60-1.26],0.4633677959683008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRD54,Ankyrin repeat domain-containing protein 54,21052,127,1.17 [0.92-1.50],0.1989473422742666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,18378,94,1.25 [0.83-1.89],0.2896418541040415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANPEP,Aminopeptidase N,21640,132,1.69 [1.00-2.84],0.0494052111081748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA1,Annexin A1,18349,91,1.13 [0.73-1.75],0.5857786289670379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA10,Annexin A10,21055,131,1.11 [0.93-1.31],0.2411495590897314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA11,Annexin A11,21478,131,1.19 [0.93-1.51],0.1685861201880508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,18095,94,1.38 [1.10-1.72],0.0053028846607885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA3,Annexin A3,21693,134,1.27 [1.03-1.58],0.0259223316264551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA4,Annexin A4,21462,132,1.16 [0.94-1.43],0.1772208554761881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA5,Annexin A5,20997,131,0.99 [0.58-1.67],0.9613577939979968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC1,Amiloride-sensitive amine oxidase [copper-containing],21136,129,0.86 [0.63-1.18],0.3495671741129067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC3,Membrane primary amine oxidase,21671,132,1.51 [0.89-2.54],0.1239636160898312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP1G2,AP-1 complex subunit gamma-like 2,18757,97,0.99 [0.77-1.27],0.9319439398470972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP2B1,AP-2 complex subunit beta,18334,92,0.65 [0.40-1.05],0.0765650974167238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3B1,AP-3 complex subunit beta-1,18745,97,0.97 [0.75-1.25],0.7931975902176106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3S2,AP-3 complex subunit sigma-2,18809,98,1.16 [0.78-1.72],0.4682597304388832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,21446,131,1.23 [0.90-1.70],0.1949989242766013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APCS,Serum amyloid P-component,18687,97,0.79 [0.44-1.42],0.431727638705327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,21643,133,1.24 [0.97-1.58],0.0810551245741817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APLP1,Amyloid-like protein 1,21557,132,0.84 [0.62-1.13],0.2472630414847944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA1,Apolipoprotein A-I,18873,98,1.14 [0.57-2.32],0.7071360784787817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA2,Apolipoprotein A-II,18856,97,1.21 [0.82-1.78],0.3487309317782241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA4,Apolipoprotein A-IV,18873,98,1.36 [0.84-2.23],0.2134955973100213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOB,Apolipoprotein B-100,18856,97,0.60 [0.26-1.34],0.2118269298834701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOBR,Apolipoprotein B receptor,18378,94,1.11 [0.69-1.77],0.6759161188161797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOC1,Apolipoprotein C-I,18841,98,0.94 [0.56-1.60],0.8305170807623946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOD,Apolipoprotein D,18065,96,1.05 [0.65-1.68],0.8383968103062159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOE,Apolipoprotein E,18873,98,1.05 [0.81-1.37],0.7220214815837867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOF,Apolipoprotein F,18856,97,0.93 [0.46-1.88],0.8442429996322627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOH,Beta-2-glycoprotein 1,21578,131,1.16 [0.77-1.73],0.4770236136924397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOL1,Apolipoprotein L1,18856,97,0.96 [0.68-1.36],0.8192986704646269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOM,Apolipoprotein M,21625,132,0.71 [0.42-1.21],0.2084752376544887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APP,Amyloid-beta precursor protein,21557,131,1.04 [0.82-1.31],0.7596586834754491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APPL2,DCC-interacting protein 13-beta,18442,92,0.96 [0.81-1.15],0.6856646487306091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APRT,Adenine phosphoribosyltransferase,21318,132,1.06 [0.76-1.47],0.7350890592939279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARAF,Serine/threonine-protein kinase A-Raf,18501,97,1.16 [0.90-1.50],0.2406160966483021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,21446,131,1.83 [1.35-2.49],0.0001160088179364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARF6,ADP-ribosylation factor 6,18745,97,0.92 [0.77-1.11],0.3937300318844082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARFIP1,Arfaptin-1,18806,96,0.93 [0.70-1.25],0.6412088265385378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG1,Arginase-1,21395,131,0.87 [0.65-1.16],0.3343193434855566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG2,"Arginase-2, mitochondrial",18757,97,0.65 [0.38-1.12],0.121454032436133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP1,Rho GTPase-activating protein 1,21052,127,0.95 [0.67-1.35],0.785984345762645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP25,Rho GTPase-activating protein 25,21052,127,1.13 [0.88-1.45],0.3399171241345226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP30,Rho GTPase-activating protein 30,18501,97,0.59 [0.30-1.16],0.1254998585219538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP45,Rho GTPase-activating protein 45,18442,92,0.89 [0.69-1.14],0.3423948144963277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP5,Rho GTPase-activating protein 5,18165,95,1.11 [0.88-1.40],0.3739391530531702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF1,Rho guanine nucleotide exchange factor 1,18809,98,1.00 [0.81-1.25],0.97146894951549
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF10,Rho guanine nucleotide exchange factor 10,18806,96,0.95 [0.77-1.17],0.6228288096266839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF12,Rho guanine nucleotide exchange factor 12,21505,131,0.98 [0.85-1.14],0.8375410135955528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF5,Rho guanine nucleotide exchange factor 5,18213,94,1.09 [0.84-1.41],0.5318102826718956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID3A,AT-rich interactive domain-containing protein 3A,18213,94,1.27 [0.81-1.99],0.3011133889815026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID4B,AT-rich interactive domain-containing protein 4B,21055,131,0.91 [0.61-1.34],0.6263591512908486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL13B,ADP-ribosylation factor-like protein 13B,18209,92,0.96 [0.71-1.30],0.7956206951975932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,18209,92,0.81 [0.48-1.36],0.4230563972078502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARMCX2,Armadillo repeat-containing X-linked protein 2,18213,94,1.00 [0.72-1.38],0.9841249085555016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNT,Aryl hydrocarbon receptor nuclear translocator,21136,129,0.82 [0.52-1.30],0.4032007963252172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,18209,92,0.89 [0.59-1.35],0.5888423751731534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSA,Arylsulfatase A,21578,131,1.07 [0.76-1.50],0.7047176649468254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSB,Arylsulfatase B,21446,131,1.19 [0.90-1.57],0.2205384876938493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART3,Ecto-ADP-ribosyltransferase 3,21671,132,1.07 [0.69-1.64],0.7683399882819548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART5,Ecto-ADP-ribosyltransferase 5,18213,94,0.84 [0.58-1.21],0.3457826962604976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARTN,Artemin,21136,129,0.95 [0.65-1.38],0.787392924967754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH1,Acid ceramidase,18659,99,0.89 [0.58-1.38],0.612078719159004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH2,Neutral ceramidase,21365,132,0.85 [0.65-1.10],0.2165163651097343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR1,Asialoglycoprotein receptor 1,21365,132,1.60 [0.98-2.62],0.0624724267447819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR2,Asialoglycoprotein receptor 2,18856,97,1.12 [0.54-2.32],0.753696098213183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPN,Asporin,18843,97,0.94 [0.46-1.89],0.85356092386526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPSCR1,Tether containing UBX domain for GLUT4,18806,96,0.89 [0.66-1.19],0.4303836793621415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASRGL1,Isoaspartyl peptidase/L-asparaginase,18378,94,0.95 [0.78-1.16],0.6453639185318292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASS1,Argininosuccinate synthase,18209,92,0.98 [0.75-1.28],0.889254910723228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF2,Cyclic AMP-dependent transcription factor ATF-2,21055,131,0.85 [0.64-1.13],0.2560165357856196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF4,Cyclic AMP-dependent transcription factor ATF-4,18165,95,0.80 [0.43-1.49],0.4913227712499703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG16L1,Autophagy-related protein 16-1,18745,97,0.94 [0.75-1.19],0.6094259427793974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG4A,Cysteine protease ATG4A,21052,127,1.07 [0.82-1.39],0.6073536935754582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATOX1,Copper transport protein ATOX1,21637,130,1.16 [0.92-1.45],0.2082384448817613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,18209,92,1.04 [0.69-1.56],0.8480574838376438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,18209,92,1.53 [1.00-2.36],0.050499699942764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,18209,92,0.84 [0.48-1.47],0.5395303247813401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B4,Protein ATP1B4,18165,95,0.59 [0.34-1.02],0.0590770952825996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP2B4,Plasma membrane calcium-transporting ATPase 4,18209,92,0.83 [0.56-1.22],0.3434128094428542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5F1D,"ATP synthase subunit delta, mitochondrial",18209,92,1.11 [0.79-1.55],0.5584499605459899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5IF1,"ATPase inhibitor, mitochondrial",21644,130,1.06 [0.92-1.22],0.3943958999852244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5PO,"ATP synthase subunit O, mitochondrial",21055,131,0.81 [0.55-1.20],0.2955971665801271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6AP2,Renin receptor,21052,127,1.24 [0.87-1.76],0.2395590832666932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1D,V-type proton ATPase subunit D,21446,131,1.13 [0.66-1.94],0.6476936409656013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1F,V-type proton ATPase subunit F,21022,131,0.90 [0.70-1.14],0.3764703266424868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G1,V-type proton ATPase subunit G 1,18378,94,0.96 [0.72-1.27],0.7652707666178337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G2,V-type proton ATPase subunit G 2,18209,92,0.96 [0.77-1.20],0.7140992333132461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRAID,All-trans retinoic acid-induced differentiation factor,18745,97,1.67 [0.97-2.88],0.0627243562614055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRN,"Attractin, Isoform 2",18873,98,1.28 [0.40-4.07],0.6763690014146695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN10,Ataxin-10,21055,131,1.21 [0.98-1.51],0.0819624267869208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2,Ataxin-2,18213,94,0.98 [0.82-1.18],0.8610548531206303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2L,Ataxin-2-like protein,18806,96,1.13 [0.76-1.68],0.5525815605194508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN3,Ataxin-3,18809,98,0.76 [0.55-1.04],0.0896092764823166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXIN1,Axin-1,21505,131,1.03 [0.87-1.21],0.7516378577317023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXL,Tyrosine-protein kinase receptor UFO,21671,132,0.91 [0.52-1.59],0.741382273467086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZI2,5-azacytidine-induced protein 2,18806,96,0.89 [0.61-1.28],0.5221288609566932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZU1,Azurocidin,20902,129,1.09 [0.90-1.32],0.3770550497519105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,18873,98,1.52 [1.04-2.20],0.0296108274185862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,18209,92,1.46 [0.58-3.67],0.4256128243234357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",18378,94,1.27 [0.74-2.19],0.3855497185573951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",21644,130,2.28 [1.34-3.88],0.0023534668460961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GAT1,"Beta-1,4-glucuronyltransferase 1",21578,131,1.02 [0.54-1.94],0.949936268618044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BABAM1,BRISC and BRCA1-A complex member 1,18284,95,0.92 [0.45-1.89],0.8258995552279729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BACH1,Transcription regulator protein BACH1,21505,131,0.97 [0.78-1.21],0.7981084834444613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG3,BAG family molecular chaperone regulator 3,21332,132,1.03 [0.71-1.50],0.8766500047933032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG4,BAG family molecular chaperone regulator 4,18284,95,0.89 [0.59-1.37],0.6056740443998874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG6,Large proline-rich protein BAG6,21144,129,1.05 [0.67-1.63],0.844573328933768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,21052,127,1.32 [1.05-1.65],0.0162314206617079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAMBI,BMP and activin membrane-bound inhibitor homolog,21052,127,1.63 [1.01-2.64],0.0466279159902048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BANK1,B-cell scaffold protein with ankyrin repeats,21505,131,0.98 [0.85-1.14],0.8069066991678497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAP18,Chromatin complexes subunit BAP18,18809,98,1.09 [0.84-1.41],0.5354333613361151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BATF,Basic leucine zipper transcriptional factor ATF-like,18334,92,0.93 [0.72-1.21],0.6007488410923392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAX,Apoptosis regulator BAX,21028,131,1.07 [0.90-1.27],0.4648992678990002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,21578,131,2.09 [1.15-3.82],0.0163310182761191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,21365,132,0.56 [0.36-0.87],0.0105747263637587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",18843,97,1.21 [0.64-2.26],0.557577163287853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",18213,94,0.72 [0.46-1.14],0.1612171037225874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,18516,96,0.50 [0.31-0.81],0.0050075263324241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2,Apoptosis regulator Bcl-2,18745,97,1.19 [0.89-1.60],0.2492572487416963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L1,Bcl-2-like protein 1,18809,98,0.98 [0.80-1.19],0.8041485495274165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",21505,131,1.04 [0.71-1.51],0.8509859479420941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L15,Bcl-2-like protein 15,18284,95,1.17 [0.85-1.60],0.3307971732930057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7A,B-cell CLL/lymphoma 7 protein family member A,18165,95,1.15 [0.87-1.53],0.3214478491339939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7B,B-cell CLL/lymphoma 7 protein family member B,18757,97,0.47 [0.27-0.83],0.00912569729568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCR,Breakpoint cluster region protein,21505,131,1.02 [0.86-1.21],0.8241032450419552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BDNF,Brain-derived neurotrophic factor,18852,99,0.95 [0.76-1.19],0.6583951184583285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BECN1,Beclin-1,18378,94,0.84 [0.59-1.20],0.3343791542665668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BEX3,Protein BEX3,18165,95,0.99 [0.64-1.54],0.9816597419364812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGLAP,Osteocalcin,18852,99,1.11 [0.89-1.38],0.3381335648925081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGN,Biglycan,21011,127,0.89 [0.78-1.02],0.1048839345260562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHLHE40,Class E basic helix-loop-helix protein 40,18213,94,0.91 [0.68-1.22],0.5402741520869258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,18209,92,0.89 [0.41-1.95],0.7755236338969748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BID,BH3-interacting domain death agonist,21505,131,1.14 [0.92-1.43],0.2332327938808124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIN2,Bridging integrator 2,21578,131,1.06 [0.89-1.26],0.5158793043501185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIRC2,Baculoviral IAP repeat-containing protein 2,21052,127,1.09 [0.85-1.40],0.4825247381579701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLMH,Bleomycin hydrolase,21821,134,1.21 [0.75-1.95],0.4242376666626887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLNK,B-cell linker protein,18284,95,0.84 [0.49-1.44],0.5287141699962783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,18213,94,0.92 [0.69-1.23],0.5685570535828544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,18809,98,0.91 [0.55-1.51],0.7158381002591139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLVRB,Flavin reductase,21578,131,0.93 [0.74-1.18],0.567523090564633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP10,Bone morphogenetic protein 10,18442,92,1.00 [0.49-2.02],0.9931241272152826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP4,Bone morphogenetic protein 4,21332,132,1.11 [0.79-1.55],0.5635234529077707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP6,Bone morphogenetic protein 6,21117,129,1.10 [0.75-1.63],0.6272708738260907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMPER,BMP-binding endothelial regulator protein,18442,92,1.75 [0.75-4.07],0.1922987125983759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,18843,97,0.93 [0.51-1.69],0.8034988510994019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,18284,95,1.06 [0.67-1.67],0.8011062155772675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOC,Brother of CDO,21144,129,1.82 [0.93-3.55],0.0807919685476738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA1,BolA-like protein 1,18213,94,1.14 [0.80-1.61],0.4731237882838391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA2_BOLA2B,BolA-like protein 2,18378,94,0.67 [0.46-0.97],0.0329683871670879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFA2,BPI fold-containing family A member 2,17729,92,0.97 [0.81-1.16],0.7263403081190465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB1,BPI fold-containing family B member 1,21498,133,1.21 [0.95-1.54],0.1167166128020872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB2,BPI fold-containing family B member 2,18800,97,1.13 [0.86-1.48],0.3868628787680555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRAP,BRCA1-associated protein,18589,97,0.96 [0.80-1.15],0.6314000732728139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD1,Bromodomain-containing protein 1,18501,97,0.66 [0.32-1.36],0.263094959822799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD2,Bromodomain-containing protein 2,18213,94,0.72 [0.37-1.39],0.3299122472804905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD3,Bromodomain-containing protein 3,18209,92,1.35 [1.01-1.80],0.0408198039107777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRDT,Bromodomain testis-specific protein,18209,92,0.95 [0.55-1.65],0.8640998038856452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRK1,Protein BRICK1,21055,131,1.29 [0.92-1.81],0.1427430814990869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRME1,Break repair meiotic recombinase recruitment factor 1,18213,94,1.01 [0.63-1.64],0.962504442171803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRSK2,Serine/threonine-protein kinase BRSK2,18806,96,1.04 [0.61-1.77],0.8740795465207453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,21736,131,2.98 [1.47-6.05],0.0025158314762113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSND,Barttin,18165,95,1.18 [0.70-1.98],0.5335757009638498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,21734,134,1.36 [0.91-2.02],0.135786180477253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST2,Bone marrow stromal antigen 2,21734,134,1.14 [0.84-1.53],0.3998250932513519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTC,Probetacellulin,21052,127,1.10 [0.89-1.35],0.3733049890430691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTD,Biotinidase,18873,98,0.69 [0.27-1.72],0.4222790387575765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTLA,B- and T-lymphocyte attenuator,18165,95,0.95 [0.74-1.21],0.676462316854259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN1A1,Butyrophilin subfamily 1 member A1,18720,97,1.29 [0.86-1.94],0.2095712605753491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN2A1,Butyrophilin subfamily 2 member A1,21644,130,1.83 [1.08-3.10],0.023529741893472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN3A2,Butyrophilin subfamily 3 member A2,21505,131,1.39 [0.97-2.00],0.0767834401179617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTNL10,Butyrophilin-like protein 10,18165,95,1.19 [0.81-1.75],0.3682418944586506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C19orf12,Protein C19orf12,21055,131,1.23 [1.00-1.50],0.049473859556395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1GALT1C1,C1GALT1-specific chaperone 1,18209,92,1.25 [0.71-2.19],0.439667819539243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,21668,131,2.87 [1.51-5.45],0.0012850694938907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",18806,96,0.86 [0.62-1.19],0.374426662503221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QL2,Complement C1q-like protein 2,18284,95,0.76 [0.47-1.22],0.2497918487686344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,21671,132,1.13 [0.79-1.62],0.500519244568936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,18442,92,1.08 [0.63-1.86],0.7771388713596543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,18806,96,0.73 [0.37-1.41],0.3487966639577146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,18406,92,0.84 [0.56-1.24],0.371288545450893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1R,Complement C1r subcomponent,18873,98,1.97 [0.91-4.25],0.0853168920869146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1RL,Complement C1r subcomponent-like protein,18837,97,1.28 [0.47-3.49],0.6333027521877699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1S,Complement C1s subcomponent,18873,98,1.09 [0.43-2.77],0.8526226542105385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2,Complement C2,21625,132,1.09 [0.55-2.16],0.8040153794721476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2CD2L,Phospholipid transfer protein C2CD2L,21022,131,1.17 [0.82-1.67],0.3807543526918397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2orf69,UPF0565 protein C2orf69,18334,92,1.02 [0.73-1.43],0.9182196944090544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C3,Complement C3,17894,95,1.53 [1.10-2.12],0.0121041730853322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C4BPB,C4b-binding protein beta chain,21637,130,1.14 [0.78-1.69],0.4953834041296957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C5,Complement C5,18873,98,3.59 [1.09-11.84],0.0358253642555266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,18398,97,3.71 [2.09-6.58],7.626293858884979e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7orf50,Uncharacterized protein C7orf50,18809,98,0.77 [0.29-2.00],0.5882242359121225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C8B,Complement component C8 beta chain,18873,98,1.14 [0.60-2.16],0.6894930289064956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9,Complement component C9,18856,97,1.07 [0.75-1.52],0.7247088121290447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9orf40,Uncharacterized protein C9orf40,18745,97,0.86 [0.68-1.10],0.2294296154966208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA1,Carbonic anhydrase 1,21110,129,0.97 [0.75-1.26],0.821555340749108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA11,Carbonic anhydrase-related protein 11,21052,127,0.75 [0.42-1.35],0.3394276043699652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,21446,131,1.98 [1.28-3.07],0.0022931884020044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA13,Carbonic anhydrase 13,21338,130,1.07 [0.92-1.25],0.3538421883973383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA14,Carbonic anhydrase 14,21724,133,0.85 [0.55-1.31],0.4569031317428832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA2,Carbonic anhydrase 2,21500,130,1.03 [0.83-1.28],0.7881882839353347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA3,Carbonic anhydrase 3,21785,134,1.24 [0.97-1.58],0.0832281171056494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA4,Carbonic anhydrase 4,21821,134,1.03 [0.55-1.92],0.9337019280789076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA5A,"Carbonic anhydrase 5A, mitochondrial",21144,129,1.05 [0.88-1.24],0.5858121002957997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA6,Carbonic anhydrase 6,21516,131,0.86 [0.67-1.11],0.2525879924913364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA7,Carbonic anhydrase 7,18501,97,0.53 [0.28-1.03],0.0618043050158496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA8,Carbonic anhydrase-related protein,18284,95,1.60 [1.06-2.40],0.025157164123623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA9,Carbonic anhydrase 9,21724,133,1.20 [0.89-1.62],0.2374353629002807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CABP2,Calcium-binding protein 2,18334,92,0.83 [0.59-1.18],0.3089652919274461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,18213,94,0.57 [0.28-1.16],0.1191682158189991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,18209,92,0.79 [0.51-1.22],0.289427806252752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,18213,94,0.94 [0.67-1.33],0.7342475075504689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,18806,96,1.17 [0.93-1.48],0.1750706332430728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACYBP,Calcyclin-binding protein,18414,92,0.98 [0.80-1.19],0.8124114934335451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CADPS,Calcium-dependent secretion activator 1,18334,92,0.88 [0.52-1.49],0.6288832227604887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,21446,131,1.66 [1.19-2.31],0.0028200397332634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB2,Calretinin,21055,131,1.38 [0.99-1.92],0.0557587356487864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCA,Calcitonin,21332,132,1.07 [0.85-1.35],0.5552330712002924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCB,Calcitonin gene-related peptide 2,18809,98,1.30 [0.87-1.93],0.2042337869639252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,21650,133,0.98 [0.84-1.14],0.8132127437090837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,18378,94,0.91 [0.69-1.20],0.507398299787261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALY,Neuron-specific vesicular protein calcyon,18209,92,1.10 [0.66-1.82],0.7212788721316914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,21052,127,1.42 [1.02-1.97],0.0376380645795202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,18334,92,1.14 [0.81-1.62],0.4468839499183565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,18806,96,0.96 [0.80-1.16],0.668638362525811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CANT1,Soluble calcium-activated nucleotidase 1,21480,132,1.58 [0.75-3.35],0.2285114918858493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,21362,132,1.32 [1.03-1.69],0.0270931300921073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPN3,Calpain-3,18757,97,1.16 [0.72-1.87],0.5293339971206783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPS,Calcyphosin,18809,98,0.99 [0.82-1.21],0.9582270828730264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CARHSP1,Calcium-regulated heat-stable protein 1,21055,131,0.96 [0.71-1.29],0.7843151051358862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASC3,Protein CASC3,18334,92,0.90 [0.55-1.49],0.6880320385423541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP1,Caspase-1,21055,131,1.07 [0.87-1.33],0.5130273717486323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP10,Caspase-10,21055,131,1.10 [0.88-1.37],0.4022245145784833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP2,Caspase-2,21505,131,1.04 [0.83-1.31],0.7269168121830163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP3,Caspase-3,21821,134,1.04 [0.87-1.24],0.6598768903763172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP4,Caspase-4,18501,97,1.05 [0.94-1.16],0.4155444110612961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP7,Caspase-7,18809,98,0.92 [0.73-1.17],0.4941003265697625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP8,Caspase-8,21652,133,1.09 [0.85-1.39],0.4884375902415047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP9,Caspase-9,18284,95,1.05 [0.76-1.45],0.7669629908746642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASQ2,Calsequestrin-2,18209,92,1.11 [0.76-1.63],0.5760953964639495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAT,Catalase,18593,96,0.74 [0.51-1.08],0.1170438091485344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLIF,Cobalamin binding intrinsic factor,21515,132,1.21 [0.99-1.47],0.0563774918509091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN1,Cerebellin-1,18213,94,0.92 [0.72-1.17],0.4903878721481729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN4,Cerebellin-4,21724,133,0.67 [0.42-1.07],0.0965411321956384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBS,Cystathionine beta-synthase,18378,94,0.84 [0.55-1.28],0.4245361635155205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBX2,Chromobox protein homolog 2,18209,92,1.21 [0.79-1.85],0.383838680796338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,21365,132,1.05 [0.85-1.30],0.6324757863178914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCAR2,Cell cycle and apoptosis regulator protein 2,18809,98,0.84 [0.54-1.29],0.4169914941274986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC134,Coiled-coil domain-containing protein 134,18757,97,1.52 [1.10-2.09],0.0116291437811523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC28A,Coiled-coil domain-containing protein 28A,18334,92,1.06 [0.54-2.09],0.8687181741601623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC50,Coiled-coil domain-containing protein 50,18806,96,1.20 [0.96-1.48],0.1032742392850751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,21557,132,2.04 [1.42-2.92],0.0001065731786827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,18378,94,1.35 [1.01-1.82],0.04413525203132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,21768,132,1.61 [1.06-2.45],0.0240197118166043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL13,C-C motif chemokine 13,21734,132,1.08 [0.86-1.34],0.5153199096958936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,21526,132,1.60 [1.16-2.19],0.0036760730358458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL15,C-C motif chemokine 15,21821,134,1.41 [1.02-1.95],0.0391676367877525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL16,C-C motif chemokine 16,21821,134,1.40 [1.03-1.92],0.0326454319585622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL17,C-C motif chemokine 17,21519,130,1.22 [1.03-1.44],0.0198504784550179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL18,C-C motif chemokine 18,21274,130,1.07 [0.86-1.34],0.5249937631869264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL19,C-C motif chemokine 19,21734,134,1.04 [0.93-1.16],0.5396830399531403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL2,C-C motif chemokine 2,21332,132,1.09 [0.82-1.45],0.5462604976844869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL20,C-C motif chemokine 20,21768,132,1.18 [1.02-1.36],0.0300254933513909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,21644,130,1.47 [1.11-1.93],0.0066909683558622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,21363,130,1.42 [1.08-1.86],0.0113311286537455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,21644,130,1.77 [1.24-2.54],0.0016797063213594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL24,C-C motif chemokine 24,21610,130,1.05 [0.88-1.27],0.5740785486008959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,21768,132,1.57 [1.15-2.15],0.0048455947740274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL26,C-C motif chemokine 26,21505,131,0.93 [0.78-1.11],0.4344470327769614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL27,C-C motif chemokine 27,21557,132,0.95 [0.73-1.23],0.7052585941813703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL28,C-C motif chemokine 28,21429,131,1.31 [1.03-1.67],0.0283737291669666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL3,C-C motif chemokine 3,21505,131,1.13 [0.90-1.41],0.2909241267111377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL4,C-C motif chemokine 4,21581,130,1.20 [1.01-1.44],0.041860452774761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL5,C-C motif chemokine 5,21671,132,1.04 [0.89-1.21],0.6174798348549431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL7,C-C motif chemokine 7,21505,131,1.20 [0.95-1.52],0.1284081754470093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL8,C-C motif chemokine 8,21690,133,1.17 [0.90-1.51],0.2374397255550013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN1,CCN family member 1,21405,131,1.13 [0.91-1.40],0.2824225547060794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN2,CCN family member 2,21528,129,1.28 [0.97-1.69],0.0792706642464454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,21786,134,1.82 [1.22-2.71],0.0035561194553182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN4,CCN family member 4,21724,133,1.21 [0.83-1.77],0.3230612693178259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,21578,131,1.85 [1.25-2.72],0.0019578512268222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCND2,G1/S-specific cyclin-D2,18501,97,1.40 [0.81-2.42],0.2231325064994524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCNE1,G1/S-specific cyclin-E1,18284,95,0.75 [0.52-1.07],0.113398207537771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCS,Copper chaperone for superoxide dismutase,21365,132,0.91 [0.66-1.27],0.5811630983789113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCT5,T-complex protein 1 subunit epsilon,21052,127,1.23 [0.88-1.73],0.2212693657228651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD101,Immunoglobulin superfamily member 2,18745,97,1.01 [0.64-1.59],0.9599871586381996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD109,CD109 antigen,21578,131,1.15 [0.72-1.84],0.5514944629563225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,21172,130,1.52 [1.07-2.16],0.0186065928092687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD160,CD160 antigen,21768,132,1.16 [0.85-1.58],0.3564070192802597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD163,Scavenger receptor cysteine-rich type 1 protein M130,21671,132,0.93 [0.65-1.34],0.7037654343623821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164,Sialomucin core protein 24,21578,131,1.46 [0.98-2.16],0.0611032625010587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164L2,CD164 sialomucin-like 2 protein,18334,92,1.05 [0.60-1.81],0.8744731714190976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD177,CD177 antigen,21543,131,1.02 [0.91-1.16],0.695910085894475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD1C,T-cell surface glycoprotein CD1c,21637,130,0.67 [0.37-1.24],0.2070579018587235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2,T-cell surface antigen CD2,18209,92,1.02 [0.61-1.70],0.9486641175772396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200,OX-2 membrane glycoprotein,21505,131,1.23 [0.71-2.14],0.4615589935447379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200R1,Cell surface glycoprotein CD200 receptor 1,21444,131,0.73 [0.47-1.15],0.1752130428280633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD207,C-type lectin domain family 4 member K,21067,128,1.43 [0.96-2.12],0.0781599545707229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD209,CD209 antigen,21629,132,1.13 [0.76-1.67],0.5515493286728512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD22,B-cell receptor CD22,21768,132,0.73 [0.51-1.04],0.0829173411382056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD226,CD226 antigen,18284,95,1.01 [0.63-1.61],0.9796977270855214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD244,Natural killer cell receptor 2B4,21768,132,1.29 [0.74-2.27],0.3712549590151714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD248,Endosialin,18852,99,0.92 [0.57-1.49],0.735804180976362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,21637,130,1.64 [1.18-2.29],0.0032948773618679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,21365,132,1.72 [1.16-2.53],0.0067214020809009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,21549,130,2.61 [1.69-4.03],1.5304585871564e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD28,T-cell-specific surface glycoprotein CD28,21052,127,1.23 [0.83-1.82],0.2947022129262172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2AP,CD2-associated protein,21557,132,0.95 [0.74-1.21],0.682365348347511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300A,CMRF35-like molecule 8,18442,92,1.03 [0.53-1.99],0.9369480469036868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300C,CMRF35-like molecule 6,21734,134,1.40 [0.92-2.12],0.1155795431387774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300E,CMRF35-like molecule 2,21655,133,1.33 [0.93-1.89],0.1179372650556927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LF,CMRF35-like molecule 1,21724,133,1.12 [0.86-1.45],0.3956472766193865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LG,CMRF35-like molecule 9,21578,131,1.31 [0.88-1.96],0.1872712649740655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,21446,131,2.15 [1.40-3.32],0.0004894008978987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD33,Myeloid cell surface antigen CD33,21637,130,0.95 [0.79-1.15],0.608379448574514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD34,Hematopoietic progenitor cell antigen CD34,21671,134,0.84 [0.44-1.59],0.5869550004525923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD36,Platelet glycoprotein 4,18284,95,1.37 [0.90-2.09],0.137309036138129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,21446,131,0.95 [0.59-1.52],0.8357773454613922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3D,T-cell surface glycoprotein CD3 delta chain,18213,94,1.00 [0.57-1.77],0.9907637429294286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3E,T-cell surface glycoprotein CD3 epsilon chain,18501,97,0.72 [0.37-1.37],0.3121947542267956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3G,T-cell surface glycoprotein CD3 gamma chain,18284,95,0.85 [0.64-1.13],0.2695843688790311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD4,T-cell surface glycoprotein CD4,21470,131,1.39 [0.91-2.14],0.126715360220212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40,Tumor necrosis factor receptor superfamily member 5,21547,130,1.30 [0.96-1.76],0.0852425340988386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40LG,CD40 ligand,21768,132,1.09 [0.89-1.32],0.3952178745246623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD46,Membrane cofactor protein,21458,132,1.36 [0.81-2.28],0.2447322991486646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD48,CD48 antigen,21610,130,1.62 [0.99-2.66],0.0554085835705152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5,T-cell surface glycoprotein CD5,21690,133,1.22 [0.81-1.83],0.3447729421629685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD55,Complement decay-accelerating factor,20839,125,1.23 [0.69-2.18],0.4888645014131973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD58,Lymphocyte function-associated antigen 3,21520,130,1.15 [0.48-2.79],0.7507744858507803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,20823,128,2.04 [1.17-3.56],0.0120212985981954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,18772,98,1.32 [0.88-1.97],0.180424076081765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD6,T-cell differentiation antigen CD6,21736,131,0.83 [0.62-1.11],0.2049438035253456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD63,CD63 antigen,21332,132,1.09 [0.80-1.48],0.5907648486816821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD69,Early activation antigen CD69,21465,132,1.06 [0.89-1.26],0.533189802525351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,18239,95,1.48 [0.98-2.24],0.0615332946218184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD70,CD70 antigen,21505,131,1.22 [0.85-1.73],0.2751014023130459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD72,B-cell differentiation antigen CD72,18442,92,0.82 [0.51-1.31],0.4043363691573618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,21734,134,1.76 [1.16-2.67],0.0074831850658636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,21768,132,1.50 [1.11-2.02],0.0084984604648995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD80,T-lymphocyte activation antigen CD80,18843,97,0.93 [0.52-1.65],0.7938043801653178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD82,CD82 antigen,18501,97,1.20 [0.79-1.83],0.3916792353391034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD83,CD83 antigen,21505,131,1.06 [0.68-1.67],0.7867546969746779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD84,SLAM family member 5,21505,131,1.00 [0.61-1.64],0.9915246327275132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD86,T-lymphocyte activation antigen CD86,18745,97,0.66 [0.35-1.24],0.1974891487387118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD8A,T-cell surface glycoprotein CD8 alpha chain,21734,134,0.88 [0.66-1.19],0.4140290738822521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD93,Complement component C1q receptor,20791,122,1.40 [0.85-2.31],0.1822164906781458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,21578,131,2.66 [1.30-5.45],0.0076245857109063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99L2,CD99 antigen-like protein 2,21578,131,1.65 [0.88-3.09],0.1188908904832674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDA,Cytidine deaminase,18806,97,0.88 [0.58-1.34],0.556063337941861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDAN1,Codanin-1,18809,98,0.89 [0.38-2.09],0.781893586210256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC123,Cell division cycle protein 123 homolog,18165,95,1.00 [0.73-1.36],0.9833791737170032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC25A,M-phase inducer phosphatase 1,18165,95,1.01 [0.60-1.71],0.9723304062563008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC26,Anaphase-promoting complex subunit CDC26,18701,97,1.04 [0.78-1.39],0.7908488779716858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC27,Cell division cycle protein 27 homolog,21052,127,1.06 [0.82-1.38],0.6525331447710103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC37,Hsp90 co-chaperone Cdc37,21637,130,1.12 [0.93-1.35],0.2411001251511442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC42BPB,Serine/threonine-protein kinase MRCK beta,18745,97,0.96 [0.79-1.16],0.6588373220990247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDCP1,CUB domain-containing protein 1,21365,132,1.00 [0.75-1.33],0.9948996272628716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH1,Cadherin-1,20878,125,1.40 [0.98-1.99],0.0639895209709749
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH15,Cadherin-15,21701,134,1.25 [1.02-1.54],0.0292355260807674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH17,Cadherin-17,21557,132,0.99 [0.79-1.24],0.93978573948351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH2,Cadherin-2,21557,132,1.28 [0.83-1.98],0.2697148348616662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH22,Cadherin-22,18501,97,0.66 [0.31-1.40],0.2799154259393667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH23,Cadherin-23,18809,98,0.54 [0.25-1.16],0.1131762711793142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH3,Cadherin-3,21734,134,1.41 [0.95-2.09],0.0897279668438212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH4,Cadherin-4,18213,94,0.80 [0.51-1.27],0.3476496680341531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH5,Cadherin-5,21821,134,1.16 [0.71-1.92],0.5512537873856108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,21557,132,1.67 [1.14-2.45],0.0080943357377836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR1,Cadherin-related family member 1,21055,131,0.79 [0.53-1.18],0.2464573358950629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR2,Cadherin-related family member 2,21446,131,1.07 [0.85-1.35],0.5734300692943148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR5,Cadherin-related family member 5,21557,132,0.83 [0.56-1.22],0.3427315779273711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK1,Cyclin-dependent kinase 1,18165,95,1.45 [0.85-2.47],0.1724045371590808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,18806,96,1.06 [0.76-1.46],0.747343498828898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKL5,Cyclin-dependent kinase-like 5,18213,94,0.92 [0.62-1.37],0.6833066401330765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN1A,Cyclin-dependent kinase inhibitor 1,21446,131,1.09 [0.95-1.27],0.2268050386746922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,21446,131,1.09 [0.92-1.29],0.3011331505003409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDNF,Cerebral dopamine neurotrophic factor,21446,131,1.34 [0.90-1.99],0.1495916996811933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,21582,130,1.45 [0.79-2.68],0.2335204019910496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDSN,Corneodesmosin,21702,131,1.47 [1.04-2.07],0.030909405556849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,21600,130,2.00 [0.97-4.11],0.0599062573199402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,18745,97,0.83 [0.65-1.06],0.1389257116831074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,18501,97,0.86 [0.62-1.19],0.3653381841559127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,18745,97,1.38 [0.86-2.22],0.1813077848680304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,18501,97,1.12 [0.74-1.70],0.6010552286757775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,21505,131,1.16 [0.98-1.38],0.0845613012780394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,21052,127,1.14 [0.83-1.55],0.4145157674362634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,20803,127,1.13 [0.89-1.44],0.3098143756388105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,18852,99,1.37 [0.95-1.97],0.0886704575241534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,21144,129,1.53 [1.15-2.02],0.003288164742897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPA,CCAAT/enhancer-binding protein alpha,18284,95,0.79 [0.41-1.52],0.4824683847923604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPB,CCAAT/enhancer-binding protein beta,21144,129,1.37 [0.94-2.00],0.1035950366659043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA2A,Chymotrypsin-like elastase family member 2A,18852,99,1.14 [0.84-1.54],0.3936419783259572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA3A,Chymotrypsin-like elastase family member 3A,21787,134,1.06 [0.83-1.37],0.6327616744653748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,18442,92,1.06 [0.54-2.08],0.8612407955223975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEMIP2,Cell surface hyaluronidase,18284,95,0.68 [0.33-1.39],0.2942288566679067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEND1,Cell cycle exit and neuronal differentiation protein 1,18213,94,1.24 [0.98-1.58],0.0763942127861733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPF,Centromere protein F,18501,97,0.69 [0.47-1.01],0.0560507169527145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPJ,Centromere protein J,18501,97,0.86 [0.63-1.17],0.3236240101284184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP112,Centrosomal protein of 112 kDa,18209,92,1.05 [0.68-1.63],0.8169761135197948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP152,Centrosomal protein of 152 kDa,18165,95,1.04 [0.65-1.65],0.8759736435054659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP164,Centrosomal protein of 164 kDa,21136,129,0.94 [0.72-1.21],0.6182252487346347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP170,Centrosomal protein of 170 kDa,18378,94,0.91 [0.69-1.20],0.5044134629643652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP20,Centrosomal protein 20,21052,127,1.22 [1.00-1.50],0.0545215234693181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP290,Centrosomal protein of 290 kDa,18501,97,1.36 [1.05-1.77],0.0208839602039222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP350,Centrosome-associated protein 350,18165,95,0.92 [0.54-1.56],0.7449515007661385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP43,Centrosomal protein 43,20973,126,0.99 [0.79-1.26],0.9603710230782948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP85,Centrosomal protein of 85 kDa,21052,127,0.98 [0.76-1.27],0.8895550700450507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CERT,Ceramide transfer protein,21055,131,1.06 [0.82-1.37],0.6488750280574732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES1,Liver carboxylesterase 1,21632,134,0.90 [0.75-1.09],0.2824234854276383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES2,Cocaine esterase,21446,131,1.07 [0.81-1.41],0.6224657836968969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES3,Carboxylesterase 3,21446,131,0.91 [0.71-1.16],0.4368884741438973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN2,Centrin-2,21055,131,1.14 [0.91-1.43],0.2619631669762042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN3,Centrin-3,18745,97,1.01 [0.78-1.30],0.9616478240146674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFB,Complement factor B,18535,97,1.66 [0.90-3.07],0.1030853020485957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFC1,Cryptic protein,21052,127,1.12 [0.80-1.57],0.5165612979519603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,18873,98,2.21 [1.05-4.63],0.0364292057632295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFH,Complement factor H,17763,95,1.24 [0.52-2.97],0.6330702481948216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR2,Complement factor H-related protein 2,18726,98,0.93 [0.67-1.30],0.6852685067730975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR4,Complement factor H-related protein 4,18839,98,0.94 [0.72-1.22],0.6308111851687805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR5,Complement factor H-related protein 5,18608,96,1.24 [0.77-2.00],0.3808907154389278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFI,Complement factor I,18873,98,2.16 [0.80-5.86],0.1286385649628554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFP,Properdin,18873,98,0.90 [0.36-2.26],0.8175491959611266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGA,Glycoprotein hormones alpha chain,21578,131,1.15 [0.90-1.46],0.2623249755779589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,18856,97,0.94 [0.56-1.57],0.8046801986596727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGN,Cingulin,18334,92,0.86 [0.50-1.49],0.595089541078848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGREF1,Cell growth regulator with EF hand domain protein 1,21557,132,1.26 [0.88-1.79],0.2042467426326915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,21052,127,0.93 [0.71-1.22],0.5888686165608956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAD,Chondroadherin,18442,92,1.09 [0.72-1.63],0.6882451688008038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18809,98,2.03 [1.37-3.00],0.0003938290378859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD6,MICOS complex subunit MIC25,18757,97,1.56 [0.88-2.77],0.1288399842973721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHEK2,Serine/threonine-protein kinase Chk2,21144,129,0.81 [0.50-1.33],0.4081556803500316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGA,Chromogranin-A,18852,99,1.22 [1.02-1.45],0.0270523252010433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGB,Secretogranin-1,21669,134,1.41 [1.00-2.01],0.0525026983946897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,21131,129,1.30 [1.09-1.54],0.0028704029308158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHIT1,Chitotriosidase-1,21651,134,0.98 [0.89-1.07],0.5822594113455537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHL1,Neural cell adhesion molecule L1-like protein,21639,131,1.26 [0.76-2.08],0.3663234555021977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHM,Rab proteins geranylgeranyltransferase component A 1,18334,92,0.81 [0.58-1.15],0.2452520658723462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP1A,Charged multivesicular body protein 1a,21365,132,1.13 [0.92-1.38],0.2423000419100149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP6,Charged multivesicular body protein 6,18843,97,0.89 [0.63-1.27],0.5238301674000828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHP1,Calcineurin B homologous protein 1,18213,94,1.08 [0.84-1.39],0.5670712315531076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,21610,130,2.19 [1.37-3.48],0.0009836688082975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL2,Chordin-like protein 2,21557,132,1.16 [0.84-1.61],0.3621217778281612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRM1,Muscarinic acetylcholine receptor M1,18334,92,1.17 [0.72-1.91],0.5181042114123884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIAPIN1,Anamorsin,21637,130,1.15 [0.90-1.49],0.2697218403174157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CILP,Cartilage intermediate layer protein 1,18852,99,1.52 [1.04-2.22],0.0294055705031038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,18501,97,0.43 [0.24-0.77],0.0043282440755373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIRBP,Cold-inducible RNA-binding protein,18745,97,0.95 [0.78-1.17],0.6347390436565117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIT,Citron Rho-interacting kinase,18334,92,0.72 [0.44-1.17],0.1835295191120713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,21674,131,2.28 [1.52-3.42],6.118263444037152e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,18852,99,1.68 [1.22-2.31],0.0014879417735679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",21485,130,1.18 [0.93-1.50],0.1734323464459364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLASP1,CLIP-associating protein 1,18165,95,0.94 [0.71-1.24],0.6447760858688073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLC,Galectin-10,21519,132,1.21 [0.98-1.51],0.0829995008419878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC10A,C-type lectin domain family 10 member A,21365,132,0.80 [0.52-1.22],0.2944960295598132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,21545,131,1.52 [1.10-2.09],0.0105416401904358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC12A,C-type lectin domain family 12 member A,18284,95,0.72 [0.26-2.00],0.527594393339966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC14A,C-type lectin domain family 14 member A,21578,131,1.56 [0.99-2.44],0.0547407678859079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1A,C-type lectin domain family 1 member A,21144,129,1.42 [0.91-2.21],0.1223450563070148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1B,C-type lectin domain family 1 member B,21734,134,1.05 [0.89-1.23],0.5796343780848445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC2L,C-type lectin domain family 2 member L,18334,92,0.61 [0.35-1.06],0.080562067574269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC3B,Tetranectin,18423,97,0.46 [0.18-1.16],0.0993231809541469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4A,C-type lectin domain family 4 member A,21505,131,0.87 [0.56-1.34],0.5258577801309149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4C,C-type lectin domain family 4 member C,21505,131,0.70 [0.51-0.96],0.0286369396303068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,21505,131,1.32 [1.04-1.68],0.0211315357137634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4G,C-type lectin domain family 4 member G,21505,131,1.36 [0.86-2.16],0.1902118714108531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4M,C-type lectin domain family 4 member M,18817,99,0.83 [0.56-1.23],0.3498654758994582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,21495,132,1.94 [1.19-3.14],0.0074497824474115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC6A,C-type lectin domain family 6 member A,21052,127,1.27 [0.92-1.76],0.1441245942499167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC7A,C-type lectin domain family 7 member A,21768,132,1.06 [0.81-1.38],0.674084934442367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLGN,Calmegin,18334,92,0.95 [0.61-1.48],0.8138714216599585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIC5,Chloride intracellular channel protein 5,18334,92,0.84 [0.43-1.64],0.6089826900712706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLINT1,Clathrin interactor 1,18165,95,1.18 [0.83-1.68],0.3587846359301785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIP2,CAP-Gly domain-containing linker protein 2,21505,131,1.06 [0.92-1.22],0.4254625894665949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,21724,133,2.71 [1.44-5.11],0.0021009667732187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLNS1A,Methylosome subunit pICln,18334,92,0.60 [0.32-1.16],0.1296230257468148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",21332,132,1.06 [0.90-1.25],0.4736498120165254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPS,Colipase,21537,130,1.01 [0.81-1.25],0.9397008160819884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSPN,Claspin,21022,131,1.22 [0.85-1.74],0.2804366305298855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN1,Calsyntenin-1,21055,131,1.01 [0.75-1.35],0.9729565052275316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,21768,132,2.18 [1.63-2.93],1.9848293357207746e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN3,Calsyntenin-3,18809,98,1.24 [0.67-2.32],0.4920461825182998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLTA,Clathrin light chain A,21144,129,1.13 [0.82-1.56],0.4637632751282341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,18873,98,1.57 [1.06-2.32],0.0250610930213736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLUL1,Clusterin-like protein 1,21523,132,1.06 [0.75-1.49],0.7313230619626789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMC1,COX assembly mitochondrial protein homolog,18843,97,0.97 [0.78-1.21],0.8006566020905521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMIP,C-Maf-inducing protein,18757,97,0.98 [0.78-1.25],0.8945718455933878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNDP1,Beta-Ala-His dipeptidase,21671,132,1.02 [0.73-1.42],0.9058093454441972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNGB3,Cyclic nucleotide-gated cation channel beta-3,18213,94,0.63 [0.38-1.04],0.0704082385997785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",18344,94,0.88 [0.68-1.14],0.3314705202101681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY2,Protein canopy homolog 2,21144,129,1.06 [0.83-1.34],0.6441850127242943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY4,Protein canopy homolog 4,21446,131,1.16 [0.95-1.43],0.151589308652887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNST,Consortin,21557,132,1.00 [0.87-1.15],0.9743476644257044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTF,Ciliary neurotrophic factor,18213,94,0.84 [0.47-1.50],0.5554092389754566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN1,Contactin-1,21821,134,1.50 [0.86-2.64],0.155422436796112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN2,Contactin-2,21724,133,1.24 [0.88-1.74],0.2203096287167985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN3,Contactin-3,21578,131,0.89 [0.53-1.48],0.6467789750205897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN4,Contactin-4,21578,131,1.50 [0.79-2.88],0.2183112425200322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN5,Contactin-5,21601,134,0.80 [0.53-1.20],0.2802989264131265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP2,Contactin-associated protein-like 2,21505,131,1.24 [0.87-1.77],0.2390097274210844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP4,Contactin-associated protein-like 4,18334,92,1.06 [0.88-1.26],0.5505292138051346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COCH,Cochlin,18843,97,0.93 [0.61-1.42],0.7346638720019457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL15A1,Collagen alpha-1(XV) chain,18852,99,1.45 [0.74-2.85],0.282624600431711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,21667,133,3.92 [2.13-7.23],1.1825390975299397e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL1A1,Collagen alpha-1(I) chain,21821,134,1.54 [0.84-2.83],0.1663337634515352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL24A1,Collagen alpha-1(XXIV) chain,18745,97,1.26 [0.88-1.79],0.2035255122316744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL28A1,Collagen alpha-1(XXVIII) chain,18334,92,0.83 [0.64-1.09],0.1749479299293986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL2A1,Collagen alpha-1(II) chain,18378,94,0.90 [0.70-1.16],0.421880368121361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL3A1,Collagen alpha-1(III) chain,18852,99,1.49 [0.68-3.28],0.3212781245560203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,21557,132,2.09 [1.47-2.98],4.005678747298759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A4,Collagen alpha-4(IV) chain,18471,97,0.87 [0.62-1.22],0.4095356248028287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL5A1,Collagen alpha-1(V) chain,18442,92,1.10 [0.67-1.80],0.7081400557252825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,21821,134,2.16 [1.51-3.09],2.819567932499156e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A1,Collagen alpha-1(IX) chain,21505,131,1.22 [0.90-1.67],0.2020809893235384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A2,Collagen alpha-2(IX) chain,18501,97,1.13 [0.75-1.71],0.5672240364658443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,21549,130,2.33 [1.39-3.92],0.0013652071972806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD1,COMM domain-containing protein 1,18378,94,0.95 [0.68-1.34],0.7872370229997632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD9,COMM domain-containing protein 9,18757,97,0.84 [0.50-1.41],0.4996053829161252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMP,Cartilage oligomeric matrix protein,21338,128,1.05 [0.66-1.67],0.8412929294533533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMT,Catechol O-methyltransferase,20928,128,1.08 [0.89-1.31],0.4185736296357425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPB2,Coatomer subunit beta',18209,92,1.21 [0.80-1.85],0.3695650127178521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPE,Coatomer subunit epsilon,21055,131,0.88 [0.62-1.26],0.4979601536900498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",18378,94,1.21 [0.79-1.87],0.3830116199518298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO1A,Coronin-1A,21111,127,1.10 [0.93-1.30],0.2688596094161942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,18213,94,1.84 [1.23-2.76],0.0031006191405184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",21446,131,1.19 [0.96-1.48],0.1028826608072645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX6B1,Cytochrome c oxidase subunit 6B1,18843,97,1.02 [0.56-1.85],0.9580297595075952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA1,Carboxypeptidase A1,21821,134,1.10 [0.86-1.40],0.4437281757096538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA2,Carboxypeptidase A2,21671,134,1.15 [0.92-1.44],0.2199571751148059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA4,Carboxypeptidase A4,18080,91,1.07 [0.67-1.73],0.7764335588784679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB1,Carboxypeptidase B,21821,134,1.02 [0.79-1.31],0.904731782476646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB2,Carboxypeptidase B2,18841,98,1.14 [0.47-2.72],0.7761877882952523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPE,Carboxypeptidase E,21535,133,1.08 [0.72-1.61],0.7214300359721126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPLX2,Complexin-2,18165,95,0.53 [0.27-1.07],0.0782090200999071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPM,Carboxypeptidase M,21618,133,1.29 [0.83-2.00],0.2590323670458663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",18284,95,0.95 [0.45-1.98],0.8858340866825352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPPED1,Serine/threonine-protein phosphatase CPPED1,21734,134,1.03 [0.81-1.30],0.8312155644623868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPQ,Carboxypeptidase Q,18813,99,1.20 [0.70-2.06],0.5097455546434695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPTP,Ceramide-1-phosphate transfer protein,18209,92,1.16 [0.72-1.88],0.5457122965214605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPVL,Probable serine carboxypeptidase CPVL,21693,133,1.43 [0.97-2.11],0.0691676655064369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM1,Probable carboxypeptidase X1,21637,130,1.12 [0.90-1.39],0.3194291621813041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,18843,97,2.18 [1.32-3.61],0.0024390320137065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR1,Complement receptor type 1,18793,97,1.01 [0.58-1.75],0.9798765390415144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR2,Complement receptor type 2,21671,132,1.21 [0.88-1.66],0.2513901690138613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,21052,127,1.08 [0.90-1.30],0.384946011159423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRADD,Death domain-containing protein CRADD,21332,132,1.07 [0.87-1.32],0.5286439718131632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREB3,Cyclic AMP-responsive element-binding protein 3,18165,95,0.84 [0.56-1.24],0.3758416394869562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREBZF,CREB/ATF bZIP transcription factor,18165,95,1.29 [0.63-2.64],0.4807144271885993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREG1,Protein CREG1,21298,125,1.05 [0.71-1.57],0.8008382458772769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD1,Protein disulfide isomerase CRELD1,18442,92,1.30 [0.76-2.22],0.345444691560836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD2,Protein disulfide isomerase CRELD2,21610,130,1.22 [0.91-1.64],0.1887851925280731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRH,Corticoliberin,21016,127,1.01 [0.84-1.22],0.9091931329300244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHBP,Corticotropin-releasing factor-binding protein,21549,130,1.76 [1.00-3.08],0.0491966808876942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHR1,Corticotropin-releasing factor receptor 1,21144,129,1.01 [0.79-1.30],0.9192492782025518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,21644,130,2.73 [1.32-5.64],0.0067492714573531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,21365,132,1.68 [1.27-2.23],0.0003017630819965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP2,Cysteine-rich secretory protein 2,21724,133,1.01 [0.77-1.31],0.9675588609270948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP3,Cysteine-rich secretory protein 3,18692,96,0.57 [0.28-1.15],0.1166411576454207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRKL,Crk-like protein,21581,130,1.10 [0.95-1.28],0.2223234891620217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRLF1,Cytokine receptor-like factor 1,21644,130,1.84 [0.99-3.43],0.0550075190224058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRNN,Cornulin,20946,128,1.09 [0.86-1.36],0.4799303274882028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAC1,Cartilage acidic protein 1,21821,134,1.09 [0.66-1.82],0.7305562429886808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAM,Cytotoxic and regulatory T-cell molecule,21365,132,1.17 [0.87-1.59],0.2978919818848239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAP,Cartilage-associated protein,18334,92,0.87 [0.55-1.37],0.5463927697976899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRX,Cone-rod homeobox protein,21144,129,1.04 [0.90-1.19],0.6128316183401522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB1,Beta-crystallin B1,18843,97,0.94 [0.69-1.29],0.7165279192721896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB2,Beta-crystallin B2,18809,98,0.77 [0.55-1.08],0.1278502577397397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYGD,Gamma-crystallin D,18809,98,1.01 [0.82-1.23],0.9466650838878884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYM,Ketimine reductase mu-crystallin,18213,94,0.84 [0.62-1.14],0.2666787912808662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYZL1,Quinone oxidoreductase-like protein 1,18378,94,0.91 [0.73-1.13],0.3966636829925689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSDE1,Cold shock domain-containing protein E1,18209,92,0.91 [0.75-1.11],0.3521148558399466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,21644,130,2.65 [1.57-4.47],0.0002747777960278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1R,Macrophage colony-stimulating factor 1 receptor,18856,97,0.76 [0.47-1.25],0.2858045256815068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2,Granulocyte-macrophage colony-stimulating factor,18209,92,1.01 [0.58-1.76],0.9669290814986043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,21365,132,1.16 [0.91-1.48],0.2271145448488449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RB,Cytokine receptor common subunit beta,18284,95,0.79 [0.50-1.25],0.316707545818141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3,Granulocyte colony-stimulating factor,21136,129,0.95 [0.69-1.32],0.7772371792746162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3R,Granulocyte colony-stimulating factor receptor,18284,95,0.91 [0.46-1.81],0.7879817578655606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSH1,Chorionic somatomammotropin hormone 1,18856,97,0.70 [0.36-1.38],0.3077740247621001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK1D,Casein kinase I isoform delta,18284,95,0.85 [0.60-1.20],0.3524748682640454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK2A1,Casein kinase II subunit alpha,18806,96,0.84 [0.54-1.30],0.4262719503095971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG4,Chondroitin sulfate proteoglycan 4,18852,99,1.24 [0.69-2.22],0.468899354609245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG5,Chondroitin sulfate proteoglycan 5,18213,94,1.06 [0.72-1.56],0.7815266122881608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,18209,92,1.32 [1.12-1.54],0.000606110302237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST1,Cystatin-SN,16393,83,1.01 [0.82-1.25],0.9085329452406156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,21638,132,2.00 [1.25-3.21],0.0039026683825872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST5,Cystatin-D,21140,131,1.04 [0.79-1.37],0.7779381587221765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST6,Cystatin-M,20984,129,1.02 [0.74-1.39],0.9132556447070572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,21581,130,1.24 [1.10-1.40],0.0006118304789436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,21269,131,1.89 [1.36-2.63],0.0001418470152379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTAG1A_CTAG1B,Cancer/testis antigen 1,18472,97,0.83 [0.55-1.26],0.3881601777689351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTBS,Di-N-acetylchitobiase,18570,95,0.79 [0.38-1.66],0.540584873664047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTF1,Cardiotrophin-1,21144,129,1.02 [0.84-1.22],0.8646325298025996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTHRC1,Collagen triple helix repeat-containing protein 1,18852,99,1.29 [0.67-2.48],0.4411201800102374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTLA4,Cytotoxic T-lymphocyte protein 4,18852,99,0.76 [0.40-1.46],0.4181573787798026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTNNA1,Catenin alpha-1,18213,94,0.47 [0.21-1.04],0.0626926823836108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRB1,Chymotrypsinogen B,21578,131,1.09 [0.83-1.42],0.5281156990867357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRC,Chymotrypsin-C,21552,129,1.08 [0.85-1.36],0.5337058926178417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRL,Chymotrypsin-like protease CTRL-1,18809,98,0.95 [0.72-1.25],0.712047185533183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,21604,134,1.51 [1.16-1.96],0.0022102176989701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSC,Dipeptidyl peptidase 1,21508,128,1.05 [0.74-1.50],0.7758702672417321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSD,Cathepsin D,20235,121,1.14 [0.78-1.65],0.4983725767793655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSE,Cathepsin E,18442,92,0.86 [0.58-1.26],0.426146974091544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSF,Cathepsin F,21637,130,1.01 [0.68-1.50],0.9454961782415144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSH,Pro-cathepsin H,21067,128,1.10 [0.89-1.36],0.3645185689106698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSL,Cathepsin L1,21557,132,1.78 [0.97-3.26],0.0617038823136516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSO,Cathepsin O,21768,132,1.27 [0.78-2.07],0.3336263763926965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,16851,104,3.09 [1.47-6.48],0.0028104689415726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSV,Cathepsin L2,21650,133,0.83 [0.57-1.20],0.3208381297634582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSZ,Cathepsin Z,21614,131,1.27 [0.79-2.04],0.3158785203547177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CUZD1,CUB and zona pellucida-like domain-containing protein 1,18334,92,0.51 [0.26-0.99],0.0481886393357502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CWC15,Spliceosome-associated protein CWC15 homolog,18630,96,0.88 [0.61-1.26],0.4873982611960487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CX3CL1,Fractalkine,21365,132,1.51 [0.97-2.35],0.0649680807613947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,21505,131,1.40 [1.06-1.86],0.0190451867253626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL1,Growth-regulated alpha protein,21515,130,1.09 [0.93-1.27],0.2765357675000855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL10,C-X-C motif chemokine 10,21644,130,1.22 [0.98-1.51],0.0744180666343311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL11,C-X-C motif chemokine 11,21734,134,1.16 [0.97-1.38],0.09509382855703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL12,Stromal cell-derived factor 1,21136,129,1.22 [0.83-1.80],0.3036825473527813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL13,C-X-C motif chemokine 13,21734,134,1.16 [0.95-1.42],0.1461600502881594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL14,C-X-C motif chemokine 14,21136,129,1.13 [0.88-1.45],0.3324487144273708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,21793,134,2.45 [1.31-4.58],0.0051605692076659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,21768,132,1.47 [1.04-2.08],0.0276223173216218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL3,C-X-C motif chemokine 3,21547,130,1.08 [0.92-1.28],0.3505040407346051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL5,C-X-C motif chemokine 5,21491,132,1.02 [0.89-1.17],0.744630949592478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL6,C-X-C motif chemokine 6,21768,132,1.20 [0.98-1.46],0.076818453570085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL8,Interleukin-8,21397,132,1.26 [1.06-1.51],0.0102583119196921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,21644,130,1.36 [1.10-1.67],0.0040995408070819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5A,Cytochrome b5,18165,95,0.85 [0.63-1.16],0.3153386995335954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5R2,NADH-cytochrome b5 reductase 2,18548,97,1.26 [0.90-1.75],0.1741043479712251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",18209,92,0.93 [0.73-1.20],0.5873932691189105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTH3,Cytohesin-3,18165,95,1.17 [0.92-1.47],0.2018511357891734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTL1,Cytokine-like protein 1,18852,99,0.99 [0.46-2.14],0.9864630545730226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAAM1,Disheveled-associated activator of morphogenesis 1,18442,92,0.91 [0.71-1.16],0.4371109918997825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAB2,Disabled homolog 2,21724,133,1.04 [0.90-1.19],0.6042624170732778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAG1,Dystroglycan,21644,130,1.24 [0.89-1.73],0.2122788989218356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAND5,DAN domain family member 5,18284,95,1.28 [1.00-1.63],0.0466245138902102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPK2,Death-associated protein kinase 2,18284,95,1.13 [0.81-1.58],0.4590376132143663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,21505,131,1.05 [0.92-1.19],0.4825588262809284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DARS1,"Aspartate--tRNA ligase, cytoplasmic",21332,132,1.04 [0.84-1.29],0.7329202693501959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBH,Dopamine beta-hydroxylase,18819,97,1.05 [0.87-1.26],0.6064677105261236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBI,Acyl-CoA-binding protein,21481,130,1.25 [1.03-1.53],0.0274022232298867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBN1,Drebrin,18284,95,0.90 [0.59-1.36],0.6160119361597438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBNL,Drebrin-like protein,21644,130,1.08 [0.91-1.28],0.3962341380393261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",21637,130,1.38 [0.89-2.13],0.148143392375821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCC,Netrin receptor DCC,18334,92,0.30 [0.10-0.90],0.0312801178458522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCDC2C,Doublecortin domain-containing protein 2C,18165,95,0.96 [0.69-1.34],0.815312542354523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCLRE1C,Protein artemis,18165,95,0.63 [0.32-1.23],0.1763718262445144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCN,Decorin,21144,129,1.80 [0.97-3.34],0.0643050963768449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTD,Deoxycytidylate deaminase,18442,92,0.96 [0.77-1.18],0.67665733853826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN1,Dynactin subunit 1,21724,133,1.02 [0.80-1.30],0.8621318367777223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN2,Dynactin subunit 2,21446,131,0.99 [0.83-1.17],0.8687616671888695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN6,Dynactin subunit 6,21055,131,0.97 [0.78-1.21],0.7741821859797546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTPP1,dCTP pyrophosphatase 1,21557,132,1.45 [0.89-2.35],0.1340710964771057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D1,DCN1-like protein 1,18213,94,0.85 [0.63-1.16],0.3079649786513547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D2,DCN1-like protein 2,18165,95,1.11 [0.88-1.40],0.3628303142539982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCXR,L-xylulose reductase,21637,130,1.05 [0.78-1.40],0.7608632824661525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDA1,DET1- and DDB1-associated protein 1,18209,92,0.73 [0.41-1.31],0.2953151906395073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",21446,131,1.41 [1.02-1.95],0.0386491111802177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDC,Aromatic-L-amino-acid decarboxylase,21515,132,0.98 [0.70-1.36],0.8860258739172439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDHD2,Phospholipase DDHD2,18806,96,0.88 [0.65-1.20],0.4253445935720765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDI2,Protein DDI1 homolog 2,18442,92,0.84 [0.65-1.08],0.1777359094822458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,21734,134,2.72 [1.48-5.00],0.0013048597717636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDT,D-dopachrome decarboxylase,18852,99,0.88 [0.55-1.41],0.6083749622187635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX1,ATP-dependent RNA helicase DDX1,18745,97,1.05 [0.72-1.55],0.7952570616295255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX25,ATP-dependent RNA helicase DDX25,18334,92,0.79 [0.43-1.45],0.450323168315056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX39A,ATP-dependent RNA helicase DDX39A,18284,95,1.29 [0.63-2.67],0.484553144428462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX4,Probable ATP-dependent RNA helicase DDX4,18284,95,0.85 [0.56-1.28],0.4317198740027456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX53,Probable ATP-dependent RNA helicase DDX53,18334,92,0.87 [0.49-1.55],0.6435906860246823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX58,Antiviral innate immune response receptor RIG-I,21052,127,1.06 [0.82-1.39],0.6433913427711637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",21505,131,1.06 [0.90-1.24],0.5045551041574918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFA1_DEFA1B,Neutrophil defensin 1,21155,128,1.21 [0.93-1.57],0.1485023444096101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB103A_DEFB103B,Beta-defensin 103,18142,94,1.36 [0.95-1.94],0.092708881672657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB104A_DEFB104B,Beta-defensin 104,18213,94,1.03 [0.72-1.47],0.8819387696305806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB116,Beta-defensin 116,18213,94,1.02 [0.78-1.33],0.8959373442757305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,18213,94,1.37 [1.11-1.70],0.0036014358985208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB4A_DEFB4B,Beta-defensin 4A,21267,131,1.07 [0.96-1.18],0.2254026445665201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENND2B,DENN domain-containing protein 2B,18209,92,0.98 [0.65-1.48],0.919497018552065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENR,Density-regulated protein,18284,95,0.90 [0.63-1.30],0.5903558111546654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DFFA,DNA fragmentation factor subunit alpha,21768,132,1.11 [0.88-1.39],0.3917099449158289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGCR6,Protein DGCR6,18213,94,0.85 [0.50-1.43],0.5399452165593513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKA,Diacylglycerol kinase alpha,18284,95,1.06 [0.74-1.53],0.7475922866437816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKZ,Diacylglycerol kinase zeta,21136,129,1.03 [0.66-1.60],0.903047559869144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHODH,Dihydroorotate dehydrogenase,18209,92,1.24 [0.86-1.77],0.2496889595599188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHPS,Deoxyhypusine synthase,18757,97,0.96 [0.59-1.56],0.8710637497965812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,18809,98,1.00 [0.66-1.50],0.9819933887363024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIABLO,"Diablo homolog, mitochondrial",21495,132,1.06 [0.92-1.22],0.3941146176147011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK1C,Divergent protein kinase domain 1C,18334,92,1.01 [0.63-1.62],0.9747573187479028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK2B,Divergent protein kinase domain 2B,18442,92,0.72 [0.35-1.50],0.382715135523432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK1,Dickkopf-related protein 1,21734,134,1.06 [0.81-1.37],0.6766925777673396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK3,Dickkopf-related protein 3,21821,134,1.81 [1.10-2.98],0.0187607794370977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK4,Dickkopf-related protein 4,21335,132,1.31 [0.96-1.79],0.0873259277074635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKKL1,Dickkopf-like protein 1,21446,131,1.21 [0.99-1.47],0.0584400729411563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLG4,Disks large homolog 4,18809,98,0.78 [0.58-1.04],0.0922870590296232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLGAP5,Disks large-associated protein 5,18806,96,0.98 [0.67-1.44],0.9112162632793688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLK1,Protein delta homolog 1,21821,134,0.89 [0.68-1.18],0.4263073079996362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,21637,130,2.11 [1.32-3.37],0.0017200562135048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL4,Delta-like protein 4,18378,94,1.01 [0.82-1.25],0.906605497241662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMD,Dystrophin,18378,94,1.35 [0.97-1.88],0.075179504305196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMP1,Dentin matrix acidic phosphoprotein 1,18378,94,0.84 [0.61-1.15],0.2695127112369754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA1,DnaJ homolog subfamily A member 1,18165,95,0.81 [0.50-1.31],0.384250313911645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA2,DnaJ homolog subfamily A member 2,21706,132,1.02 [0.84-1.23],0.8320884620739748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA4,DnaJ homolog subfamily A member 4,18809,98,0.79 [0.60-1.04],0.0967209291597652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB1,DnaJ homolog subfamily B member 1,21446,131,1.03 [0.86-1.23],0.7481978177855049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB14,DnaJ homolog subfamily B member 14,18745,97,1.01 [0.74-1.38],0.9296242640018204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB2,DnaJ homolog subfamily B member 2,18442,92,0.71 [0.48-1.04],0.0803854734805706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB6,DnaJ homolog subfamily B member 6,18276,91,0.98 [0.77-1.25],0.8591849519231614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB8,DnaJ homolog subfamily B member 8,21144,129,1.01 [0.77-1.33],0.927878540068243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC21,DnaJ homolog subfamily C member 21,18809,98,0.76 [0.44-1.31],0.3225168857466475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC6,Putative tyrosine-protein phosphatase auxilin,18378,94,0.90 [0.70-1.14],0.3807832433963584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC9,DnaJ homolog subfamily C member 9,18745,97,0.88 [0.68-1.14],0.3503351949734578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNER,Delta and Notch-like epidermal growth factor-related receptor,21510,129,1.17 [0.63-2.16],0.6139360522704056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNLZ,DNL-type zinc finger protein,18213,94,1.02 [0.82-1.27],0.8805892238017371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM1,Dynamin-1,18745,97,1.03 [0.87-1.23],0.7013760154932724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM3,Dynamin-3,18806,96,1.16 [0.83-1.62],0.3884625337134341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNMBP,Dynamin-binding protein,21365,132,1.11 [0.86-1.43],0.4203133914887801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPEP,Aspartyl aminopeptidase,18809,98,0.97 [0.68-1.37],0.8564186819606445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,21615,130,1.17 [0.87-1.58],0.2932553259782444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOC2B,Double C2-like domain-containing protein beta,18334,92,1.29 [0.81-2.04],0.2769572775116529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOCK9,Dedicator of cytokinesis protein 9,18213,94,0.98 [0.82-1.17],0.828494749671524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK1,Docking protein 1,18809,98,0.96 [0.84-1.11],0.5955548707392144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK2,Docking protein 2,21557,132,1.05 [0.92-1.19],0.4830807711376615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP1,Dipeptidase 1,21332,132,0.86 [0.63-1.17],0.3445610647964493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP2,Dipeptidase 2,21446,131,1.44 [0.87-2.39],0.1567783614645427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP10,Inactive dipeptidyl peptidase 10,21505,131,1.12 [0.74-1.70],0.5961238778770723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP4,Dipeptidyl peptidase 4,21204,128,0.86 [0.49-1.50],0.5865908896157981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP6,Dipeptidyl aminopeptidase-like protein 6,21446,131,1.02 [0.64-1.60],0.9468639371771348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP7,Dipeptidyl peptidase 2,21392,132,1.08 [0.84-1.39],0.5541286814441904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,21821,134,4.27 [2.20-8.27],1.7130347181842906e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,21643,133,1.32 [1.05-1.65],0.0170434697906193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRAXIN,Draxin,21365,132,1.32 [0.93-1.87],0.1233671486840575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRG2,Developmentally-regulated GTP-binding protein 2,21446,131,1.08 [0.82-1.42],0.5859545712951066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,21356,130,1.78 [1.18-2.67],0.005514938787004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSCAM,Down syndrome cell adhesion molecule,18806,96,0.55 [0.32-0.96],0.0350972692541616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,21578,131,1.76 [1.02-3.05],0.0434826002780931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG3,Desmoglein-3,21645,133,1.61 [1.05-2.46],0.0287744843637676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG4,Desmoglein-4,21384,131,0.79 [0.58-1.07],0.1291325571996505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTD1,D-aminoacyl-tRNA deacylase 1,18442,92,0.99 [0.78-1.25],0.9347547388877718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,18713,97,2.21 [1.51-3.23],4.188763912546517e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX2,Probable E3 ubiquitin-protein ligase DTX2,18334,92,0.98 [0.70-1.38],0.9185915518347636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,21446,131,2.90 [1.83-4.62],6.508802652309494e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTYMK,Thymidylate kinase,18843,97,0.80 [0.60-1.07],0.1300868145105437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUOX2,Dual oxidase 2,21144,129,0.89 [0.69-1.13],0.3303548484171161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP13,Dual specificity protein phosphatase 13 isoform A,18757,97,1.19 [0.77-1.84],0.4446217763030979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP29,Dual specificity phosphatase 29,18334,92,1.28 [1.02-1.62],0.0365135812874552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP3,Dual specificity protein phosphatase 3,21055,131,1.04 [0.88-1.24],0.6491063634317292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",18745,97,0.96 [0.80-1.16],0.6821351019389181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DXO,Decapping and exoribonuclease protein,18809,98,0.69 [0.44-1.08],0.1013537890416381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,18757,97,0.70 [0.42-1.17],0.1754161313643181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT1,Dynein light chain Tctex-type 1,18334,92,0.71 [0.52-0.96],0.024530749423105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT3,Dynein light chain Tctex-type 3,18757,97,0.96 [0.61-1.51],0.8651505100025899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,21365,132,1.10 [0.94-1.30],0.2359321929592845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,21686,133,1.94 [1.20-3.14],0.0067106099494411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECE1,Endothelin-converting enzyme 1,21055,131,0.97 [0.63-1.51],0.899406463615191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",18843,97,1.20 [0.93-1.54],0.1601799404380026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHS1,"Enoyl-CoA hydratase, mitochondrial",18378,94,0.96 [0.78-1.18],0.6799144736213414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECI2,Enoyl-CoA delta isomerase 2,18209,92,1.24 [0.93-1.65],0.1466346454755832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECM1,Extracellular matrix protein 1,18380,95,1.69 [0.94-3.03],0.0771028281508163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,18213,94,0.51 [0.29-0.92],0.0253816832651337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,21724,133,2.42 [1.74-3.38],1.9423965800312095e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDAR,Tumor necrosis factor receptor superfamily member EDAR,21505,131,1.06 [0.89-1.25],0.530597118172484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDDM3B,Epididymal secretory protein E3-beta,18757,97,0.81 [0.56-1.17],0.2568116838369926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,18209,92,0.95 [0.54-1.67],0.8656571325971868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDF1,Endothelial differentiation-related factor 1,18806,96,0.93 [0.68-1.26],0.626958829082128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,21144,129,1.54 [1.00-2.37],0.049005383425668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,18378,94,2.72 [1.44-5.13],0.0019755956606514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDNRB,Endothelin receptor type B,18284,95,0.69 [0.39-1.23],0.208311334240669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EEF1D,Elongation factor 1-delta,18843,97,0.90 [0.72-1.12],0.329490919661538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB14,EF-hand calcium-binding domain-containing protein 14,18745,97,1.50 [0.93-2.43],0.0989913306851454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB2,Dynein regulatory complex protein 8,18501,97,1.06 [0.60-1.87],0.8367778591421715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,21643,132,1.92 [1.21-3.04],0.0056456662975602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFHD1,EF-hand domain-containing protein D1,18806,96,1.47 [0.90-2.39],0.1255463081934247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,21546,130,1.96 [1.22-3.15],0.0054250998049739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,21332,132,1.85 [1.22-2.80],0.0036173655667752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNB2,Ephrin-B2,18334,92,0.77 [0.51-1.15],0.2005111608825274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGF,Pro-epidermal growth factor,21515,129,1.05 [0.90-1.22],0.5674690821586881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFL7,Epidermal growth factor-like protein 7,21052,127,1.24 [0.84-1.82],0.2765931968057403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFLAM,Pikachurin,18745,97,1.26 [0.69-2.29],0.4561609244065278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFR,Epidermal growth factor receptor,21821,134,0.54 [0.21-1.39],0.2008923133047678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGLN1,Egl nine homolog 1,21505,131,1.16 [0.91-1.47],0.2221610001320644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHBP1,EH domain-binding protein 1,18843,97,0.97 [0.74-1.26],0.7999908935067319
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHD3,EH domain-containing protein 3,18378,94,0.91 [0.77-1.08],0.2847405234505965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",18809,98,0.71 [0.46-1.09],0.1210068318035155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",18664,97,1.01 [0.84-1.21],0.939665860599222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,18209,92,1.06 [0.78-1.44],0.7152236564011182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,18378,94,0.74 [0.44-1.26],0.2731334375108835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4B,Eukaryotic translation initiation factor 4B,21365,132,0.99 [0.75-1.30],0.9332543198838988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4E,Eukaryotic translation initiation factor 4E,18284,95,0.92 [0.73-1.15],0.4671757606182449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,21557,132,1.18 [0.94-1.49],0.1524328370490204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,21768,132,1.01 [0.86-1.18],0.904868417282086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,18806,96,1.03 [0.76-1.40],0.8331479570724272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5,Eukaryotic translation initiation factor 5,18209,92,0.85 [0.52-1.39],0.5097919674188401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5A,Eukaryotic translation initiation factor 5A-1,21136,129,1.15 [0.70-1.90],0.5843816144053109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAC1,Zinc phosphodiesterase ELAC protein 1,18806,96,0.99 [0.78-1.25],0.9147698782420242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAVL4,ELAV-like protein 4,18213,94,1.04 [0.82-1.32],0.7504342839605289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,18843,97,2.07 [1.22-3.50],0.0066665149769098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOA,Elongin-A,21446,131,1.22 [0.97-1.53],0.0860125050265314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOB,Elongin-B,18209,92,0.90 [0.52-1.56],0.7120293190624867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,21136,129,1.69 [1.28-2.22],0.0001880008687587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENDOU,Poly(U)-specific endoribonuclease,17385,92,1.37 [0.96-1.95],0.0872857588527244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENG,Endoglin,21821,134,2.36 [1.01-5.51],0.0462355637892591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO1,Alpha-enolase,21541,134,1.07 [0.88-1.30],0.4925182795193825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO2,Gamma-enolase,21734,134,1.04 [0.82-1.32],0.7395151681463519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO3,Beta-enolase,18378,94,1.06 [0.76-1.48],0.7300733903860583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOPH1,Enolase-phosphatase E1,18757,97,0.83 [0.53-1.29],0.4075800928773939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,18209,92,1.05 [0.52-2.12],0.8936342002205185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPEP,Glutamyl aminopeptidase,18209,92,1.04 [0.68-1.59],0.8620543681906723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,21821,134,1.28 [0.73-2.23],0.3901759380232594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,21644,130,1.29 [0.86-1.94],0.2189282831505182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,18378,94,1.15 [0.66-1.99],0.6205082581265307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,20842,126,1.06 [0.88-1.28],0.5453070111534019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENSA,Alpha-endosulfine,18757,97,1.28 [0.94-1.74],0.1218004261170546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,21052,127,0.95 [0.65-1.37],0.7747345846665232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,21144,129,1.38 [0.66-2.89],0.3915275112446673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,21144,129,2.14 [1.14-4.03],0.0183776000767759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTR1,Endosome-associated-trafficking regulator 1,18378,94,0.86 [0.60-1.24],0.4254724274192165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EP300,Histone acetyltransferase p300,18284,95,0.99 [0.53-1.86],0.9766616987469878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPB41L5,Band 4.1-like protein 5,18334,92,0.81 [0.56-1.17],0.2575898590508504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPCAM,Epithelial cell adhesion molecule,21540,130,0.97 [0.83-1.14],0.7198110664018751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPGN,Epigen,18757,97,1.12 [0.76-1.65],0.5727308204368331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA1,Ephrin type-A receptor 1,21615,130,1.43 [0.88-2.31],0.1491100709851208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA10,Ephrin type-A receptor 10,21055,131,0.96 [0.75-1.23],0.7446969250452636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,20772,123,2.13 [1.51-3.00],1.814183566847923e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA4,Ephrin type-A receptor 4,18442,92,0.99 [0.50-1.98],0.9855884703061216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,21821,134,2.35 [1.38-4.01],0.0017129108646203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,21332,132,1.89 [1.21-2.95],0.0052192372202689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHX2,Bifunctional epoxide hydrolase 2,21144,129,0.91 [0.70-1.19],0.504197228016116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,18501,97,0.39 [0.21-0.73],0.0034844478199688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPO,Erythropoietin,21505,131,1.15 [0.95-1.40],0.145804999694393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPPK1,Epiplakin,18378,94,1.26 [0.97-1.62],0.0802585301046219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,21681,133,1.65 [1.03-2.65],0.0383606970731301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB2,Receptor tyrosine-protein kinase erbB-2,21637,130,0.89 [0.46-1.74],0.7400096308636113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB3,Receptor tyrosine-protein kinase erbB-3,21490,130,1.29 [0.59-2.86],0.5245416999718955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB4,Receptor tyrosine-protein kinase erbB-4,21637,130,1.19 [0.61-2.30],0.6081815497586442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBIN,Erbin,21446,131,1.03 [0.88-1.19],0.7478794018759678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERC2,ERC protein 2,18334,92,0.91 [0.68-1.23],0.5484152627844205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERCC1,DNA excision repair protein ERCC-1,18165,95,1.21 [0.74-1.98],0.445447976647254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EREG,Proepiregulin,21332,132,1.09 [0.90-1.32],0.3690017827489572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERI1,3'-5' exoribonuclease 1,18501,97,0.66 [0.36-1.22],0.1859444847867215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERMAP,Erythroid membrane-associated protein,18284,95,1.13 [0.72-1.77],0.6039222052722157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,18757,97,1.09 [0.65-1.84],0.7349699166762635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP29,Endoplasmic reticulum resident protein 29,18442,92,1.00 [0.84-1.18],0.9585076233103392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP44,Endoplasmic reticulum resident protein 44,21405,131,1.46 [0.80-2.67],0.2177923421977785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,18209,92,1.16 [0.75-1.79],0.5085791340719836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESAM,Endothelial cell-selective adhesion molecule,21821,134,1.70 [1.08-2.67],0.0216338806063315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESM1,Endothelial cell-specific molecule 1,21549,130,1.28 [0.81-2.01],0.2857547675379204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESPL1,Separin,18165,95,0.97 [0.68-1.38],0.8603456021498525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESR1,Estrogen receptor,18284,95,0.97 [0.66-1.42],0.8716605843091376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESYT2,Extended synaptotagmin-2,18809,98,0.96 [0.75-1.22],0.7217448488520035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI2B,Protein EVI2B,18165,95,1.50 [1.09-2.07],0.0121855980529096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI5,Ecotropic viral integration site 5 protein homolog,18284,95,0.87 [0.70-1.10],0.2416301318812567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVPL,Envoplakin,18501,97,0.85 [0.45-1.59],0.6026010080498528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXOSC10,Exosome component 10,18209,92,0.87 [0.59-1.29],0.5002481122622817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXTL1,Exostosin-like 1,18209,92,0.69 [0.41-1.14],0.1476498579256324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EZR,Ezrin,21734,134,1.28 [0.69-2.36],0.4365982424128167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F10,Coagulation factor X,18856,97,0.99 [0.50-1.96],0.9858467665971504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11,Coagulation factor XI,18614,97,1.69 [1.11-2.58],0.0144360843145196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11R,Junctional adhesion molecule A,21578,131,1.06 [0.80-1.40],0.6918587253985014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F12,Coagulation factor XII,18873,98,1.32 [0.81-2.13],0.2642814787926589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F13B,Coagulation factor XIII B chain,18772,98,0.78 [0.36-1.66],0.514493024138691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2,Prothrombin,18873,98,0.76 [0.21-2.78],0.683679505274837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2R,Proteinase-activated receptor 1,21610,130,1.24 [0.94-1.63],0.1302760666977943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F3,Tissue factor,21594,132,1.31 [0.75-2.31],0.3421780447742457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F7,Coagulation factor VII,21636,132,0.68 [0.42-1.08],0.0983889410576806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F9,Coagulation factor IX,21625,132,0.76 [0.33-1.78],0.5337380349957362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP1,"Fatty acid-binding protein, liver",21549,130,1.21 [1.03-1.41],0.0186726063914242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP2,"Fatty acid-binding protein, intestinal",21557,132,1.04 [0.86-1.26],0.6782881403786429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",18843,97,1.80 [1.32-2.46],0.0001892407865095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",21821,134,1.71 [1.31-2.23],8.166282131453974e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP5,Fatty acid-binding protein 5,21651,133,1.26 [1.01-1.57],0.0414765886062524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP6,Gastrotropin,21103,128,1.14 [0.89-1.47],0.294395426917137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP9,Fatty acid-binding protein 9,21505,131,0.73 [0.55-0.97],0.0314835008653766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FADD,FAS-associated death domain protein,21557,132,1.10 [0.90-1.35],0.3652849310261014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM13A,Protein FAM13A,18745,97,0.99 [0.74-1.34],0.9630890937854252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171A2,Protein FAM171A2,18806,96,1.08 [0.96-1.21],0.1876421728300487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171B,Protein FAM171B,18757,97,1.16 [0.60-2.24],0.6489181478288459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM172A,Cotranscriptional regulator FAM172A,18378,94,0.88 [0.63-1.23],0.4616946662366467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM20A,Pseudokinase FAM20A,18843,97,1.51 [0.80-2.88],0.2067663381995907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3B,Protein FAM3B,21446,131,1.26 [0.80-1.98],0.3150398802193192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,21515,132,2.32 [1.45-3.71],0.0004360455435313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3D,Protein FAM3D,18745,97,1.03 [0.82-1.29],0.7955418165929862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAP,Prolyl endopeptidase FAP,21821,134,1.05 [0.60-1.84],0.877724797387704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FARSA,Phenylalanine--tRNA ligase alpha subunit,18334,92,0.66 [0.47-0.94],0.0209392939130982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAS,Tumor necrosis factor receptor superfamily member 6,21758,134,1.40 [0.99-1.99],0.0577173237545386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FASLG,Tumor necrosis factor ligand superfamily member 6,21768,132,0.79 [0.52-1.19],0.2601201967367917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBLN2,Fibulin-2,18852,99,1.49 [0.83-2.66],0.179280868331976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBN2,Fibrillin-2,18334,92,1.30 [0.93-1.82],0.1208493015144653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBP1,"Fructose-1,6-bisphosphatase 1",21557,132,0.96 [0.77-1.18],0.6860813752704396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,18843,97,0.96 [0.73-1.25],0.7380518007662877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAR,Immunoglobulin alpha Fc receptor,21505,131,1.06 [0.77-1.46],0.7093674598106581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,18806,96,1.11 [0.49-2.53],0.7976601181787373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER2,Low affinity immunoglobulin epsilon Fc receptor,21578,131,0.98 [0.73-1.31],0.8877478002207416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,21488,131,1.12 [0.84-1.47],0.4414955720590933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,21052,127,0.96 [0.73-1.27],0.7963597570407552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,21603,132,0.98 [0.72-1.34],0.90366787306526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN1,Ficolin-1,18819,97,1.04 [0.73-1.47],0.8315070855360949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN2,Ficolin-2,21484,131,0.90 [0.62-1.30],0.580746670735032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL1,Fc receptor-like protein 1,21557,132,0.77 [0.55-1.08],0.1259242868002565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL2,Fc receptor-like protein 2,21657,131,1.23 [0.94-1.62],0.1370943568169768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL3,Fc receptor-like protein 3,21136,129,0.90 [0.68-1.20],0.4741052506559663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL5,Fc receptor-like protein 5,21578,131,1.16 [0.89-1.50],0.2663715588983685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL6,Fc receptor-like protein 6,21505,131,0.95 [0.76-1.19],0.6584082098828377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,21052,127,1.25 [1.02-1.53],0.0315823224858945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",18209,92,1.40 [1.12-1.76],0.0036932626175358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX2,"Ferredoxin-2, mitochondrial",18209,92,1.22 [0.89-1.66],0.2128866859289853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FEN1,Flap endonuclease 1,21052,127,1.15 [0.95-1.40],0.1524746079963008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FES,Tyrosine-protein kinase Fes/Fps,21052,127,1.21 [0.91-1.62],0.1833327709474181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FETUB,Fetuin-B,21625,132,1.14 [0.70-1.86],0.6017499279512505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGA,Fibrinogen alpha chain,18429,96,1.69 [0.91-3.14],0.0963384757979852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",18806,96,1.00 [0.78-1.28],0.9801463623495426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF12,Fibroblast growth factor 12,18284,95,0.92 [0.57-1.47],0.7231716128870631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF16,Fibroblast growth factor 16,18284,95,0.90 [0.58-1.42],0.6638764658253911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF19,Fibroblast growth factor 19,21644,130,1.05 [0.86-1.28],0.6210642425683199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF2,Fibroblast growth factor 2,21505,131,1.27 [1.03-1.58],0.0279665971816136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF20,Fibroblast growth factor 20,18284,95,1.12 [0.74-1.69],0.6039520528380807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF21,Fibroblast growth factor 21,21686,133,1.11 [0.98-1.26],0.1080925340237797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,21693,133,1.46 [1.18-1.81],0.0004971366459692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF3,Fibroblast growth factor 3,18284,95,1.16 [0.65-2.08],0.6171147751071425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF5,Fibroblast growth factor 5,21136,129,1.67 [1.09-2.58],0.0198018289942416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF6,Fibroblast growth factor 6,18284,95,1.08 [0.69-1.71],0.7286535277059147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF7,Fibroblast growth factor 7,18165,95,1.09 [0.86-1.36],0.4843369909704786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF9,Fibroblast growth factor 9,18138,95,0.88 [0.54-1.41],0.5868228471763794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP1,Fibroblast growth factor-binding protein 1,21637,130,1.03 [0.64-1.65],0.9009754097622932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP2,Fibroblast growth factor-binding protein 2,18852,99,1.00 [0.68-1.46],0.9862024427770996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP3,Fibroblast growth factor-binding protein 3,18809,98,0.96 [0.56-1.62],0.8678301435908349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,21637,130,2.23 [1.15-4.31],0.0168943980213534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR4,Fibroblast growth factor receptor 4,18442,92,1.06 [0.72-1.55],0.7655733103910839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,18856,97,1.41 [1.06-1.88],0.0188816339604704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGR,Tyrosine-protein kinase Fgr,21055,131,1.20 [0.98-1.47],0.0794499213050898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FH,"Fumarate hydratase, mitochondrial",18213,94,0.90 [0.68-1.18],0.4320363558217982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIP2A,FHF complex subunit HOOK interacting protein 2A,18209,92,0.72 [0.45-1.16],0.1779377307003009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIT,Bis(5'-adenosyl)-triphosphatase,21055,131,1.03 [0.84-1.28],0.7535367198843583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FIS1,Mitochondrial fission 1 protein,21552,130,1.15 [0.94-1.40],0.1785566410445418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,18806,96,1.03 [0.84-1.25],0.8011115523988073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,21596,129,1.02 [0.88-1.17],0.8276487682634427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,21365,132,1.24 [0.87-1.79],0.2354060112113488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,21365,132,1.11 [0.94-1.31],0.2317013466146584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,21022,131,1.15 [0.86-1.53],0.345472546639166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBPL,FK506-binding protein-like,18745,97,0.76 [0.54-1.07],0.1217314483416318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLI1,Friend leukemia integration 1 transcription factor,21052,127,1.08 [0.94-1.25],0.2628697454042122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,21365,132,1.93 [1.14-3.29],0.0152543102111024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,21410,131,2.48 [1.59-3.86],6.281184152847503e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3,Receptor-type tyrosine-protein kinase FLT3,21052,127,1.10 [0.67-1.80],0.7035834754797834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3LG,Fms-related tyrosine kinase 3 ligand,21768,132,1.52 [0.97-2.38],0.0655840663773176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT4,Vascular endothelial growth factor receptor 3,21637,130,1.14 [0.71-1.82],0.5922452444271196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMNL1,Formin-like protein 1,21055,131,1.13 [0.92-1.37],0.2408700854255809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMR1,Synaptic functional regulator FMR1,21052,127,0.92 [0.59-1.45],0.7313753139141815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FN1,Fibronectin,18873,98,0.80 [0.39-1.67],0.5584517937219142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNDC1,Fibronectin type III domain-containing protein 1,18809,98,1.08 [0.71-1.64],0.7211223955324373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,18757,97,0.89 [0.49-1.60],0.6933787297298348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLH1,Glutamate carboxypeptidase 2,18284,95,0.93 [0.75-1.17],0.5528978893065484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR1,Folate receptor alpha,21555,130,1.54 [0.93-2.55],0.092333719754441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR2,Folate receptor beta,21734,134,1.63 [0.98-2.71],0.0600763093977422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR3,Folate receptor gamma,21571,130,1.06 [0.99-1.14],0.1132757787344897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOS,Proto-oncogene c-Fos,18138,95,0.95 [0.55-1.66],0.8653729148900479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOSB,Protein fosB,21055,131,1.04 [0.70-1.54],0.8517617041928105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXJ3,Forkhead box protein J3,18284,95,0.86 [0.53-1.38],0.5268551118939684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO1,Forkhead box protein O1,21505,131,1.05 [0.87-1.26],0.6144821779404251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO3,Forkhead box protein O3,21052,127,0.94 [0.79-1.12],0.4628619877629302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD4B,FERM domain-containing protein 4B,18209,92,0.96 [0.71-1.30],0.8121873065312675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD7,FERM domain-containing protein 7,18334,92,1.09 [0.61-1.93],0.7802824232622473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRZB,Secreted frizzled-related protein 3,21297,132,0.91 [0.49-1.69],0.7628253719573108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSHB,Follitropin subunit beta,18378,94,1.06 [0.72-1.57],0.7561755917982573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FST,Follistatin,21610,130,1.12 [0.82-1.53],0.4791571799348302
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL1,Follistatin-related protein 1,18378,94,1.22 [0.49-3.01],0.6706922003939173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,21514,130,2.59 [1.72-3.90],4.706042973660358e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FTCD,Formimidoyltransferase-cyclodeaminase,18765,98,1.01 [0.81-1.27],0.9061337589258092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUCA1,Tissue alpha-L-fucosidase,21710,133,0.98 [0.82-1.17],0.8094273893247819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUOM,Fucose mutarotase,18442,92,0.88 [0.64-1.21],0.4268653728269083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FURIN,Furin,21637,130,0.94 [0.58-1.52],0.795060596103738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUS,RNA-binding protein FUS,21022,127,1.33 [0.92-1.91],0.1304101029672288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",18462,97,0.84 [0.59-1.20],0.3325137605684467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,21734,134,1.16 [0.84-1.60],0.3761296917334441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT8,"Alpha-(1,6)-fucosyltransferase",21365,132,1.13 [0.87-1.46],0.3534587539578029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXN,"Frataxin, mitochondrial",21724,133,1.12 [0.91-1.38],0.2774018128640779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXYD5,FXYD domain-containing ion transport regulator 5,21136,129,1.15 [0.91-1.45],0.2549319725627808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FYB1,FYN-binding protein 1,21537,130,1.01 [0.85-1.20],0.9083904323527512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD10,Frizzled-10,18334,92,1.07 [0.78-1.46],0.6793358603535191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD8,Frizzled-8,18213,94,0.98 [0.62-1.55],0.9294826503333672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,18757,97,1.56 [1.17-2.08],0.0024562994398394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,18501,97,0.71 [0.48-1.05],0.0823315104602799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,18213,94,0.94 [0.67-1.31],0.7099777441691405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD1,Glutamate decarboxylase 1,18165,95,1.42 [0.67-3.02],0.3579148493954612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD2,Glutamate decarboxylase 2,18284,95,1.10 [0.76-1.59],0.5979723009736393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,18501,97,0.79 [0.47-1.31],0.3591388247117255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,18378,94,0.99 [0.67-1.45],0.9479889088561344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAGE2A,G antigen 2A,18165,95,1.17 [0.92-1.49],0.1948582489798516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAL,Galanin peptides,21644,130,1.08 [0.85-1.37],0.5337018993811882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,21446,131,1.62 [0.93-2.82],0.0886012759093603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,21724,133,0.83 [0.47-1.48],0.5339085718133375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,21136,129,0.89 [0.62-1.29],0.5342392077543362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,18843,97,0.82 [0.41-1.64],0.5700881925987054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT7,N-acetylgalactosaminyltransferase 7,21446,131,1.36 [0.65-2.83],0.4133331671709794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAMT,Guanidinoacetate N-methyltransferase,18209,92,0.90 [0.49-1.63],0.7230646992649483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18029,89,0.72 [0.40-1.30],0.2730879916680043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GART,Trifunctional purine biosynthetic protein adenosine-3,18806,96,1.24 [0.63-2.42],0.5323961264691421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS2,Growth arrest-specific protein 2,18501,97,0.70 [0.44-1.12],0.1361785995923562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,21699,134,2.19 [1.19-4.02],0.012027089282332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GASK1A,Golgi-associated kinase 1A,18209,92,0.75 [0.47-1.22],0.2482987897323755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAST,Gastrin,18809,98,1.07 [0.95-1.21],0.2749584291294878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,18165,95,0.54 [0.25-1.13],0.1014715344305716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",18378,94,1.01 [0.78-1.32],0.9276925174259708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBA,Lysosomal acid glucosylceramidase,18334,92,1.02 [0.71-1.47],0.9000069093886417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP1,Guanylate-binding protein 1,18776,97,0.86 [0.64-1.15],0.3212754667322975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP2,Guanylate-binding protein 2,21136,129,1.01 [0.77-1.32],0.9408716174405916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP4,Guanylate-binding protein 4,21055,131,0.96 [0.69-1.34],0.8291886110218443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP6,Guanylate-binding protein 6,18209,92,1.03 [0.66-1.60],0.9019893885336022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GC,Vitamin D-binding protein,18873,98,1.38 [0.66-2.88],0.3937186668661322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCC1,GRIP and coiled-coil domain-containing protein 1,18809,98,0.98 [0.82-1.18],0.8569321853476068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,21052,127,1.17 [1.03-1.32],0.0144062747399018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,17999,89,0.90 [0.58-1.39],0.6336145107736966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCLM,Glutamate--cysteine ligase regulatory subunit,18209,92,0.99 [0.64-1.54],0.9600007909259852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",21446,131,1.22 [0.78-1.90],0.3927765305002787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,21821,134,2.27 [1.80-2.86],3.48596645004276e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF2,Growth/differentiation factor 2,21557,132,1.37 [0.89-2.09],0.1500029768317227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDNF,Glial cell line-derived neurotrophic factor,21055,131,1.40 [0.96-2.04],0.0846100784709152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GET3,ATPase GET3,18843,97,1.24 [0.90-1.69],0.1907050858710921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,21015,126,2.10 [1.58-2.80],3.356705775165527e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFER,FAD-linked sulfhydryl oxidase ALR,21052,127,1.28 [1.00-1.64],0.0466261251919219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,21052,127,0.90 [0.77-1.05],0.1791545247412566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,21686,133,3.61 [2.32-5.64],1.5115824551752323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA2,GDNF family receptor alpha-2,21446,131,1.48 [0.74-2.96],0.2691968803620574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA3,GDNF family receptor alpha-3,21304,132,1.21 [0.70-2.07],0.4927273687858737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRAL,GDNF family receptor alpha-like,18245,96,1.17 [0.86-1.59],0.3096907859810713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGA1,ADP-ribosylation factor-binding protein GGA1,21055,131,0.84 [0.64-1.11],0.2315736384297767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGACT,Gamma-glutamylaminecyclotransferase,18843,97,0.90 [0.68-1.20],0.4728920551853903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGCT,Gamma-glutamylcyclotransferase,18804,97,0.87 [0.57-1.32],0.5094111873787117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGH,Gamma-glutamyl hydrolase,21244,127,0.94 [0.59-1.50],0.8057795814846144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,21546,130,1.40 [1.05-1.86],0.0209727752098289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT5,Glutathione hydrolase 5 proenzyme,21365,132,1.28 [0.66-2.46],0.4686774015780575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH1,Somatotropin,21515,132,1.00 [0.91-1.09],0.9899803125152122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH2,Growth hormone variant,21052,127,0.95 [0.86-1.05],0.3282159656754538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHR,Growth hormone receptor,18442,92,0.46 [0.23-0.95],0.035118890324386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRHR,Growth hormone-releasing hormone receptor,21055,131,1.12 [0.86-1.44],0.4012845939652322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRL,Appetite-regulating hormone,21557,132,1.06 [0.88-1.27],0.5495904072032075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GID8,Glucose-induced degradation protein 8 homolog,18806,96,0.71 [0.35-1.46],0.3515905361812677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIGYF2,GRB10-interacting GYF protein 2,18806,96,1.08 [0.83-1.41],0.5556621118870301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP7,GTPase IMAP family member 7,18442,92,0.76 [0.39-1.50],0.4304136813806543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP8,GTPase IMAP family member 8,18165,95,0.99 [0.67-1.47],0.9636894929288138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIP,Gastric inhibitory polypeptide,18378,94,1.18 [0.86-1.62],0.2932235715768291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,18809,98,2.04 [1.16-3.59],0.0136522438961287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC3,PDZ domain-containing protein GIPC3,18745,97,0.94 [0.77-1.14],0.519406982635432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPR,Gastric inhibitory polypeptide receptor,18284,95,0.90 [0.57-1.42],0.6487374700190358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIT1,ARF GTPase-activating protein GIT1,18284,95,0.91 [0.74-1.12],0.3771157837101698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GJA8,Gap junction alpha-8 protein,18165,95,0.69 [0.47-1.02],0.0644677887788881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GKN1,Gastrokine-1,20663,127,1.00 [0.56-1.77],0.9897996100266458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLA,Alpha-galactosidase A,18414,92,0.97 [0.56-1.67],0.902879826124292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLB1,Beta-galactosidase,21365,132,1.13 [0.77-1.64],0.5336561727240823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLI2,Zinc finger protein GLI2,18284,95,0.72 [0.36-1.46],0.3635792578507268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLO1,Lactoylglutathione lyase,21144,129,1.17 [0.90-1.52],0.251272690159094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLOD4,Glyoxalase domain-containing protein 4,21518,130,1.32 [0.85-2.07],0.220060147408459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLP1R,Glucagon-like peptide 1 receptor,18213,94,0.63 [0.33-1.18],0.147113681883858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX,Glutaredoxin-1,21408,132,1.01 [0.77-1.33],0.9256595347678154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",18442,92,1.01 [0.80-1.27],0.9126830023374848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,21055,131,0.74 [0.49-1.12],0.1556898603299111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLYR1,Putative oxidoreductase GLYR1,18757,97,0.95 [0.66-1.36],0.7779178177146369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GM2A,Ganglioside GM2 activator,18378,98,1.36 [0.95-1.97],0.0969815103779952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMFG,Glia maturation factor gamma,18843,97,0.95 [0.72-1.25],0.7291132898687357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR,GMP reductase 1,21768,132,1.09 [0.80-1.49],0.6015267341523174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR2,GMP reductase 2,18442,92,0.80 [0.59-1.09],0.1568995264001504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNAS,Neuroendocrine secretory protein 55,18806,96,0.87 [0.67-1.13],0.2905563289862154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,21052,127,1.12 [0.88-1.42],0.3537208190334814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,18334,92,0.79 [0.49-1.26],0.3156602711742433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNLY,Granulysin,21578,131,0.95 [0.71-1.27],0.7279144473292513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA1,Glucosamine-6-phosphate isomerase 1,18378,94,0.59 [0.28-1.24],0.1657583473386681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA2,Glucosamine-6-phosphate isomerase 2,18442,92,0.93 [0.54-1.62],0.8002954177727166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLGA3,Golgin subfamily A member 3,18806,96,0.82 [0.63-1.07],0.1492639222075497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLM2,Protein GOLM2,21734,134,1.65 [0.93-2.91],0.0848303237390422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,21505,131,1.01 [0.87-1.18],0.8561101200519394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GORASP2,Golgi reassembly-stacking protein 2,18745,97,0.87 [0.57-1.33],0.5294783329436087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOT1,"Aspartate aminotransferase, cytoplasmic",18852,99,1.20 [0.77-1.85],0.4207219228225453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BA,Platelet glycoprotein Ib alpha chain,21480,130,0.96 [0.60-1.54],0.8588744865526099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BB,Platelet glycoprotein Ib beta chain,18209,92,1.05 [0.78-1.41],0.7555480836863642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,20875,129,1.24 [1.05-1.47],0.0099622537126165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP5,Platelet glycoprotein V,18442,92,0.71 [0.42-1.20],0.2042161672793965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP6,Platelet glycoprotein VI,21537,130,1.08 [0.90-1.29],0.3957855413666153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPA33,Cell surface A33 antigen,21446,131,0.94 [0.84-1.06],0.3173634186196267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC1,Glypican-1,21724,133,1.83 [1.10-3.05],0.0202554627350584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC5,Glypican-5,21365,132,0.90 [0.69-1.19],0.4706553501683733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,18757,97,1.45 [1.04-2.03],0.0295899237799762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPHA2,Glycoprotein hormone alpha-2,18745,97,0.73 [0.43-1.25],0.2535404682474806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPI,Glucose-6-phosphate isomerase,18856,97,0.98 [0.65-1.50],0.943197402345828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,18745,97,1.12 [0.84-1.49],0.4454976091436279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPKOW,G-patch domain and KOW motifs-containing protein,21055,131,1.12 [0.70-1.79],0.6366938058935419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPNMB,Transmembrane glycoprotein NMB,20961,130,1.08 [0.63-1.86],0.781686961939968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR101,Probable G-protein coupled receptor 101,18213,94,0.65 [0.41-1.04],0.0720433093926794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR158,Probable G-protein coupled receptor 158,18806,96,1.23 [0.73-2.06],0.4414560087011493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR15L,Protein GPR15L,18745,97,1.14 [0.84-1.56],0.401967841513615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR37,Prosaposin receptor GPR37,21144,129,1.17 [0.92-1.48],0.2036403006931035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,18757,97,1.40 [1.05-1.88],0.0236203378747155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRAP2,GRB2-related adapter protein 2,21557,132,1.03 [0.91-1.16],0.65448521607014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,18843,97,0.91 [0.66-1.24],0.535210890140105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIK2,"Glutamate receptor ionotropic, kainate 2",18806,96,1.13 [0.75-1.70],0.5551286380029052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",18213,94,0.69 [0.43-1.12],0.138405294343918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRK5,G protein-coupled receptor kinase 5,21144,129,1.01 [0.73-1.39],0.9642175316823416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRN,Progranulin,21473,129,1.84 [1.00-3.40],0.0499968624131692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRP,Gastrin-releasing peptide,18378,94,1.16 [0.81-1.66],0.4303988967010199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRPEL1,"GrpE protein homolog 1, mitochondrial",21446,131,1.34 [1.05-1.70],0.0189540937651218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRSF1,G-rich sequence factor 1,18076,95,1.00 [0.78-1.28],0.9748918684548382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSAP,Gamma-secretase-activating protein,21052,127,0.88 [0.71-1.10],0.2706077113655171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSN,Gelsolin,18793,97,0.85 [0.30-2.37],0.7564363979558002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSR,"Glutathione reductase, mitochondrial",18751,97,0.54 [0.25-1.20],0.1304854583721187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA1,Glutathione S-transferase A1,21519,132,0.88 [0.72-1.07],0.188788249210226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA3,Glutathione S-transferase A3,21052,127,0.88 [0.70-1.09],0.2313358742991533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTM4,Glutathione S-transferase Mu 4,18209,92,1.16 [0.92-1.46],0.1986817937224578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTP1,Glutathione S-transferase P,20930,130,0.80 [0.62-1.02],0.0755183497765533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTT2B,Glutathione S-transferase theta-2B,18809,98,0.97 [0.90-1.06],0.5306810844882202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,18501,97,0.91 [0.66-1.24],0.5421859152497535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTPBP2,GTP-binding protein 2,18334,92,0.93 [0.72-1.20],0.5520383975035114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCA2A,Guanylin,21470,130,1.43 [0.94-2.18],0.0933160567248775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCY2C,Heat-stable enterotoxin receptor,18501,97,1.25 [1.03-1.51],0.0255861933601752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUK1,Guanylate kinase,18209,92,1.14 [0.70-1.88],0.5957055178269033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUSB,Beta-glucuronidase,21678,133,1.14 [0.90-1.45],0.2851179193045986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GYS1,"Glycogen [starch] synthase, muscle",21144,129,1.15 [0.97-1.36],0.1024582372740571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMA,Granzyme A,21768,132,0.85 [0.54-1.33],0.4668770985657426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMB,Granzyme B,21505,131,0.95 [0.74-1.21],0.6710250749121991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMH,Granzyme H,21144,129,1.04 [0.86-1.27],0.659863676807173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,H2AP,Huntingtin-interacting protein M,18165,95,0.97 [0.64-1.47],0.8878945899296974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",18209,92,0.79 [0.54-1.16],0.228955259362511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",21652,133,0.92 [0.74-1.14],0.44764861263043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAO1,Hydroxyacid oxidase 1,21724,133,1.07 [0.94-1.20],0.3032253015465619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HARS1,"Histidine--tRNA ligase, cytoplasmic",21578,131,1.14 [0.93-1.40],0.2030734858581431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,21690,133,1.49 [1.20-1.84],0.0003034319376134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,21578,131,1.64 [1.09-2.46],0.01700686895264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBEGF,Proheparin-binding EGF-like growth factor,21652,133,0.94 [0.76-1.16],0.5823780997347073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBQ1,Hemoglobin subunit theta-1,21724,133,1.05 [0.82-1.34],0.6880726156396393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBZ,Hemoglobin subunit zeta,18843,97,1.00 [0.84-1.20],0.9730100932862424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCG22,Protein PBMUCL2,18209,92,1.19 [0.92-1.53],0.1781315816752435
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCLS1,Hematopoietic lineage cell-specific protein,21768,132,1.13 [0.85-1.50],0.3907788481301562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC8,Histone deacetylase 8,18284,95,0.62 [0.38-1.01],0.0537811063129201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC9,Histone deacetylase 9,18213,94,0.95 [0.69-1.29],0.7305871628211134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDDC2,5'-deoxynucleotidase HDDC2,18745,97,0.91 [0.58-1.43],0.6954952772957625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,21684,132,1.19 [1.01-1.41],0.0335761640807054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGFL2,Hepatoma-derived growth factor-related protein 2,18809,98,0.91 [0.67-1.25],0.5621424259009596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEBP1,Heme-binding protein 1,21144,129,0.76 [0.55-1.05],0.0987956887468505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEG1,Protein HEG homolog 1,18442,92,1.12 [0.53-2.35],0.768458567427636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPACAM2,HEPACAM family member 2,18809,98,1.43 [0.92-2.25],0.1143010135380832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPH,Hephaestin,18843,97,1.02 [0.50-2.07],0.9595578120527336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEXIM1,Protein HEXIM1,21505,131,1.03 [0.85-1.26],0.7369478136913845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,21768,132,2.24 [1.52-3.30],4.599923132650145e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGFAC,Hepatocyte growth factor activator,18681,97,0.85 [0.43-1.70],0.6530986585922844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,21052,127,1.11 [0.91-1.36],0.2930081078905535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HHEX,Hematopoietically-expressed homeobox protein HHEX,18809,98,1.14 [0.88-1.48],0.3061943205745337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIF1A,Hypoxia-inducible factor 1-alpha,18284,95,1.06 [0.78-1.43],0.7236072618437716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1,Huntingtin-interacting protein 1,18209,92,0.87 [0.46-1.68],0.687600580351057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1R,Huntingtin-interacting protein 1-related protein,18764,98,1.23 [0.86-1.76],0.2651698822619273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HJV,Hemojuvelin,18806,96,1.04 [0.66-1.62],0.8754332240935672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HK2,Hexokinase-2,21144,129,0.89 [0.50-1.59],0.7009396796455778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",18806,96,0.77 [0.43-1.39],0.3886979527255835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",21446,130,0.89 [0.58-1.37],0.6078147489833692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",21505,131,1.22 [0.74-2.03],0.4353113939971869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMBS,Porphobilinogen deaminase,21724,133,1.07 [0.75-1.53],0.6989570903057791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMCN2,Hemicentin-2,18413,92,1.21 [0.84-1.73],0.3003634309206524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",18378,94,0.97 [0.64-1.47],0.8701007778426586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",18209,92,1.06 [0.69-1.63],0.7890725580337551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMMR,Hyaluronan mediated motility receptor,18122,95,1.01 [0.68-1.50],0.963299019866529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX1,Heme oxygenase 1,21312,132,0.85 [0.62-1.18],0.3329849433358914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX2,Heme oxygenase 2,21055,131,1.29 [0.95-1.73],0.0996059626927276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNF1A,Hepatocyte nuclear factor 1-alpha,18334,92,0.86 [0.61-1.20],0.3665835419090553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNMT,Histamine N-methyltransferase,21268,132,1.07 [0.78-1.49],0.6638321926788482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,21083,129,1.11 [0.91-1.36],0.3147454575585036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,18806,96,0.84 [0.55-1.29],0.4380440276617803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPCAL1,Hippocalcin-like protein 1,21768,132,1.12 [0.90-1.38],0.3009016396324511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPGDS,Hematopoietic prostaglandin D synthase,21052,127,0.62 [0.41-0.96],0.0327303377414362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPSE,Heparanase,18611,99,1.00 [0.82-1.23],0.9769099952470452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRAS,GTPase Hras,18458,97,1.00 [0.81-1.22],0.9811020247844616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,18378,94,0.99 [0.55-1.78],0.9742306589240252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRG,Histidine-rich glycoprotein,18772,98,1.13 [0.62-2.05],0.6919393015752535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS1BP3,HCLS1-binding protein 3,18378,94,1.00 [0.80-1.26],0.9974472954284174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,21446,131,0.87 [0.58-1.31],0.5129797470546513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,21724,133,1.02 [0.66-1.57],0.9331968331114834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,18284,95,0.94 [0.53-1.65],0.8267168151423357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSBP1,Heat shock factor-binding protein 1,18378,94,1.08 [0.88-1.33],0.4678190594882792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,21505,131,1.32 [0.89-1.95],0.1617255396362576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,18809,98,1.08 [0.79-1.48],0.6342570624082794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B3,Testosterone 17-beta-dehydrogenase 3,18209,92,0.65 [0.40-1.04],0.0751265381804039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,18378,94,0.99 [0.65-1.50],0.9581780412748044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSP90B1,Endoplasmin,20949,130,0.98 [0.77-1.26],0.9016451167274738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA1A,Heat shock 70 kDa protein 1A,21615,130,1.23 [0.99-1.52],0.0575931570336937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA2,Heat shock-related 70 kDa protein 2,18757,97,1.23 [0.71-2.10],0.4616653837177832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB1,Heat shock protein beta-1,21228,132,1.04 [0.83-1.31],0.7328639342258638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,21724,133,2.46 [1.76-3.44],1.2326463809405226e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,21417,130,1.73 [1.03-2.90],0.0381553838580403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1A,5-hydroxytryptamine receptor 1A,18213,94,1.06 [0.83-1.36],0.6437677148458383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1B,5-hydroxytryptamine receptor 1B,18213,94,0.52 [0.29-0.92],0.0247918727438057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTRA2,"Serine protease HTRA2, mitochondrial",21637,130,1.18 [0.91-1.52],0.2085801612365335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYAL1,Hyaluronidase-1,21468,131,1.48 [0.78-2.81],0.2280324234849885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYOU1,Hypoxia up-regulated protein 1,21821,134,1.61 [0.84-3.09],0.1484012499618933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICA1,Islet cell autoantigen 1,21136,129,0.99 [0.81-1.21],0.892928881973914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM1,Intercellular adhesion molecule 1,21477,131,1.45 [0.86-2.44],0.1579219824130213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM2,Intercellular adhesion molecule 2,21821,134,1.50 [0.93-2.41],0.0974954766141932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM3,Intercellular adhesion molecule 3,21821,134,1.50 [0.86-2.63],0.1530720691685032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM4,Intercellular adhesion molecule 4,21505,131,1.02 [0.76-1.37],0.8920894630171583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM5,Intercellular adhesion molecule 5,21557,132,1.10 [0.78-1.54],0.5907602196212782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICOSLG,ICOS ligand,21446,131,1.06 [0.47-2.37],0.8919309528776571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ID4,DNA-binding protein inhibitor ID-4,18501,97,0.88 [0.53-1.44],0.604528290484337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDI2,Isopentenyl-diphosphate delta-isomerase 2,21055,131,1.33 [1.01-1.75],0.0410052887347794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDO1,"Indoleamine 2,3-dioxygenase 1",18378,94,1.05 [0.76-1.43],0.7748019509680855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDS,Iduronate 2-sulfatase,21768,132,3.24 [0.51-20.66],0.2133875536044776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDUA,Alpha-L-iduronidase,21724,133,1.02 [0.74-1.42],0.8977512037426761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,18274,97,1.29 [0.80-2.10],0.2944092691206331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,18501,97,0.72 [0.48-1.08],0.1135117255862129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,18501,97,0.86 [0.50-1.48],0.5916896474167104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNAR1,Interferon alpha/beta receptor 1,18745,97,0.86 [0.39-1.90],0.7032697412253623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNG,Interferon gamma,21136,129,1.05 [0.91-1.21],0.5092510234095773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,21644,130,2.39 [1.27-4.49],0.0067111187273121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR2,Interferon gamma receptor 2,21365,132,0.99 [0.73-1.33],0.939740960510443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL1,Interferon lambda-1,21055,131,0.89 [0.63-1.27],0.5203705591903633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL2,Interferon lambda-2,18213,94,0.77 [0.51-1.16],0.2067276785721878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNLR1,Interferon lambda receptor 1,21505,131,0.78 [0.49-1.25],0.3035852086046721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNW1,Interferon omega-1,18209,92,1.50 [1.06-2.13],0.0231379072111495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFT20,Intraflagellar transport protein 20 homolog,18334,92,0.85 [0.51-1.39],0.510039802973939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGBP1,Immunoglobulin-binding protein 1,18806,96,0.86 [0.62-1.19],0.3538838112185696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,18213,94,0.90 [0.58-1.40],0.6546716932299788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,18852,99,1.19 [0.58-2.43],0.6315934847732478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF1R,Insulin-like growth factor 1 receptor,21446,131,1.48 [0.74-2.97],0.2679488988033647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,18209,92,0.64 [0.37-1.12],0.1190464040131094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2R,Cation-independent mannose-6-phosphate receptor,21578,131,1.82 [0.94-3.54],0.0773026668499043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP1,Insulin-like growth factor-binding protein 1,21785,134,1.16 [1.02-1.32],0.0206628212196555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,21795,134,1.75 [1.36-2.26],1.6620665710772542e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP3,Insulin-like growth factor-binding protein 3,21671,132,0.98 [0.62-1.57],0.9479829427125828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,21301,129,1.92 [1.47-2.52],2.081775008426969e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP6,Insulin-like growth factor-binding protein 6,21477,131,1.38 [0.87-2.18],0.1703817319022235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,21821,134,2.07 [1.51-2.84],6.003997649063742e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,21557,132,1.88 [1.25-2.83],0.0025530490443446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFL4,Insulin growth factor-like family member 4,18284,95,0.82 [0.58-1.15],0.2499205337835923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGHMBP2,DNA-binding protein SMUBP-2,18209,92,0.95 [0.65-1.39],0.7868598719766728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,18835,98,1.91 [1.30-2.82],0.0010960756799712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLON5,IgLON family member 5,18165,95,0.89 [0.69-1.15],0.3825671120452918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF21,Immunoglobulin superfamily member 21,18378,94,0.79 [0.45-1.37],0.3956287315106553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF3,Immunoglobulin superfamily member 3,21446,131,1.45 [0.99-2.10],0.0543610557085253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF8,Immunoglobulin superfamily member 8,21557,132,1.38 [0.85-2.24],0.1900880541472341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF9,Protein turtle homolog A,18843,97,1.06 [0.85-1.34],0.5954490715076526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKBKG,NF-kappa-B essential modulator,21505,131,0.96 [0.81-1.14],0.6202290908616106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKZF2,Zinc finger protein Helios,21052,127,0.80 [0.63-1.01],0.0629661999747547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10,Interleukin-10,21136,129,1.06 [0.88-1.28],0.53270961671035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RA,Interleukin-10 receptor subunit alpha,21136,129,0.94 [0.71-1.25],0.6791954486950511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RB,Interleukin-10 receptor subunit beta,21644,130,1.48 [0.90-2.46],0.1241528195555777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL11,Interleukin-11,21136,129,0.98 [0.76-1.27],0.8930731861686374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12A_IL12B,Interleukin-12,21446,131,1.08 [0.89-1.31],0.4287788086909176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12B,Interleukin-12 subunit beta,21768,132,1.08 [0.82-1.42],0.6013302655778079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB1,Interleukin-12 receptor subunit beta-1,21136,129,1.28 [0.85-1.93],0.2312287674198412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB2,Interleukin-12 receptor subunit beta-2,18284,95,1.11 [0.70-1.76],0.6577767660028301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13,Interleukin-13,21136,129,1.15 [0.88-1.51],0.2902727184841477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA1,Interleukin-13 receptor subunit alpha-1,21317,128,0.53 [0.26-1.09],0.0855824975560773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA2,Interleukin-13 receptor subunit alpha-2,18213,94,0.98 [0.49-1.96],0.9607695182054669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,21505,131,1.94 [1.27-2.97],0.0023565827622075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15RA,Interleukin-15 receptor subunit alpha,21136,129,1.43 [0.92-2.23],0.110886658437783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL16,Pro-interleukin-16,21768,132,1.04 [0.73-1.49],0.812766349567951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17A,Interleukin-17A,21104,129,1.28 [0.93-1.75],0.1297043699425305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17C,Interleukin-17C,21136,129,1.21 [1.00-1.46],0.0450975310034794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17D,Interleukin-17D,21136,129,1.35 [0.97-1.89],0.075510727324346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17F,Interleukin-17F,21136,129,1.05 [0.86-1.28],0.6120609685292885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RA,Interleukin-17 receptor A,21578,131,1.05 [0.74-1.48],0.7886559652502645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RB,Interleukin-17 receptor B,21246,131,0.97 [0.72-1.30],0.8318286614583437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,21484,130,1.51 [1.10-2.06],0.0107381284169462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18BP,Interleukin-18-binding protein,21671,132,1.42 [0.89-2.26],0.139742014296184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18R1,Interleukin-18 receptor 1,21768,132,0.99 [0.62-1.59],0.9723048778254092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18RAP,Interleukin-18 receptor accessory protein,21233,132,1.04 [0.95-1.13],0.3809774823659072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,21011,129,1.29 [1.06-1.57],0.0098753658425573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1A,Interleukin-1 alpha,21136,129,0.98 [0.75-1.26],0.8503985334415409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,21037,128,1.38 [1.09-1.74],0.0069243525571985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,21546,130,2.98 [1.62-5.48],0.0004594783901599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R2,Interleukin-1 receptor type 2,21514,130,1.42 [0.65-3.10],0.3817892449383931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RAP,Interleukin-1 receptor accessory protein,21578,131,1.34 [0.96-1.86],0.0813526251007389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL1,Interleukin-1 receptor-like 1,21758,134,1.05 [0.75-1.48],0.7634028106758455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL2,Interleukin-1 receptor-like 2,21136,129,0.75 [0.49-1.13],0.1634835913178379
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,21510,130,1.45 [1.13-1.85],0.003200684129691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2,Interleukin-2,21136,129,0.94 [0.58-1.54],0.8203687538567858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20,Interleukin-20,21136,129,1.25 [0.96-1.62],0.0928070839240739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RA,Interleukin-20 receptor subunit alpha,21136,129,0.83 [0.56-1.25],0.3729354688356858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RB,Interleukin-20 receptor subunit beta,18284,95,0.67 [0.41-1.09],0.1056746219198959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL21R,Interleukin-21 receptor,18284,95,1.03 [0.74-1.44],0.8573849221113227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22,Interleukin-22,18757,97,1.22 [0.94-1.59],0.1319973904406108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22RA1,Interleukin-22 receptor subunit alpha-1,21136,129,0.83 [0.56-1.23],0.3499835917297665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL24,Interleukin-24,21136,129,1.06 [0.79-1.43],0.6878498502836573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL25,Interleukin-25,18103,95,0.79 [0.45-1.40],0.4274189681475628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RA,Interleukin-2 receptor subunit alpha,21387,133,1.31 [0.92-1.87],0.1374400972578073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RB,Interleukin-2 receptor subunit beta,21136,129,0.79 [0.50-1.24],0.3008754112054402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RG,Cytokine receptor common subunit gamma,18757,97,1.42 [0.98-2.06],0.0616140993104012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3,Interleukin-3,18165,95,0.79 [0.61-1.02],0.0709226329717208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31,Interleukin-31,18284,95,1.15 [0.84-1.57],0.3879242366222702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31RA,Interleukin-31 receptor subunit alpha,18204,95,0.89 [0.52-1.51],0.6638989090088906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL32,Interleukin-32,21505,131,1.41 [1.02-1.96],0.0379783720253237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL33,Interleukin-33,21136,129,0.96 [0.64-1.43],0.8224080782861891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL34,Interleukin-34,21028,131,1.13 [0.73-1.75],0.5691927239245025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36A,Interleukin-36 alpha,18284,95,0.95 [0.65-1.37],0.7793475166674801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,18207,95,1.36 [1.11-1.66],0.0032291288294141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3RA,Interleukin-3 receptor subunit alpha,21136,129,0.87 [0.53-1.43],0.5853606411523767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4,Interleukin-4,21136,129,1.12 [0.93-1.36],0.2409546740881991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,21505,131,1.73 [1.19-2.52],0.0044796275475813
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,21136,129,1.10 [1.00-1.21],0.0439125969768773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,21505,131,1.44 [1.12-1.86],0.0049315573439792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,21446,131,1.25 [1.07-1.46],0.0052973734657208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6R,Interleukin-6 receptor subunit alpha,21450,131,1.16 [0.74-1.82],0.506344763927822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6ST,Interleukin-6 receptor subunit beta,21557,132,2.76 [1.20-6.33],0.0168546082305797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7,Interleukin-7,21505,131,0.98 [0.76-1.25],0.8471850106793694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7R,Interleukin-7 receptor subunit alpha,21578,131,0.85 [0.64-1.13],0.2680897098099534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL9,Interleukin-9,18501,97,0.78 [0.51-1.19],0.2411772643822609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,21018,131,1.26 [0.99-1.60],0.0644486510107433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,18757,97,1.53 [1.07-2.20],0.0198302384969108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPA1,Inositol monophosphatase 1,21365,132,1.14 [0.89-1.48],0.2993937198143023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPACT,Protein IMPACT,18809,98,0.80 [0.56-1.14],0.2111508753458114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPG1,Interphotoreceptor matrix proteoglycan 1,18213,94,0.88 [0.44-1.76],0.717655803827367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ING1,Inhibitor of growth protein 1,21022,131,1.12 [0.83-1.51],0.4469934462560933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBB,Inhibin beta B chain,18442,92,1.22 [0.85-1.77],0.2779257834311129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBC,Inhibin beta C chain,21578,131,0.98 [0.67-1.45],0.9338395272404092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP1,Inositol polyphosphate 1-phosphatase,21446,131,1.08 [0.81-1.45],0.5975398469577691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",18378,94,0.83 [0.58-1.20],0.3205726174616761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",18806,96,0.73 [0.43-1.24],0.2491847391197642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",21446,131,1.03 [0.88-1.22],0.6808444141662315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL3,Insulin-like 3,18809,98,0.94 [0.75-1.17],0.5629062731294132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL4,Early placenta insulin-like peptide,18757,97,1.12 [0.78-1.62],0.541887005415941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL5,Insulin-like peptide INSL5,18745,97,1.18 [0.98-1.43],0.0849804588230283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSR,Insulin receptor,18284,95,1.67 [0.55-5.10],0.3688370900998168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IPCEF1,Interactor protein for cytohesin exchange factors 1,21332,132,1.08 [0.91-1.29],0.3794664548471363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IQGAP2,Ras GTPase-activating-like protein IQGAP2,21446,131,1.01 [0.76-1.36],0.9265706873126524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",21144,129,1.06 [0.89-1.27],0.4840905997545219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK1,Interleukin-1 receptor-associated kinase 1,21136,129,0.98 [0.77-1.24],0.8399151995743801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK4,Interleukin-1 receptor-associated kinase 4,21505,131,1.08 [0.93-1.26],0.3244172444254393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,20780,128,0.96 [0.63-1.46],0.831228805682091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM1,Isthmin-1,21505,131,0.86 [0.58-1.29],0.4723401993357915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM2,Isthmin-2,18852,99,1.18 [0.77-1.82],0.4513540756921624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IST1,IST1 homolog,18612,97,0.98 [0.80-1.20],0.8556894508629451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,21505,131,0.57 [0.37-0.90],0.0153784111169139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA2,Integrin alpha-2,18442,92,0.50 [0.28-0.89],0.018820932284371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA5,Integrin alpha-5,21578,131,0.91 [0.49-1.70],0.767918023939476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA6,Integrin alpha-6,21505,131,1.23 [0.93-1.64],0.1456302570091183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAL,Integrin alpha-L,18284,95,1.16 [0.73-1.86],0.5274939347773491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAM,Integrin alpha-M,21578,131,0.68 [0.41-1.13],0.1391028311159844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAV,Integrin alpha-V,21724,133,0.38 [0.15-0.96],0.0408425799675589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAX,Integrin alpha-X,18501,97,1.00 [0.70-1.44],0.9893442025786912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1,Integrin beta-1,21565,132,0.97 [0.47-2.03],0.9430712726839244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP1,Integrin beta-1-binding protein 1,21052,127,1.49 [1.02-2.17],0.0370805650533791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP2,Integrin beta-1-binding protein 2,21144,129,1.03 [0.89-1.18],0.7083841387281504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB2,Integrin beta-2,21438,131,0.85 [0.49-1.49],0.5719171428806094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB5,Integrin beta-5,21637,130,1.16 [0.77-1.75],0.47727283970855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB6,Integrin beta-6,21136,129,1.15 [0.69-1.91],0.6027196462721413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB7,Integrin beta-7,21724,133,1.07 [0.77-1.49],0.693618305383237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,18852,99,1.56 [1.02-2.39],0.0423778192492348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,18873,98,1.90 [0.67-5.36],0.2258078026832976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,21671,132,2.01 [1.33-3.02],0.0008170984117922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,18873,98,2.01 [1.04-3.85],0.0366109772223933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,18757,97,0.91 [0.58-1.43],0.6792593709034531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITM2A,Integral membrane protein 2A,21505,131,1.18 [0.92-1.51],0.2037579500608466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPA,Inosine triphosphate pyrophosphatase,18209,92,0.93 [0.68-1.26],0.6255851683496332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",18378,94,0.95 [0.70-1.28],0.7334262006618177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",18213,94,1.07 [0.69-1.67],0.7592895929521056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",21055,131,0.94 [0.69-1.30],0.7274157159357671
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IZUMO1,Izumo sperm-egg fusion protein 1,18165,95,0.95 [0.61-1.47],0.8183833330923613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,21734,134,2.11 [1.28-3.46],0.0032484033228758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM3,Junctional adhesion molecule C,18442,92,0.86 [0.56-1.31],0.4709530811248743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JCHAIN,Immunoglobulin J chain,21136,129,1.23 [0.96-1.58],0.0965290604810136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,18165,95,1.22 [0.91-1.62],0.1782258070334811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JPT2,Jupiter microtubule associated homolog 2,18745,97,0.96 [0.76-1.20],0.7003542502893696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JUN,Transcription factor AP-1,21136,129,1.19 [0.90-1.57],0.2211639677527526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,21446,131,1.26 [0.89-1.79],0.1986238925321958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZN,Kazrin,18745,97,0.97 [0.81-1.17],0.7686922834713268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNC4,Potassium voltage-gated channel subfamily C member 4,18213,94,1.09 [0.78-1.52],0.6060798643234576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNH2,Potassium voltage-gated channel subfamily H member 2,18334,92,0.81 [0.59-1.13],0.2107087766673004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNIP4,Kv channel-interacting protein 4,21055,131,1.02 [0.75-1.39],0.893752764561804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCTD5,BTB/POZ domain-containing protein KCTD5,18466,98,0.96 [0.62-1.49],0.8577124617522761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDM3A,Lysine-specific demethylase 3A,18284,95,0.94 [0.73-1.22],0.6591908101651425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDR,Vascular endothelial growth factor receptor 2,21637,130,0.61 [0.33-1.12],0.107788295930503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KEL,Kell blood group glycoprotein,21055,131,1.30 [0.85-1.99],0.2250159367815599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHDC3L,KH domain-containing protein 3,18165,95,0.74 [0.50-1.08],0.1189975713780221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHK,Ketohexokinase,18378,94,0.85 [0.61-1.16],0.3028883086248169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA0319,Dyslexia-associated protein KIAA0319,18809,98,0.93 [0.50-1.76],0.8343828223575177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549,UPF0606 protein KIAA1549,18501,97,0.81 [0.61-1.06],0.1288453543018663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549L,UPF0606 protein KIAA1549L,18501,97,0.59 [0.28-1.22],0.1530950684591179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA2013,Uncharacterized protein KIAA2013,18757,97,0.99 [0.68-1.44],0.9565879198033042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF1C,Kinesin-like protein KIF1C,18209,92,1.24 [0.74-2.08],0.4049878137303039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF20B,Kinesin-like protein KIF20B,18213,94,0.89 [0.67-1.18],0.4068339352805212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF22,Kinesin-like protein KIF22,18209,92,1.00 [0.85-1.18],0.9612144304923436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIFBP,KIF-binding protein,21446,131,1.06 [0.88-1.28],0.5229104492035193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,18757,97,1.01 [0.82-1.25],0.9258016133038534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,21052,127,0.97 [0.80-1.18],0.7637114695044298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,18745,97,1.05 [0.94-1.18],0.368839758997909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,21052,127,1.08 [0.96-1.23],0.1979129850977337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18165,95,0.83 [0.61-1.12],0.2248159580873506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL1,Kin of IRRE-like protein 1,18213,94,1.11 [0.81-1.52],0.5124643524022081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL2,Kin of IRRE-like protein 2,21055,131,1.02 [0.69-1.50],0.9190246160789992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIT,Mast/stem cell growth factor receptor Kit,21625,132,0.77 [0.46-1.28],0.3099609730642716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KITLG,Kit ligand,21557,132,1.14 [0.75-1.73],0.5399480606252274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLB,Beta-klotho,21055,131,0.95 [0.77-1.17],0.6021483261937741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLF4,Krueppel-like factor 4,18213,94,1.40 [0.92-2.11],0.1156410065861195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLHL41,Kelch-like protein 41,18806,96,1.24 [0.86-1.78],0.2470294732491322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK1,Kallikrein-1,21357,128,1.08 [0.97-1.21],0.1707013905012946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK10,Kallikrein-10,21574,128,1.25 [0.88-1.78],0.2165457717356422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK11,Kallikrein-11,21432,128,1.55 [1.07-2.25],0.0214408937788898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK12,Kallikrein-12,21052,127,0.90 [0.80-1.00],0.0534146204955392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK13,Kallikrein-13,21076,130,1.11 [0.79-1.54],0.5487080747346067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK14,Kallikrein-14,21724,133,1.45 [1.06-1.98],0.0194305712321553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK15,Kallikrein-15,18718,97,1.18 [0.82-1.70],0.3816534331975171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK3,Prostate-specific antigen,18852,99,0.96 [0.80-1.14],0.630196210222971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,21724,133,1.41 [1.14-1.74],0.0014375002316074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK6,Kallikrein-6,21595,130,1.07 [0.65-1.76],0.7790547421210332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK7,Kallikrein-7,17981,90,1.12 [0.67-1.89],0.659793364250242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK8,Kallikrein-8,20852,121,1.41 [0.93-2.14],0.1025618708675105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLKB1,Plasma kallikrein,18475,97,1.45 [0.65-3.25],0.3666118857506628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRB1,Killer cell lectin-like receptor subfamily B member 1,21768,132,1.30 [0.89-1.90],0.1755689937615425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,18213,94,1.03 [0.74-1.42],0.8828140368787499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRD1,Natural killer cells antigen CD94,21768,132,1.02 [0.74-1.41],0.9085593311446306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRF1,Killer cell lectin-like receptor subfamily F member 1,18284,95,1.01 [0.66-1.54],0.974941957299908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRK1,NKG2-D type II integral membrane protein,18809,98,1.12 [0.74-1.68],0.59184236591544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT14,"Keratin, type I cytoskeletal 14",20403,127,1.01 [0.59-1.73],0.9719157810295086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT17,"Keratin, type I cytoskeletal 17",18209,92,1.60 [1.10-2.31],0.0132090586763962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT18,"Keratin, type I cytoskeletal 18",21446,131,1.15 [0.96-1.37],0.1325744149676112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT19,"Keratin, type I cytoskeletal 19",21464,131,1.26 [1.03-1.56],0.027599048672801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT5,"Keratin, type II cytoskeletal 5",21055,131,1.01 [0.74-1.37],0.9448165047118562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT6C,"Keratin, type II cytoskeletal 6C",18209,92,0.71 [0.38-1.34],0.2918130888062912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT8,"Keratin, type II cytoskeletal 8",18213,94,1.05 [0.85-1.31],0.6317158739737088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYAT1,Kynurenine--oxoglutarate transaminase 1,21529,132,1.08 [0.82-1.41],0.5956433393557445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYNU,Kynureninase,21768,132,1.04 [0.74-1.47],0.8247937903641083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L1CAM,Neural cell adhesion molecule L1,21637,130,1.04 [0.61-1.76],0.8874228788997381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,18843,97,0.99 [0.80-1.23],0.9418567068994226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACRT,Extracellular glycoprotein lacritin,18724,97,0.87 [0.57-1.33],0.5176129732092349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACTB2,Endoribonuclease LACTB2,21557,132,1.07 [0.85-1.36],0.5527822863119378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAG3,Lymphocyte activation gene 3 protein,21446,131,0.77 [0.51-1.15],0.1961431625255666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,21549,130,1.69 [1.22-2.33],0.0013780342006126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,21365,132,1.12 [0.96-1.31],0.135166730545091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA1,Laminin subunit alpha-1,18209,92,1.01 [0.69-1.48],0.9489276708899648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA4,Laminin subunit alpha-4,21644,130,1.71 [1.09-2.66],0.0188831023617916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMB1,Laminin subunit beta-1,18378,94,1.33 [0.69-2.58],0.3934558853395579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP1,Lysosome-associated membrane glycoprotein 1,18316,97,0.90 [0.43-1.91],0.7834943428094138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP2,Lysosome-associated membrane glycoprotein 2,20901,127,1.95 [0.87-4.40],0.1052697727691719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,21736,131,1.32 [0.99-1.76],0.0616860578920254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMTOR5,Ragulator complex protein LAMTOR5,18757,97,0.89 [0.53-1.48],0.6478830248951799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAP3,Cytosol aminopeptidase,21136,129,1.20 [0.89-1.63],0.224435081478711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LARP1,La-related protein 1,18757,97,0.91 [0.66-1.27],0.5925500551266568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT,Linker for activation of T-cells family member 1,21768,132,1.07 [0.87-1.31],0.5441262930128555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT2,Linker for activation of T-cells family member 2,21446,131,1.04 [0.91-1.17],0.5852451140541164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LATS1,Serine/threonine-protein kinase LATS1,18284,95,1.03 [0.81-1.30],0.8272354589659041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,21332,132,1.75 [1.19-2.57],0.0040593425599066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBP,Lipopolysaccharide-binding protein,21671,132,1.29 [0.99-1.67],0.0555736080120072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBR,Delta(14)-sterol reductase LBR,21734,134,1.12 [0.92-1.38],0.2539487113206002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCAT,Phosphatidylcholine-sterol acyltransferase,18856,97,0.53 [0.25-1.13],0.1014820035222388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN15,Lipocalin-15,18806,96,1.05 [0.78-1.43],0.7320916763837557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN2,Neutrophil gelatinase-associated lipocalin,20958,126,1.12 [0.76-1.65],0.5705959023381588
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCP1,Plastin-2,18852,99,1.24 [0.86-1.78],0.2549439495915611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLR,Low-density lipoprotein receptor,21617,132,0.81 [0.60-1.10],0.1789253743186248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLRAP1,Low density lipoprotein receptor adapter protein 1,18806,96,1.07 [0.88-1.31],0.4936810956066553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,18843,97,1.45 [1.10-1.92],0.0094787835160973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEFTY2,Left-right determination factor 2,21686,133,1.11 [0.82-1.50],0.5162365380238575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEG1,Protein LEG1 homolog,17851,91,1.05 [0.78-1.40],0.765849080285262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LELP1,Late cornified envelope-like proline-rich protein 1,18213,94,0.87 [0.65-1.18],0.3775393178304167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEO1,RNA polymerase-associated protein LEO1,18806,96,0.81 [0.40-1.64],0.5653487523414058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEP,Leptin,21557,132,0.99 [0.78-1.25],0.9415048954884656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEPR,Leptin receptor,21557,132,1.12 [0.69-1.82],0.6603450147211627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LETM1,Mitochondrial proton/calcium exchanger protein,18806,96,1.15 [0.81-1.64],0.426633151644036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,21557,132,1.73 [1.15-2.61],0.0082127933369514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3,Galectin-3,21618,134,1.27 [0.77-2.10],0.3538433099988519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3BP,Galectin-3-binding protein,18873,98,1.27 [0.71-2.26],0.4149650283413419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS4,Galectin-4,21549,130,1.40 [1.08-1.81],0.0106258404375171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,21457,132,1.56 [1.18-2.07],0.001643695586872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS8,Galectin-8,21734,134,1.03 [0.80-1.33],0.8048246161408827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,21547,130,1.65 [1.03-2.63],0.0369901021716395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGMN,Legumain,21644,130,1.24 [0.81-1.91],0.3162814241237897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHB,Lutropin subunit beta,21052,127,1.13 [0.97-1.33],0.118015085121854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,21573,130,0.98 [0.76-1.27],0.8833020935896332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIF,Leukemia inhibitory factor,21055,131,0.85 [0.61-1.19],0.3368343356278015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,21505,131,1.87 [1.00-3.49],0.0502349562621517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,21578,131,0.99 [0.65-1.52],0.9726310685237882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,18852,99,0.99 [0.87-1.13],0.8499994236807834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,18209,92,1.10 [0.76-1.59],0.628771389034501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,21515,132,1.06 [0.66-1.71],0.7996699442375669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,18843,97,1.08 [0.83-1.40],0.5868417593006714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,21821,134,1.13 [0.65-1.97],0.6602356134926933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,21732,134,1.57 [0.99-2.48],0.0530963028754162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,21136,129,1.47 [1.05-2.05],0.0241235200720961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,21821,134,1.02 [0.82-1.27],0.8402540894588839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIPF,Gastric triacylglycerol lipase,18378,94,1.06 [0.77-1.44],0.7284527467075503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB1,Lamin-B1,18715,97,1.14 [0.86-1.52],0.3622878201953421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB2,Lamin-B2,18809,98,1.22 [0.62-2.42],0.5689597847621005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,18806,96,2.33 [1.64-3.31],2.3697645658697807e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD2,Leiomodin-2,18213,94,0.80 [0.55-1.16],0.2385707940937087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LONP1,"Lon protease homolog, mitochondrial",18378,94,0.94 [0.74-1.19],0.5818945620776914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPA,Apolipoprotein(a),18444,97,1.03 [0.92-1.15],0.5937331228172122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPCAT2,Lysophosphatidylcholine acyltransferase 2,21446,131,1.14 [0.85-1.54],0.3668840978040998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPL,Lipoprotein lipase,21557,132,0.93 [0.67-1.29],0.6815353276002893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPO,Lactoperoxidase,20823,128,1.06 [0.82-1.37],0.6698352686932738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPP,Lipoma-preferred partner,18209,92,1.16 [0.85-1.58],0.344204299118652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,18209,92,1.03 [0.76-1.39],0.8557326980235104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,18334,92,0.97 [0.60-1.54],0.8840802837049516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRG1,Leucine-rich alpha-2-glycoprotein,18873,98,2.24 [1.12-4.46],0.0223222471706591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,21652,133,1.47 [0.96-2.25],0.0778744129153058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,18221,95,1.76 [1.05-2.94],0.0305834629063038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP1,Prolow-density lipoprotein receptor-related protein 1,21446,131,1.05 [0.59-1.88],0.8708021688072145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,21557,132,1.91 [1.29-2.84],0.0012419743187755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2,Low-density lipoprotein receptor-related protein 2,18334,92,0.69 [0.37-1.26],0.2263687747370205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2BP,LRP2-binding protein,18334,92,0.79 [0.58-1.07],0.1320599447445585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,21734,134,0.89 [0.67-1.19],0.4417731859500553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC25,Leucine-rich repeat-containing protein 25,21446,131,1.17 [0.80-1.73],0.4137495138352615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC37A2,Leucine-rich repeat-containing protein 37A2,18745,97,1.12 [0.72-1.76],0.6105755044396644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC38,Leucine-rich repeat-containing protein 38,18334,92,1.12 [0.75-1.68],0.5696245890888618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC59,Leucine-rich repeat-containing protein 59,18843,97,0.95 [0.63-1.44],0.8089491708445904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,18757,97,1.00 [0.66-1.51],0.990774075052853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,21136,129,0.61 [0.41-0.91],0.0141731046269097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,18334,92,1.66 [1.23-2.25],0.0009613350805506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,18806,96,0.61 [0.28-1.36],0.2263028123886076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM1,U6 snRNA-associated Sm-like protein LSm1,21052,127,1.04 [0.80-1.37],0.7607180747915866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM8,U6 snRNA-associated Sm-like protein LSm8,18501,97,0.74 [0.54-1.02],0.0662104578116303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSP1,Lymphocyte-specific protein 1,21505,131,1.09 [0.75-1.60],0.6521309223099587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA,Lymphotoxin-alpha,21505,131,0.78 [0.52-1.15],0.2035281150529884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA4H,Leukotriene A-4 hydrolase,21724,133,0.96 [0.74-1.24],0.7367957391686504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTB,Lymphotoxin-beta,18757,97,0.83 [0.45-1.52],0.541072511804484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,21821,134,2.58 [1.68-3.98],1.676481964602369e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP3,Latent-transforming growth factor beta-binding protein 3,21052,127,1.14 [0.86-1.50],0.3613348130274127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,21457,130,2.05 [1.27-3.29],0.0030629461205501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTO1,Protein LTO1 homolog,21136,129,0.92 [0.62-1.38],0.7000591764282214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LUZP2,Leucine zipper protein 2,18757,97,0.92 [0.59-1.44],0.7183108605549129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LXN,Latexin,21273,131,0.96 [0.77-1.21],0.7492077788825792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,21446,129,1.65 [1.17-2.31],0.0041514818879468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY75,Lymphocyte antigen 75,21505,131,1.09 [0.73-1.63],0.6798822228752912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY9,T-lymphocyte surface antigen Ly-9,21285,131,1.28 [0.77-2.14],0.3437451493193115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY96,Lymphocyte antigen 96,21365,132,1.26 [0.83-1.90],0.276826321602575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYAR,Cell growth-regulating nucleolar protein,21052,127,0.83 [0.59-1.16],0.2841907897754923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYN,Tyrosine-protein kinase Lyn,21446,131,1.12 [0.94-1.35],0.2127513206183803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD1,Ly6/PLAUR domain-containing protein 1,21055,131,1.00 [0.78-1.28],0.985810332038982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD3,Ly6/PLAUR domain-containing protein 3,21458,129,0.86 [0.54-1.38],0.5409813608248153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD8,Ly6/PLAUR domain-containing protein 8,21052,127,1.23 [0.93-1.61],0.1402463154538741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPLA2,Acyl-protein thioesterase 2,18213,94,0.96 [0.79-1.16],0.6477593932097256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,18334,92,0.82 [0.65-1.03],0.0841423000138904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,18873,98,0.96 [0.36-2.57],0.9300873660727682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYZL2,Lysozyme-like protein 2,18165,95,0.62 [0.33-1.15],0.1307183004644667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LZTFL1,Leucine zipper transcription factor-like protein 1,18442,92,0.95 [0.71-1.27],0.7221807786678744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,M6PR,Cation-dependent mannose-6-phosphate receptor,18378,94,1.03 [0.63-1.68],0.9198155171077502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,21288,132,1.28 [1.01-1.62],0.0378214666153155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAEA,E3 ubiquitin-protein transferase MAEA,21052,127,0.88 [0.57-1.36],0.5675700360756335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAG,Myelin-associated glycoprotein,18334,92,0.88 [0.59-1.31],0.5176990242029944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,18501,97,0.80 [0.68-0.94],0.0060924302854672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGED1,Melanoma-associated antigen D1,21052,127,1.15 [0.84-1.57],0.3947278043233374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC2,MAM domain-containing protein 2,18843,97,1.03 [0.60-1.78],0.9127152225878924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC4,Apical endosomal glycoprotein,18757,97,1.04 [0.73-1.47],0.8449065397548544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",18378,94,1.51 [0.69-3.31],0.3045601087920974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN2B2,Epididymis-specific alpha-mannosidase,18843,97,1.04 [0.75-1.44],0.8121642289161741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",18165,95,0.93 [0.63-1.38],0.7235996106167271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANF,Mesencephalic astrocyte-derived neurotrophic factor,21644,130,1.07 [0.94-1.23],0.2880245057270342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC1,MANSC domain-containing protein 1,21637,130,1.70 [0.99-2.92],0.0525889450527943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC4,MANSC domain-containing protein 4,18209,92,1.06 [0.81-1.40],0.6633191085617436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,18213,94,0.84 [0.45-1.58],0.5850741233036398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,18209,92,1.29 [1.05-1.57],0.0140451544724304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2,Microtubule-associated protein 2,18809,98,1.20 [0.81-1.79],0.3615485054853743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,18745,97,0.87 [0.64-1.18],0.3758825586324976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,21505,131,1.09 [0.93-1.27],0.308501751165035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,21052,127,0.96 [0.81-1.14],0.6563828441002086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,21332,132,1.06 [0.92-1.21],0.4519727215445159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK13,Mitogen-activated protein kinase 13,18165,95,1.19 [0.79-1.81],0.4034344269478946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK9,Mitogen-activated protein kinase 9,21505,131,0.96 [0.66-1.39],0.814457422610422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPKAPK2,MAP kinase-activated protein kinase 2,18501,97,0.90 [0.68-1.17],0.42206251870922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPRE3,Microtubule-associated protein RP/EB family member 3,18165,95,0.95 [0.81-1.10],0.4922674723999047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPT,Microtubule-associated protein tau,21055,131,1.18 [0.87-1.60],0.2812250993694737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARCO,Macrophage receptor MARCO,21557,132,1.08 [0.60-1.94],0.8100140204435781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARS1,"Methionine--tRNA ligase, cytoplasmic",18414,92,0.94 [0.74-1.20],0.6440420228018093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MASP1,Mannan-binding lectin serine protease 1,21332,132,1.29 [0.66-2.51],0.4589816275828828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,21582,130,2.57 [1.53-4.30],0.0003492315063916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN3,Matrilin-3,21332,132,1.38 [0.89-2.16],0.1533944921637836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAVS,Mitochondrial antiviral-signaling protein,21052,127,1.04 [0.87-1.24],0.6555961733234554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAX,Protein max,21055,131,1.02 [0.88-1.19],0.7710443463151629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MB,Myoglobin,21821,134,1.43 [1.11-1.84],0.0053356774401376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MBL2,Mannose-binding protein C,18612,97,1.08 [0.90-1.29],0.3948704215360754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCAM,Cell surface glycoprotein MUC18,21671,132,1.41 [0.90-2.20],0.1333615769748632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",18806,96,1.05 [0.66-1.64],0.8486985191033619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEMP1,Mast cell-expressed membrane protein 1,18284,95,1.11 [0.89-1.38],0.3534135445754948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCFD2,Multiple coagulation factor deficiency protein 2,21446,132,1.33 [0.94-1.89],0.1071914222899795
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCTS1,Malignant T-cell-amplified sequence 1,18745,97,0.74 [0.33-1.65],0.4660152325200113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,21365,132,1.26 [1.01-1.58],0.0441840348550332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDH1,"Malate dehydrogenase, cytoplasmic",18759,97,0.82 [0.49-1.37],0.4485489185836959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,21583,130,1.48 [1.19-1.85],0.0004141308435581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDM1,Nuclear protein MDM1,18334,92,0.93 [0.48-1.80],0.8309906608537602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",18378,94,0.99 [0.80-1.24],0.9475591846811238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED18,Mediator of RNA polymerase II transcription subunit 18,21052,127,1.18 [0.96-1.46],0.1141508797044676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED21,Mediator of RNA polymerase II transcription subunit 21,18209,92,0.87 [0.55-1.38],0.5490150550933747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF10,Multiple epidermal growth factor-like domains protein 10,21549,130,1.32 [0.88-1.98],0.1786798551861513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF11,Multiple epidermal growth factor-like domains protein 11,18209,92,1.55 [0.97-2.47],0.0678007564373723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF9,Multiple epidermal growth factor-like domains protein 9,21758,134,0.73 [0.33-1.62],0.4355092890186968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MELTF,Melanotransferrin,18843,97,1.26 [0.67-2.37],0.4777218026602848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MENT,Protein MENT,18442,92,1.41 [0.60-3.31],0.4280555263383244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1A,Meprin A subunit alpha,18745,97,0.97 [0.74-1.27],0.8407914596734958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1B,Meprin A subunit beta,21557,132,1.02 [0.90-1.17],0.725189889320665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEPE,Matrix extracellular phosphoglycoprotein,21549,130,0.74 [0.41-1.34],0.3178111929882475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,21768,132,1.83 [1.01-3.33],0.0471088027265562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MESD,LRP chaperone MESD,21578,131,1.08 [0.95-1.22],0.2527583740489544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MET,Hepatocyte growth factor receptor,21611,131,0.93 [0.43-2.02],0.8572653388684859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1,Methionine aminopeptidase 1,21055,131,0.90 [0.52-1.54],0.6927148577779592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",21505,131,1.10 [0.91-1.32],0.3326308043616481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP2,Methionine aminopeptidase 2,21686,133,1.11 [0.84-1.46],0.4579049533729464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3,Microfibril-associated glycoprotein 3,21144,129,0.85 [0.60-1.20],0.356789871943731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3L,Microfibrillar-associated protein 3-like,18334,92,0.72 [0.48-1.08],0.1168582365296821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP4,Microfibril-associated glycoprotein 4,18442,92,1.14 [0.61-2.13],0.6721574775462373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP5,Microfibrillar-associated protein 5,21821,134,1.21 [0.83-1.77],0.3191120373937839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFGE8,Lactadherin,21578,131,1.19 [0.84-1.68],0.3356308689822306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGLL,Monoglyceride lipase,21610,130,1.08 [0.90-1.29],0.4117040161625314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGMT,Methylated-DNA--protein-cysteine methyltransferase,21505,131,1.08 [0.94-1.23],0.2644887269431936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIA,Melanoma-derived growth regulatory protein,21637,130,1.18 [0.79-1.78],0.4227332614748486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICALL2,MICAL-like protein 2,18334,92,0.91 [0.67-1.26],0.5804503830143639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,21505,131,0.99 [0.90-1.10],0.8762899331270012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIF,Macrophage migration inhibitory factor,21544,131,1.15 [0.91-1.45],0.253007224146973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MILR1,Allergin-1,21136,129,1.04 [0.76-1.41],0.8150319168624718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,18757,97,1.03 [0.86-1.24],0.7110224487306123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINK1,Misshapen-like kinase 1,18809,98,0.93 [0.75-1.14],0.4893159898959441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MITD1,MIT domain-containing protein 1,21365,132,1.06 [0.90-1.24],0.4952425279058124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MKI67,Proliferation marker protein Ki-67,18284,95,1.08 [0.67-1.76],0.7509061659970067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLLT1,Protein ENL,18165,95,0.77 [0.54-1.09],0.1384007519397662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLN,Promotilin,21505,131,1.22 [1.02-1.46],0.0276754785608345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MME,Neprilysin,21446,131,1.12 [0.93-1.35],0.2415711495946703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP1,Interstitial collagenase,20762,125,1.19 [0.99-1.42],0.0646899942749723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP10,Stromelysin-2,21500,129,1.30 [1.02-1.66],0.0358658023380936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP12,Macrophage metalloelastase,21548,133,1.14 [0.87-1.50],0.3463702352330033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP13,Collagenase 3,21055,131,1.08 [0.67-1.75],0.7387169044969043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP15,Matrix metalloproteinase-15,18843,97,0.78 [0.48-1.29],0.3420557309768443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP3,Stromelysin-1,21578,131,1.25 [0.93-1.69],0.1352049089123672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,21108,129,1.74 [1.25-2.42],0.0009078819381806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,21693,134,1.35 [1.12-1.64],0.0019909858476154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,21541,131,1.40 [1.09-1.81],0.0096320815806207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",18209,92,1.48 [1.06-2.06],0.0228195585553457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MN1,Transcriptional activator MN1,18334,92,0.67 [0.44-1.03],0.0688215676627968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNAT1,CDK-activating kinase assembly factor MAT1,18501,97,1.24 [0.84-1.83],0.2811668607186783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNDA,Myeloid cell nuclear differentiation antigen,21519,132,1.14 [1.00-1.30],0.0558183880431332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOCS2,Molybdopterin synthase catalytic subunit,18442,92,0.90 [0.65-1.23],0.4930100150519548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOG,Myelin-oligodendrocyte glycoprotein,21724,133,1.17 [0.74-1.83],0.5000345802689994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORC3,MORC family CW-type zinc finger protein 3,18809,98,0.80 [0.38-1.69],0.5559573657120643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L1,Mortality factor 4-like protein 1,18501,97,1.32 [0.90-1.94],0.152920508621973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L2,Mortality factor 4-like protein 2,18165,95,0.93 [0.54-1.62],0.8008405747884279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORN4,MORN repeat-containing protein 4,18165,95,1.06 [0.84-1.34],0.609730401894883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPHOSPH8,M-phase phosphoprotein 8,21144,129,1.07 [0.87-1.31],0.5489482777143364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPI,Mannose-6-phosphate isomerase,21446,131,1.17 [0.98-1.41],0.0828080916541932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,21610,130,1.04 [0.85-1.28],0.7093144740105021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,21578,131,1.34 [1.00-1.81],0.04995010373256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPRIP,Myosin phosphatase Rho-interacting protein,18718,97,1.06 [0.68-1.66],0.7910611091734778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRC1,Macrophage mannose receptor 1,18856,97,1.68 [0.87-3.24],0.1210333997759441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRI1,Methylthioribose-1-phosphate isomerase,18334,92,0.79 [0.59-1.06],0.1115922863755579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL24,"39S ribosomal protein L24, mitochondrial",18209,92,0.84 [0.47-1.51],0.5662875335172812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL28,"39S ribosomal protein L28, mitochondrial",18806,96,0.89 [0.49-1.61],0.7052729451218114
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL46,"39S ribosomal protein L46, mitochondrial",21055,131,1.31 [0.79-2.17],0.2955234862818086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL52,"39S ribosomal protein L52, mitochondrial",18122,95,1.11 [0.58-2.14],0.7551354212794978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",18806,96,1.19 [0.95-1.49],0.1285959215646437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPS16,"28S ribosomal protein S16, mitochondrial",18284,95,0.85 [0.39-1.86],0.6882467841021453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLN,Mesothelin,21404,131,1.13 [0.88-1.46],0.3231733169965498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLNL,Mesothelin-like protein,18334,92,0.85 [0.49-1.48],0.5666995015204415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSMB,Beta-microseminoprotein,21512,134,1.09 [0.88-1.34],0.4333478179750568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSR1,Macrophage scavenger receptor types I and II,21734,134,1.01 [0.73-1.41],0.9417681756237558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSRA,Mitochondrial peptide methionine sulfoxide reductase,21637,130,1.15 [0.92-1.42],0.2152958720106434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MST1,Hepatocyte growth factor-like protein,18564,97,1.02 [0.75-1.37],0.9158072794478838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSTN,Growth/differentiation factor 8,21144,129,0.99 [0.74-1.33],0.962073376795154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTDH,Protein LYRIC,18284,95,1.07 [0.87-1.32],0.5204096483599167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",18809,98,0.77 [0.34-1.73],0.5217639617098415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,18501,97,0.99 [0.83-1.18],0.9397745953171864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTIF3,"Translation initiation factor IF-3, mitochondrial",18745,97,0.98 [0.78-1.23],0.8668415617273341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTPN,Myotrophin,21144,129,0.80 [0.47-1.34],0.3909569202947202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTR,Methionine synthase,18209,92,0.86 [0.61-1.22],0.4027874349305551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS1,Protein MTSS 1,18745,97,0.91 [0.76-1.08],0.2837751990834876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS2,Protein MTSS 2,18757,97,1.07 [0.88-1.30],0.52193263928928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTUS1,Microtubule-associated tumor suppressor 1,18501,97,1.10 [0.79-1.53],0.5843138858231611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC13,Mucin-13,21055,131,1.33 [1.00-1.78],0.0512571724114151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC16,Mucin-16,21446,131,1.00 [0.92-1.08],0.9336894344217996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC2,Mucin-2,18852,99,0.91 [0.74-1.13],0.3993411564407915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUCL3,Mucin-like protein 3,18165,95,1.09 [0.71-1.67],0.7033206684246952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MVK,Mevalonate kinase,21136,129,1.08 [0.89-1.31],0.4544467070211357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MXRA8,Matrix remodeling-associated protein 8,18442,92,0.73 [0.38-1.41],0.3479566358125338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",18843,97,1.40 [1.10-1.77],0.0061135498494027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC2,"Myosin-binding protein C, fast-type",18378,94,1.18 [0.97-1.43],0.0992305537750124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,18806,96,1.21 [0.92-1.58],0.1685353221730453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYDGF,Myeloid-derived growth factor,18843,97,1.02 [0.84-1.25],0.8316800928768064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH4,Myosin-4,18209,92,0.89 [0.55-1.44],0.6424777783473619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH7B,Myosin-7B,18165,95,0.84 [0.51-1.37],0.4859197055887583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH9,Myosin-9,18852,99,0.89 [0.75-1.06],0.1837323206521819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",18209,92,0.73 [0.40-1.31],0.2855640949370226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL3,Myosin light chain 3,18378,94,1.30 [1.00-1.69],0.0484757233680242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL4,Myosin light chain 4,18378,94,1.01 [0.70-1.46],0.9568224941866192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL6B,Myosin light chain 6B,18334,92,0.82 [0.63-1.07],0.1421518491543432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",18334,92,1.29 [0.93-1.79],0.1279313812776286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO6,Unconventional myosin-VI,18806,96,0.96 [0.56-1.66],0.8856883508102553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO9B,Unconventional myosin-IXb,21136,129,1.00 [0.78-1.27],0.9856968125955772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOC,Myocilin,21578,131,1.15 [0.81-1.64],0.4269838009274614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM1,Myomesin-1,18213,94,0.78 [0.47-1.29],0.3276066139683963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM2,Myomesin-2,18209,92,1.25 [0.88-1.77],0.2117805198992308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM3,Myomesin-3,18442,92,1.22 [0.99-1.50],0.068701120574629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZB1,Marginal zone B- and B1-cell-specific protein,21616,130,1.26 [0.94-1.68],0.1229318103915722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZT1,Mitotic-spindle organizing protein 1,21052,127,1.01 [0.73-1.39],0.9489312754058036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA10,N-alpha-acetyltransferase 10,18209,92,1.43 [0.97-2.11],0.0739071549491301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA80,N-alpha-acetyltransferase 80,18334,92,1.00 [0.85-1.19],0.9595545022490002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAAA,N-acylethanolamine-hydrolyzing acid amidase,21270,131,0.85 [0.65-1.12],0.2478462606727142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NACC1,Nucleus accumbens-associated protein 1,18757,97,1.09 [0.77-1.53],0.6349746635683513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NADK,NAD kinase,21557,132,1.19 [0.93-1.52],0.1718539883806537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGA,Alpha-N-acetylgalactosaminidase,18239,95,0.66 [0.42-1.06],0.0846550359089709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGK,N-acetyl-D-glucosamine kinase,18344,94,0.69 [0.47-1.00],0.0484311049810394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,18442,92,0.55 [0.22-1.36],0.1983349721027239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAMPT,Nicotinamide phosphoribosyltransferase,21052,127,1.04 [0.79-1.37],0.7551701704254712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAP1L4,Nucleosome assembly protein 1-like 4,18701,97,0.62 [0.41-0.94],0.0239767099657155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAPRT,Nicotinate phosphoribosyltransferase,18809,98,0.68 [0.36-1.28],0.2353021426184978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NARS1,"Asparagine--tRNA ligase, cytoplasmic",18806,96,0.77 [0.51-1.15],0.196139278461116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,21637,130,2.43 [1.43-4.11],0.0009670661789587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBN,Nibrin,21136,129,0.93 [0.69-1.27],0.6566458950127612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM1,Neural cell adhesion molecule 1,21671,132,1.44 [0.89-2.33],0.137097651876366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM2,Neural cell adhesion molecule 2,21578,131,1.65 [0.94-2.92],0.0833177578818094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAN,Neurocan core protein,21734,134,0.76 [0.51-1.12],0.1681551583594331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCF2,Neutrophil cytosol factor 2,21477,131,1.16 [0.99-1.36],0.0720604269513371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCK2,Cytoplasmic protein NCK2,21644,130,1.09 [0.94-1.27],0.2295564966965456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCLN,Nicalin,21136,129,0.53 [0.33-0.87],0.0120874261040352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR1,Natural cytotoxicity triggering receptor 1,21474,130,1.10 [0.73-1.64],0.6509012987161824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,18745,97,1.44 [0.83-2.52],0.1941209796459791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,21724,133,2.69 [1.62-4.49],0.000140727970612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDRG1,Protein NDRG1,21055,131,0.95 [0.73-1.22],0.6635502770457979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,18757,97,0.87 [0.61-1.24],0.4372035262417334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,18261,95,1.11 [0.63-1.96],0.7297549978514761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,18745,97,0.94 [0.75-1.17],0.5780458860273987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",21052,127,1.05 [0.86-1.27],0.6219001014514853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEB,Nebulin,18209,92,1.37 [0.92-2.06],0.1253488252717169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECAP2,Adaptin ear-binding coat-associated protein 2,18209,92,1.06 [0.80-1.42],0.675409030434112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN1,Nectin-1,18284,95,0.94 [0.51-1.73],0.834484866093449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,21515,132,1.96 [1.23-3.11],0.0043834198732637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN4,Nectin-4,21637,130,1.66 [1.10-2.50],0.0156721280868213
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,18284,95,0.77 [0.52-1.13],0.1767579281986989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD9,Enhancer of filamentation 1,18284,95,0.92 [0.50-1.68],0.7764336565764578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,20993,130,1.70 [1.25-2.30],0.0006346161205547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEK7,Serine/threonine-protein kinase Nek7,18501,97,1.00 [0.76-1.30],0.9838445958028496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL1,Protein kinase C-binding protein NELL1,21637,130,0.94 [0.65-1.35],0.7252939353557002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL2,Protein kinase C-binding protein NELL2,21644,130,0.76 [0.44-1.30],0.3131583330111495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NENF,Neudesin,18757,97,0.96 [0.79-1.15],0.6331948635781263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEO1,Neogenin,18806,96,1.00 [0.41-2.42],0.998617322256496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEXN,Nexilin,18856,97,0.93 [0.70-1.25],0.6351169106628289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFASC,Neurofascin,21768,132,1.77 [1.06-2.97],0.0286910196637796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFAT5,Nuclear factor of activated T-cells 5,18284,95,0.92 [0.72-1.18],0.5210269380994699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",21505,131,0.96 [0.82-1.13],0.6519156978809018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",21136,129,0.92 [0.70-1.21],0.5576227264396583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFE2,Transcription factor NF-E2 45 kDa subunit,18378,94,0.86 [0.65-1.14],0.2998874379865509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFIC,Nuclear factor 1 C-type,18806,96,0.81 [0.47-1.38],0.4315038013737241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB1,Nuclear factor NF-kappa-B p105 subunit,18209,92,0.99 [0.75-1.31],0.9413112205309704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB2,Nuclear factor NF-kappa-B p100 subunit,18501,97,0.53 [0.29-0.95],0.0333495198852515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKBIE,NF-kappa-B inhibitor epsilon,21052,127,1.38 [1.03-1.86],0.0325021306880372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",18745,97,1.03 [0.85-1.25],0.7283189652317617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFX1,Transcriptional repressor NF-X1,18209,92,0.94 [0.69-1.28],0.7042026271454616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFYA,Nuclear transcription factor Y subunit alpha,18209,92,1.09 [0.68-1.76],0.7209544137575288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGF,Beta-nerve growth factor,21365,132,0.95 [0.27-3.41],0.9395639006847925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGFR,Tumor necrosis factor receptor superfamily member 16,18843,97,0.75 [0.37-1.54],0.4397268109081457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGRN,Neugrin,18809,98,1.26 [0.57-2.78],0.5685252633444247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NHLRC3,NHL repeat-containing protein 3,17984,91,1.43 [0.75-2.74],0.2773659178548371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID1,Nidogen-1,21589,132,1.31 [0.88-1.96],0.1832084648421169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID2,Nidogen-2,21578,131,1.05 [0.85-1.29],0.6568682746304757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NINJ1,Ninjurin-1,21052,127,0.73 [0.50-1.06],0.0960854641523199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT1,Deaminated glutathione amidase,18378,94,0.71 [0.48-1.07],0.1025726406186445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT2,Omega-amidase NIT2,18772,96,0.91 [0.69-1.19],0.4876068862268241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN1,Neuroligin-1,18334,92,0.86 [0.60-1.22],0.391219349321645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN2,Neuroligin-2,18213,94,0.95 [0.61-1.47],0.8132670724381925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME1,Nucleoside diphosphate kinase A,18284,95,0.56 [0.22-1.46],0.238387867156804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME3,Nucleoside diphosphate kinase 3,21582,130,1.36 [0.73-2.52],0.329358936250237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMI,N-myc-interactor,18700,97,1.09 [0.83-1.43],0.5260705639922183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,21365,132,1.13 [0.95-1.35],0.1742604461802004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMRK2,Nicotinamide riboside kinase 2,18165,95,0.86 [0.50-1.49],0.5962417299022982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,18806,96,0.87 [0.63-1.21],0.4084112140311086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOMO1,Nodal modulator 1,21578,131,0.92 [0.47-1.79],0.7967595434108905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOP56,Nucleolar protein 56,18209,92,0.79 [0.62-1.01],0.0608921501507419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS1,"Nitric oxide synthase, brain",21055,131,1.44 [1.10-1.88],0.0077507512881446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS2,"Nitric oxide synthase, inducible",18209,92,0.86 [0.50-1.48],0.584111197258262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS3,"Nitric oxide synthase, endothelial",21055,131,1.10 [0.84-1.44],0.4715178969868513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH1,Neurogenic locus notch homolog protein 1,21821,134,1.35 [0.52-3.53],0.537638525354776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH2,Neurogenic locus notch homolog protein 2,18852,99,1.02 [0.42-2.44],0.9723749118665184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,21821,134,1.71 [1.09-2.68],0.0190601009302675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,18527,98,1.70 [1.08-2.67],0.0228157558530571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,21557,132,2.17 [1.50-3.12],3.201582976030288e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS1,Nephrin,18284,95,0.92 [0.50-1.68],0.777418811679116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS2,Podocin,18284,95,1.06 [0.88-1.26],0.5507494257782266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPL,N-acetylneuraminate lyase,18843,97,0.92 [0.60-1.41],0.7048251799234023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,21144,129,1.23 [1.11-1.38],0.0001666954850348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPC,C-type natriuretic peptide,21505,131,1.09 [0.81-1.47],0.5551734111446728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPR1,Atrial natriuretic peptide receptor 1,18209,92,1.32 [0.87-2.02],0.1952189624805161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTN,Neuroplastin,21052,127,1.17 [1.00-1.38],0.0523477036288627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX1,Neuronal pentraxin-1,21578,131,0.99 [0.67-1.45],0.9461921761017332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX2,Neuronal pentraxin-2,18852,99,0.98 [0.55-1.75],0.9392087164476408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTXR,Neuronal pentraxin receptor,21557,132,0.96 [0.61-1.50],0.8450971806797639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPY,Pro-neuropeptide Y,21724,133,1.12 [0.88-1.42],0.3597965936371524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRCAM,Neuronal cell adhesion molecule,21557,132,1.03 [0.60-1.77],0.9205636014701116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRGN,Neurogranin,18856,97,1.03 [0.83-1.28],0.7919676215796873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRN1,Neuritin,18806,96,0.66 [0.34-1.29],0.225928241349529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,21700,132,2.14 [1.26-3.64],0.0048092865047979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP2,Neuropilin-2,21578,131,1.39 [0.83-2.34],0.2120713420429418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRTN,Neurturin,21136,129,0.90 [0.65-1.24],0.516073643776364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRXN3,Neurexin-3,18334,92,0.96 [0.54-1.72],0.8930056335286646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NSFL1C,NSFL1 cofactor p47,21734,134,1.06 [0.84-1.34],0.6043115202720858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",18843,97,0.96 [0.73-1.26],0.7760997554059024
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,18809,98,2.16 [1.57-2.98],2.638838097025606e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C3A,Cytosolic 5'-nucleotidase 3A,21478,131,0.99 [0.82-1.18],0.8849678648652446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5E,5'-nucleotidase,21637,130,1.18 [0.90-1.54],0.2379463815383852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF3,Neurotrophin-3,21505,131,1.21 [0.79-1.86],0.3752139893111372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF4,Neurotrophin-4,21052,127,0.78 [0.48-1.27],0.3240499020438954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK2,BDNF/NT-3 growth factors receptor,21557,132,1.39 [0.76-2.54],0.2877102276731011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK3,NT-3 growth factor receptor,21734,134,1.57 [0.77-3.19],0.2143979017493784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,21557,132,1.27 [1.13-1.43],4.982021279051946e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUB1,NEDD8 ultimate buster 1,21505,131,1.00 [0.82-1.20],0.9682238316372482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,18757,97,0.86 [0.69-1.08],0.1903509335088471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUCB2,Nucleobindin-2,21681,133,1.43 [0.95-2.14],0.0847825463803432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDC,Nuclear migration protein nudC,21768,132,1.06 [0.83-1.36],0.6299798217259645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,18378,94,0.64 [0.25-1.61],0.3421453414315113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,18209,92,0.93 [0.62-1.41],0.7373561441981695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT16,U8 snoRNA-decapping enzyme,18710,97,1.08 [0.86-1.36],0.492995292450251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],21446,131,1.10 [0.84-1.44],0.4895079357130587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT5,ADP-sugar pyrophosphatase,21578,131,1.22 [0.90-1.65],0.2023258969609253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUMB,Protein numb homolog,18284,95,0.94 [0.74-1.20],0.6441890423918426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUP50,Nuclear pore complex protein Nup50,18209,92,0.82 [0.41-1.62],0.5627344579839875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPE4,NXPE family member 4,18209,92,1.30 [0.77-2.20],0.3275705261416063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH1,Neurexophilin-1,21055,131,0.94 [0.62-1.42],0.775318245470153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH3,Neurexophilin-3,18284,95,0.76 [0.40-1.45],0.402109659788015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OBP2B,Odorant-binding protein 2b,21302,132,0.99 [0.76-1.28],0.9234313250182198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,18806,96,1.72 [1.18-2.50],0.004524287275311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ODAM,Odontogenic ameloblast-associated protein,21028,131,0.98 [0.74-1.29],0.8813902631244492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OFD1,Oral-facial-digital syndrome 1 protein,18501,97,1.04 [0.78-1.40],0.7790563202994452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGA,Protein O-GlcNAcase,18745,97,0.98 [0.74-1.30],0.8823423001047573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGFR,Opioid growth factor receptor,21446,131,1.04 [0.64-1.69],0.8652694530216714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,21578,131,1.66 [1.19-2.31],0.0026349680701692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,18501,97,0.88 [0.62-1.24],0.4624119478701425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLFM4,Olfactomedin-4,17751,89,0.94 [0.79-1.11],0.4640636910534148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,21351,130,1.31 [1.05-1.65],0.0190789626864896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMD,Osteomodulin,21644,130,1.02 [0.70-1.48],0.9074011817176691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,21446,131,0.72 [0.58-0.91],0.005775868817831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMP,Olfactory marker protein,18213,94,1.05 [0.72-1.54],0.7999161258024416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPHN1,Oligophrenin-1,18809,98,0.95 [0.79-1.13],0.5430449627146681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPLAH,5-oxoprolinase,18378,94,0.94 [0.70-1.28],0.7057452052219577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPTC,Opticin,21446,131,1.00 [0.72-1.40],0.9782060939473612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ORM1,Alpha-1-acid glycoprotein 1,18801,98,2.36 [0.93-5.95],0.06923144847611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSBPL2,Oxysterol-binding protein-related protein 2,18809,98,0.46 [0.22-0.94],0.03322277939457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,21582,130,1.62 [1.04-2.54],0.0347803701890092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,21413,131,1.35 [1.08-1.67],0.0070795320451065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSMR,Oncostatin-M-specific receptor subunit beta,21700,132,1.11 [0.51-2.39],0.7989574403715698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSTN,Osteocrin,18334,92,0.93 [0.57-1.53],0.7830499202048823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTOA,Otoancorin,18213,94,1.02 [0.71-1.47],0.9111486069428384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD6B,Deubiquitinase OTUD6B,18745,97,0.86 [0.61-1.21],0.37194621415016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD7B,OTU domain-containing protein 7B,18806,96,1.06 [0.77-1.46],0.6986186307115427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",18378,94,1.12 [0.84-1.48],0.4502912898763391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXT,Oxytocin-neurophysin 1,21734,134,0.94 [0.85-1.05],0.3028479908794467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,P4HB,Protein disulfide-isomerase,21470,128,1.08 [0.71-1.63],0.7252389955721616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PACS2,Phosphofurin acidic cluster sorting protein 2,18209,92,1.09 [0.78-1.51],0.617955408492294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI2,Protein-arginine deiminase type-2,21136,129,1.21 [0.98-1.49],0.07188215829556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI4,Protein-arginine deiminase type-4,21028,131,0.93 [0.76-1.15],0.5251292457223801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAEP,Glycodelin,21365,132,0.99 [0.84-1.16],0.8925516240016215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,18806,96,0.89 [0.73-1.09],0.2491266913205548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",18501,97,0.79 [0.52-1.19],0.2579274690093121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,21144,129,1.23 [0.95-1.60],0.1207510775499276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAGR1,PAXIP1-associated glutamate-rich protein 1,18378,94,0.64 [0.38-1.09],0.1015355221398443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18138,95,0.68 [0.45-1.05],0.0791316992698065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAK4,Serine/threonine-protein kinase PAK 4,21055,131,1.01 [0.78-1.30],0.9520341912565085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALLD,Palladin,18284,95,0.78 [0.44-1.39],0.4050189749429743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM,Paralemmin-1,18636,97,1.14 [0.61-2.14],0.6859474109094621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,18809,98,2.37 [1.57-3.57],3.9036690506922e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM3,Paralemmin-3,18209,92,0.77 [0.53-1.12],0.1774835533226395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,21719,134,2.08 [1.17-3.69],0.0127618678918369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAMR1,Inactive serine protease PAMR1,21578,131,1.11 [0.62-1.99],0.7166634409154908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAPPA,Pappalysin-1,21136,129,1.21 [0.86-1.69],0.2726406585181961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARD3,Partitioning defective 3 homolog,18501,97,0.71 [0.52-0.97],0.0333831865478437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARK7,Parkinson disease protein 7,21578,131,1.20 [0.89-1.61],0.2379444098457936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARP1,Poly [ADP-ribose] polymerase 1,21505,131,1.05 [0.82-1.34],0.7222840497017196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAXX,Protein PAXX,18442,92,0.82 [0.51-1.30],0.3914149510034935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBK,Lymphokine-activated killer T-cell-originated protein kinase,18165,95,0.98 [0.52-1.86],0.955682353132631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBLD,Phenazine biosynthesis-like domain-containing protein,21055,131,0.93 [0.68-1.27],0.665058222176679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,18745,97,1.35 [0.74-2.44],0.329483155775053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCARE,Photoreceptor cilium actin regulator,18213,94,1.12 [0.92-1.37],0.2745164183890717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,18416,92,1.11 [0.73-1.70],0.6147614528970762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBP2,Poly(rC)-binding protein 2,18806,96,0.98 [0.74-1.28],0.8589578197085834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH1,Protocadherin-1,21699,131,1.28 [0.65-2.53],0.4788672492008031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH12,Protocadherin-12,18806,96,0.87 [0.40-1.88],0.7281062483608347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH17,Protocadherin-17,21557,132,1.19 [0.79-1.79],0.4133627581459079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH7,Protocadherin-7,18745,97,1.15 [0.69-1.92],0.5838297761110506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH9,Protocadherin-9,18745,97,0.58 [0.35-0.98],0.0412565344106116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDHB15,Protocadherin beta-15,18757,97,0.81 [0.49-1.34],0.4126248329733252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCNA,Proliferating cell nuclear antigen,18165,95,0.82 [0.55-1.20],0.2992214233543667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK7,Proprotein convertase subtilisin/kexin type 7,18757,97,0.96 [0.63-1.48],0.8554542357511137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK9,Proprotein convertase subtilisin/kexin type 9,21821,134,1.25 [0.85-1.83],0.2533085827409368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCYT2,Ethanolamine-phosphate cytidylyltransferase,18745,97,1.00 [0.77-1.30],0.9879476901676196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDAP1,28 kDa heat- and acid-stable phosphoprotein,18843,97,0.98 [0.80-1.20],0.8769564242511954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1,Programmed cell death protein 1,21686,132,1.12 [0.79-1.58],0.538662390708035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1LG2,Programmed cell death 1 ligand 2,21446,131,1.50 [0.94-2.38],0.0875357141037528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD5,Programmed cell death protein 5,21734,134,1.17 [0.90-1.52],0.2481410728822895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD6,Programmed cell death protein 6,21557,132,1.32 [1.00-1.73],0.0515074335243082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCL2,Phosducin-like protein 2,18165,95,0.92 [0.62-1.36],0.6864828565935372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",18165,95,1.17 [0.86-1.60],0.3239244795198427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",18209,92,1.07 [0.78-1.48],0.6764002855186892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",18442,92,0.93 [0.77-1.12],0.4420038703126835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFA,Platelet-derived growth factor subunit A,21821,134,1.03 [0.83-1.27],0.7862110766094522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFB,Platelet-derived growth factor subunit B,21644,130,1.02 [0.85-1.22],0.8401392853974092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFC,Platelet-derived growth factor C,21052,127,0.94 [0.53-1.66],0.8253822334370777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRA,Platelet-derived growth factor receptor alpha,21557,132,1.70 [1.01-2.87],0.0467453891741629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRB,Platelet-derived growth factor receptor beta,21821,134,0.85 [0.55-1.32],0.4739296717787045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA2,Protein disulfide-isomerase A2,18165,95,0.81 [0.48-1.39],0.4496117659740481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA3,Protein disulfide-isomerase A3,18442,92,0.92 [0.40-2.10],0.8400420973702794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA4,Protein disulfide-isomerase A4,18852,99,1.06 [0.77-1.45],0.7303427946357759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA5,Protein disulfide-isomerase A5,18165,95,0.98 [0.70-1.36],0.883498658621838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM5,PDZ and LIM domain protein 5,18806,96,0.96 [0.81-1.13],0.584730305586705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM7,PDZ and LIM domain protein 7,21644,130,1.04 [0.92-1.18],0.4999332067117391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",21052,127,1.04 [0.75-1.43],0.8221828630479527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDRG1,p53 and DNA damage-regulated protein 1,18334,92,0.89 [0.59-1.35],0.5913564627811106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,18165,95,0.91 [0.61-1.34],0.6233839783244337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZD2,PDZ domain-containing protein 2,18209,92,1.03 [0.73-1.45],0.8554689703794153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,18284,95,1.14 [0.73-1.77],0.5619683554162732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEAR1,Platelet endothelial aggregation receptor 1,21821,134,1.96 [0.99-3.86],0.0527356854482806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEBP1,Phosphatidylethanolamine-binding protein 1,21578,131,1.17 [0.90-1.53],0.2504013072352619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECAM1,Platelet endothelial cell adhesion molecule,21578,131,0.80 [0.47-1.35],0.3982688293853873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECR,Peroxisomal trans-2-enoyl-CoA reductase,18378,94,0.95 [0.46-1.96],0.8958371419077684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PENK,Proenkephalin-A,18442,92,1.24 [0.67-2.30],0.4985403388996657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,18856,97,0.36 [0.17-0.74],0.0051338110838097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PER3,Period circadian protein homolog 3,18284,95,1.03 [0.88-1.21],0.7351545867954115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PF4,Platelet factor 4,18732,98,1.17 [0.97-1.43],0.105384621647349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN2,Prefoldin subunit 2,21055,131,0.96 [0.72-1.28],0.7656926242162815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN4,Prefoldin subunit 4,18165,95,0.98 [0.67-1.45],0.9228418181657532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN6,Prefoldin subunit 6,18334,92,0.93 [0.67-1.30],0.6752592448122268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",21405,131,1.08 [0.88-1.31],0.4638839411881809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGA4,Pepsin A-4,18856,97,1.24 [0.97-1.58],0.0838824958488646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",18843,97,0.99 [0.68-1.44],0.9574151477961704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,21768,132,2.24 [1.36-3.69],0.0016347582257059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,21732,134,1.46 [1.06-2.01],0.0222560927407288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,18650,97,1.09 [0.56-2.11],0.796547000138609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP4,Peptidoglycan recognition protein 4,18209,92,1.24 [0.94-1.62],0.1289417514408903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGM2,Phosphoglucomutase-2,18334,92,0.86 [0.58-1.27],0.4412890603650863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGR,Progesterone receptor,18284,95,0.89 [0.70-1.14],0.3648232122822483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHACTR2,Phosphatase and actin regulator 2,18806,96,0.97 [0.81-1.15],0.7076290301572004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB1,Pleckstrin homology-like domain family B member 1,18745,97,1.16 [0.79-1.69],0.4503954409973514
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB2,Pleckstrin homology-like domain family B member 2,18165,95,0.91 [0.72-1.15],0.4383252956966293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,21365,132,2.41 [1.47-3.93],0.0004537107570236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,18442,92,0.95 [0.59-1.55],0.8413878202159689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI16,Peptidase inhibitor 16,18856,97,0.65 [0.30-1.41],0.2735823192773684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,21307,132,1.58 [1.26-1.99],7.521828672168118e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",18806,96,0.93 [0.72-1.20],0.5709353135075999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,21290,129,2.01 [1.34-3.02],0.0007256294471639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,21505,131,0.94 [0.73-1.21],0.6141900043695996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,21578,131,1.96 [1.23-3.13],0.004955932764528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,18284,95,0.77 [0.51-1.17],0.2240663540113238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,21578,131,1.50 [1.04-2.16],0.0306142591616839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRB,Paired immunoglobulin-like type 2 receptor beta,21557,132,1.25 [0.95-1.66],0.1122580294883439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,18442,92,0.93 [0.70-1.24],0.6280735420163999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PITHD1,PITH domain-containing protein 1,18138,95,1.01 [0.79-1.30],0.926100458157042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD1,Polycystin-1,18843,97,1.28 [0.61-2.69],0.5135958507760203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD2,Polycystin-2,18209,92,1.33 [0.98-1.81],0.0698126460420188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKLR,Pyruvate kinase PKLR,21581,130,1.11 [0.89-1.40],0.3511457480420367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKN3,Serine/threonine-protein kinase N3,18501,97,0.94 [0.71-1.23],0.6357798727738626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G10,Group 10 secretory phospholipase A2,21365,132,1.07 [0.82-1.40],0.6201593919502868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,21637,130,1.88 [1.08-3.27],0.025116147241318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G1B,Phospholipase A2,21791,134,1.18 [0.84-1.64],0.3421198782124414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G2A,"Phospholipase A2, membrane associated",21518,133,1.19 [0.93-1.53],0.1724411815739736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G4A,Cytosolic phospholipase A2,21644,130,1.10 [0.92-1.31],0.2964195448203623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G7,Platelet-activating factor acetylhydrolase,21578,131,0.77 [0.49-1.21],0.260897438626487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAT,Tissue-type plasminogen activator,21758,134,1.00 [0.74-1.35],0.987675501015394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAU,Urokinase-type plasminogen activator,21578,131,1.19 [0.75-1.88],0.4628223138363236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,21418,130,3.69 [2.31-5.91],5.1337445420734544e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLB1,"Phospholipase B1, membrane-associated",18809,98,0.85 [0.61-1.17],0.312588057692156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",18284,95,1.05 [0.66-1.68],0.8272373131700403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",18809,98,0.98 [0.80-1.19],0.8254431993466239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLEKHO1,Pleckstrin homology domain-containing family O member 1,18809,98,0.99 [0.75-1.32],0.9470153492758429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,18406,97,3.19 [1.64-6.22],0.0006604605992685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN1,Perilipin-1,21055,131,1.56 [1.08-2.25],0.0190889936629256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN3,Perilipin-3,21557,132,1.24 [0.87-1.78],0.2286134608981914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLPBP,Pyridoxal phosphate homeostasis protein,21557,132,1.05 [0.83-1.32],0.6812882599055516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLSCR3,Phospholipid scramblase 3,18769,98,1.12 [0.80-1.57],0.5200902394183369
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLTP,Phospholipid transfer protein,21762,134,1.01 [0.66-1.55],0.9571687190779936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC1,Plexin domain-containing protein 1,21052,127,0.78 [0.45-1.35],0.3756219843923785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC2,Plexin domain-containing protein 2,18809,98,0.96 [0.47-1.98],0.9113581298064992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNA4,Plexin-A4,21505,131,1.01 [0.84-1.23],0.8900553779513418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB2,Plexin-B2,21710,134,1.95 [1.07-3.55],0.0290075177033568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB3,Plexin-B3,21493,132,1.06 [0.76-1.47],0.7475216772193816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,21431,131,1.03 [0.95-1.12],0.504913155542533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMCH,Pro-MCH,18209,92,1.08 [0.88-1.34],0.4648401004354888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMM2,Phosphomannomutase 2,18209,92,1.03 [0.73-1.45],0.8660010024549311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMS1,PMS1 protein homolog 1,18334,92,1.09 [0.74-1.58],0.6695186529429491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMVK,Phosphomevalonate kinase,21021,131,1.08 [0.93-1.26],0.3018053663864998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIP,Pancreatic triacylglycerol lipase,18856,97,1.06 [0.79-1.42],0.717671623836484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP1,Inactive pancreatic lipase-related protein 1,18809,98,1.18 [0.93-1.49],0.1789818951683687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP2,Pancreatic lipase-related protein 2,21549,130,0.98 [0.93-1.03],0.3708293731982905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA1,Paraneoplastic antigen Ma1,18378,94,0.99 [0.69-1.43],0.9710351372919444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA2,Paraneoplastic antigen Ma2,18213,94,1.32 [0.92-1.89],0.133283261735624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",21136,129,0.99 [0.85-1.14],0.838216893957317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL,Podocalyxin,21446,131,0.55 [0.20-1.51],0.246607380362149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL2,Podocalyxin-like protein 2,21637,130,1.29 [0.75-2.24],0.3547207089094721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POF1B,Protein POF1B,18284,95,1.07 [0.70-1.64],0.7533178732627287
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2A,DNA-directed RNA polymerase II subunit RPB1,18284,95,1.41 [0.76-2.61],0.2734762806287685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",21446,131,1.42 [1.01-1.99],0.0440666365564678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POMC,Pro-opiomelanocortin,18378,94,1.10 [0.83-1.46],0.5085466611618499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,18856,97,0.51 [0.29-0.90],0.0191991730922217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON2,Serum paraoxonase/arylesterase 2,21144,129,1.35 [0.87-2.08],0.1802456127926988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON3,Serum paraoxonase/lactonase 3,21644,130,1.12 [0.65-1.93],0.6773316815321055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POSTN,Periostin,18852,99,1.34 [0.82-2.20],0.2449616059954637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPBP,Platelet basic protein,18742,98,1.07 [0.85-1.34],0.5796005837159782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPCDC,Phosphopantothenoylcysteine decarboxylase,21734,134,1.03 [0.74-1.44],0.8594454564064234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIB,Peptidyl-prolyl cis-trans isomerase B,21596,134,1.05 [0.90-1.24],0.5212201437368698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIE,Peptidyl-prolyl cis-trans isomerase E,18501,97,1.10 [0.83-1.45],0.4924332997005654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",18852,99,1.05 [0.78-1.41],0.7503714728633312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPL,Periplakin,18284,95,1.41 [0.84-2.36],0.1936793914667141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1A,Protein phosphatase 1A,21052,127,1.28 [0.84-1.93],0.2534652138421291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1B,Protein phosphatase 1B,18284,95,0.65 [0.41-1.04],0.0755148052886934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1F,Protein phosphatase 1F,18843,97,0.98 [0.67-1.43],0.9159882292021524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPME1,Protein phosphatase methylesterase 1,21446,131,1.05 [0.81-1.36],0.7130230367340129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,18757,97,0.98 [0.77-1.25],0.8953535854107686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,21637,130,1.04 [0.88-1.22],0.6325139826156057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,18501,97,0.97 [0.73-1.28],0.8252877823327317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,18806,96,0.99 [0.77-1.26],0.9111384856195998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,18806,96,1.23 [0.79-1.93],0.3614933181034405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R2,Protein phosphatase inhibitor 2,21557,132,1.07 [0.88-1.30],0.5229023783107329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R9B,Neurabin-2,21768,132,0.96 [0.81-1.13],0.5970256383350772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,18745,97,0.99 [0.84-1.17],0.8846789367603526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP3R1,Calcineurin subunit B type 1,21365,132,1.10 [0.75-1.61],0.6394592244377605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPT1,Palmitoyl-protein thioesterase 1,18334,92,1.00 [0.77-1.30],0.9765390342576415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPY,Pancreatic prohormone,21547,129,1.09 [0.94-1.26],0.2733481453904842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PQBP1,Polyglutamine-binding protein 1,21052,127,1.05 [0.82-1.36],0.6847167985354603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAME,Melanoma antigen preferentially expressed in tumors,18165,95,1.22 [0.57-2.61],0.6055784364747057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAP1,Proline-rich acidic protein 1,18852,99,1.50 [0.91-2.46],0.1119339695719309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRC1,Protein regulator of cytokinesis 1,18757,97,1.12 [0.77-1.64],0.5422887018749953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRCP,Lysosomal Pro-X carboxypeptidase,21711,133,0.86 [0.52-1.40],0.5337686341494259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX1,Peroxiredoxin-1,20919,131,1.03 [0.86-1.23],0.7212569950979872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX2,Peroxiredoxin-2,18521,97,0.69 [0.49-0.95],0.0246403907852913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",21136,129,1.06 [0.85-1.32],0.6019747895186786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX5,"Peroxiredoxin-5, mitochondrial",21768,132,1.00 [0.80-1.27],0.9668115972856623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX6,Peroxiredoxin-6,21724,133,0.96 [0.75-1.24],0.7803264712182179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,21136,129,1.44 [0.93-2.23],0.1030501815138729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,21549,130,2.55 [1.35-4.82],0.0040255452218764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,18852,99,1.45 [1.02-2.06],0.0404841236756775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG3,Proteoglycan 3,18852,99,1.14 [0.78-1.68],0.4930384263915026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,21136,129,1.13 [0.85-1.51],0.3882765410015717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,18334,92,0.50 [0.24-1.04],0.064544027095859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,21557,132,1.06 [0.88-1.27],0.5520134275850919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,18777,98,0.94 [0.73-1.20],0.6186374073981123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKCQ,Protein kinase C theta type,21136,129,1.33 [0.99-1.78],0.0604640812386384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKD2,Serine/threonine-protein kinase D2,18209,92,0.98 [0.61-1.58],0.9413703302259118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKG1,cGMP-dependent protein kinase 1,18442,92,0.93 [0.79-1.09],0.3474013369748006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,21052,127,1.11 [0.88-1.40],0.3620979461198381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRL,Prolactin,21734,134,0.99 [0.80-1.23],0.9575453177084544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRND,Prion-like protein doppel,18809,98,0.79 [0.53-1.17],0.2373247991298483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROC,Vitamin K-dependent protein C,21625,132,0.66 [0.36-1.21],0.1749378655946831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROCR,Endothelial protein C receptor,18209,92,0.79 [0.41-1.54],0.4952532090858549
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,21505,131,1.47 [1.13-1.92],0.0039441837997647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROS1,Vitamin K-dependent protein S,18873,98,1.49 [0.71-3.13],0.2890828539262179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR4,Proline-rich protein 4,18288,92,1.02 [0.76-1.36],0.9034716138114174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR5,Proline-rich protein 5,18284,95,1.48 [1.05-2.07],0.0233512872490025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRRT3,Proline-rich transmembrane protein 3,18378,94,1.00 [0.60-1.66],0.9979013127327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS2,Trypsin-2,21671,132,1.10 [0.84-1.44],0.494107456645895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,18284,95,1.61 [1.12-2.31],0.0102925268241134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS27,Serine protease 27,21495,132,1.20 [0.82-1.76],0.3363844314858833
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS53,Serine protease 53,18809,98,0.70 [0.42-1.16],0.1636730380778218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS8,Prostasin,21473,130,1.40 [0.98-2.02],0.0672508717951166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,21055,131,1.08 [0.94-1.25],0.2669762048118823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTG,Protogenin,21724,133,1.88 [1.02-3.44],0.0421253788156734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTN3,Myeloblastin,21022,129,1.18 [0.88-1.59],0.2702187608357347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRUNE2,Protein prune homolog 2,18501,97,0.84 [0.41-1.72],0.641365940964071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAP,Prosaposin,18669,99,1.62 [0.93-2.80],0.0871634760556508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAPL1,Proactivator polypeptide-like 1,18745,97,0.97 [0.66-1.42],0.8609640265099686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSCA,Prostate stem cell antigen,18745,97,1.04 [0.96-1.12],0.3406602277808269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSG1,Pregnancy-specific beta-1-glycoprotein 1,21365,132,1.05 [0.92-1.20],0.4901806172043566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSIP1,PC4 and SFRS1-interacting protein,21505,131,1.06 [0.85-1.32],0.618836430461299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMA1,Proteasome subunit alpha type-1,21052,127,0.71 [0.48-1.05],0.0835296464768967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMC3,26S proteasome regulatory subunit 6A,18165,95,0.47 [0.24-0.92],0.0273266704240136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD1,26S proteasome non-ATPase regulatory subunit 1,18806,96,0.81 [0.53-1.22],0.3086589504964936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD5,26S proteasome non-ATPase regulatory subunit 5,18334,92,0.76 [0.48-1.19],0.230733803877834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD9,26S proteasome non-ATPase regulatory subunit 9,21446,131,1.02 [0.77-1.34],0.8987872909897152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME1,Proteasome activator complex subunit 1,21318,132,1.03 [0.68-1.57],0.8737210748272435
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME2,Proteasome activator complex subunit 2,21257,131,1.16 [0.76-1.78],0.4808902938964909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG3,Proteasome assembly chaperone 3,21505,131,1.08 [0.80-1.45],0.6115093975931913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG4,Proteasome assembly chaperone 4,18284,95,0.77 [0.53-1.11],0.1647961144192013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSPN,Persephin,21505,131,0.92 [0.78-1.09],0.3564224775744715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSRC1,Proline/serine-rich coiled-coil protein 1,21052,127,1.01 [0.77-1.32],0.9618548090231096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,17804,86,0.96 [0.79-1.17],0.7154632438337123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",21055,131,0.98 [0.59-1.65],0.9510248605723408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGDS,Prostaglandin-H2 D-isomerase,21403,131,1.51 [0.97-2.36],0.0702157715168559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGES2,Prostaglandin E synthase 2,18143,95,1.23 [0.86-1.75],0.2635647740001146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGR1,Prostaglandin reductase 1,18843,97,1.03 [0.82-1.29],0.799182743658536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH,Parathyroid hormone,18334,92,1.18 [0.93-1.50],0.174262426628128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,21505,131,1.25 [0.90-1.74],0.1876855544130908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTK7,Inactive tyrosine-protein kinase 7,21055,131,0.99 [0.65-1.50],0.9660315839253122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTN,Pleiotrophin,21144,129,1.26 [0.92-1.72],0.1498705426219902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTP4A3,Protein tyrosine phosphatase type IVA 3,18284,95,0.93 [0.63-1.38],0.7315827135273555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,21365,132,1.07 [0.88-1.31],0.4860914316318042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,21610,130,1.10 [0.92-1.31],0.3013429553974538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,18255,95,0.81 [0.46-1.44],0.4770234763597892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRB,Receptor-type tyrosine-protein phosphatase beta,18843,97,1.40 [0.72-2.70],0.3179386794539744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRC,Receptor-type tyrosine-protein phosphatase C,18852,99,0.86 [0.37-2.01],0.7327789005185714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRF,Receptor-type tyrosine-protein phosphatase F,21821,134,0.84 [0.50-1.42],0.5199669977159205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRH,Receptor-type tyrosine-protein phosphatase H,18745,97,1.03 [0.69-1.55],0.8782390170177421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,18745,97,0.80 [0.31-2.06],0.6452945147563924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRM,Receptor-type tyrosine-protein phosphatase mu,21477,130,0.77 [0.41-1.46],0.4256033541480215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,21302,132,1.01 [0.64-1.61],0.9575774450775524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRR,Receptor-type tyrosine-protein phosphatase R,18809,98,0.92 [0.54-1.56],0.7603816923019777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRS,Receptor-type tyrosine-protein phosphatase S,21821,134,1.57 [0.87-2.86],0.1373273782082736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,18843,97,0.95 [0.51-1.77],0.8749046297508974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,18442,92,0.78 [0.56-1.10],0.1627442386218936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTS,6-pyruvoyl tetrahydrobiopterin synthase,20952,131,0.90 [0.67-1.20],0.4630761016398063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTTG1,Securin,18501,97,0.64 [0.38-1.08],0.093770466908437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTX3,Pentraxin-related protein PTX3,21505,131,1.38 [0.98-1.96],0.0684567942376896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVALB,Parvalbumin alpha,21607,132,1.14 [0.99-1.32],0.0716042864419429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,21734,134,2.24 [1.56-3.22],1.2724939967941733e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXDNL,Peroxidasin-like protein,18757,97,1.04 [0.74-1.44],0.8283498124014058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXN,Paxillin,21055,131,0.98 [0.72-1.32],0.889459841551347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYDC1,Pyrin domain-containing protein 1,18378,94,1.01 [0.63-1.62],0.9783989610614082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,18209,92,1.19 [0.99-1.42],0.0663404478864471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PZP,Pregnancy zone protein,18873,98,1.06 [0.70-1.62],0.7801595049960987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QDPR,Dihydropteridine reductase,21451,132,1.09 [0.75-1.56],0.6569284626728875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,21612,133,2.72 [1.67-4.45],6.239190366209972e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,18512,96,1.51 [1.17-1.93],0.0012636199453494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB10,Ras-related protein Rab-10,18843,97,0.87 [0.59-1.26],0.4544513623494454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB11FIP3,Rab11 family-interacting protein 3,18843,97,0.90 [0.75-1.08],0.260991978947987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB27B,Ras-related protein Rab-27B,18843,97,0.90 [0.71-1.13],0.3426492847769914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB2B,Ras-related protein Rab-2B,18757,97,1.03 [0.75-1.43],0.83990539938871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB33A,Ras-related protein Rab-33A,18209,92,1.11 [0.82-1.50],0.5009764949048683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB37,Ras-related protein Rab-37,21136,129,0.89 [0.72-1.11],0.3101553666532117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB39B,Ras-related protein Rab-39B,18209,92,0.81 [0.60-1.09],0.1606958986567785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,18213,94,1.11 [0.82-1.51],0.4906649520732469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB44,Ras-related protein Rab-44,18757,97,1.17 [0.81-1.68],0.3995511346742065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6A,Ras-related protein Rab-6A,21505,131,0.83 [0.59-1.17],0.2909456131793543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6B,Ras-related protein Rab-6B,21055,131,1.09 [0.80-1.48],0.5871786810781064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEP1,Rab GTPase-binding effector protein 1,18442,92,0.83 [0.63-1.09],0.1784618136851102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEPK,Rab9 effector protein with kelch motifs,21052,127,1.16 [0.90-1.49],0.2526319678595046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABGAP1L,Rab GTPase-activating protein 1-like,21136,129,1.01 [0.78-1.31],0.9418723945928442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAC3,Ras-related C3 botulinum toxin substrate 3,18334,92,1.19 [0.93-1.51],0.1671812920592049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD23B,UV excision repair protein RAD23 homolog B,21052,127,1.18 [0.85-1.62],0.3248523701492983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD51,DNA repair protein RAD51 homolog 1,18501,97,0.74 [0.47-1.18],0.2084415758419921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALB,Ras-related protein Ral-B,18284,95,1.75 [0.94-3.26],0.0782452132376189
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALY,RNA-binding protein Raly,18757,97,1.11 [0.77-1.61],0.5720584625401441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP1,Ran-specific GTPase-activating protein,18378,94,0.95 [0.65-1.39],0.7777574042496022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP2,E3 SUMO-protein ligase RanBP2,18213,94,0.73 [0.38-1.37],0.3254438663276675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANGAP1,Ran GTPase-activating protein 1,21052,127,0.54 [0.36-0.82],0.0034841540875303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAP1A,Ras-related protein Rap-1A,18284,95,1.25 [1.02-1.53],0.0302831826476527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAPGEF2,Rap guanine nucleotide exchange factor 2,18501,97,0.78 [0.52-1.17],0.2281246409768252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES1,Retinoic acid receptor responder protein 1,21052,127,1.30 [0.88-1.92],0.182545777469942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES2,Retinoic acid receptor responder protein 2,21700,132,1.25 [0.93-1.69],0.1451196193800074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASA1,Ras GTPase-activating protein 1,21055,131,1.16 [0.73-1.85],0.5266690976825941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,18165,95,0.83 [0.52-1.33],0.4451070920496437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASSF2,Ras association domain-containing protein 2,21052,127,1.18 [0.94-1.48],0.1636668826885968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,18806,96,2.06 [1.53-2.78],1.96817036501833e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBKS,Ribokinase,21046,132,1.06 [0.78-1.44],0.7228757449749112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM17,Splicing factor 45,18806,96,0.99 [0.76-1.28],0.9180142289622234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM19,Probable RNA-binding protein 19,18209,92,0.97 [0.62-1.53],0.9006341669196234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM25,RNA-binding protein 25,18165,95,1.04 [0.68-1.59],0.8736156441303375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP1,Retinol-binding protein 1,18334,92,1.12 [0.86-1.45],0.4072761133190731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP2,Retinol-binding protein 2,21446,131,1.12 [0.92-1.36],0.2734564544019265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP5,Retinol-binding protein 5,21446,131,1.29 [0.99-1.69],0.0564397152469662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP7,Retinoid-binding protein 7,18745,97,1.18 [0.88-1.58],0.2763527451025831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS,RNA-binding protein with multiple splicing,18284,95,0.96 [0.69-1.33],0.8107848891104419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS2,RNA-binding protein with multiple splicing 2,18378,94,0.98 [0.80-1.19],0.8219494967970598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCC1,Regulator of chromosome condensation,18757,97,1.04 [0.71-1.52],0.8460382151243863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCOR1,REST corepressor 1,21144,129,0.92 [0.62-1.36],0.6782157202777137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,18378,94,1.01 [0.38-2.64],0.9891356038675012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REEP4,Receptor expression-enhancing protein 4,18806,96,0.98 [0.70-1.36],0.8840722801309677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,21429,130,1.45 [1.11-1.90],0.0062900731670038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,21821,134,1.38 [1.09-1.74],0.0073943360131173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,21821,134,1.38 [1.12-1.70],0.0029930547758111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3G,Regenerating islet-derived protein 3-gamma,18757,97,1.11 [0.70-1.76],0.6565900701856839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,21582,130,1.89 [1.46-2.45],1.759007436606352e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELB,Transcription factor RelB,18284,95,0.96 [0.63-1.46],0.8417705279041445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,21578,131,1.85 [1.16-2.95],0.0098303564564342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,21557,132,1.27 [1.08-1.50],0.0034249843329881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REPS1,RalBP1-associated Eps domain-containing protein 1,18284,95,1.05 [0.63-1.74],0.8525124225105882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REST,RE1-silencing transcription factor,18165,95,0.76 [0.41-1.40],0.3759176997269543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,21446,131,0.73 [0.49-1.09],0.1220198279320203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,21524,132,1.58 [1.15-2.17],0.0051979585998337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REXO2,"Oligoribonuclease, mitochondrial",18209,92,0.86 [0.54-1.36],0.5197389457076411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RFC4,Replication factor C subunit 4,18757,97,0.73 [0.28-1.91],0.517238503138717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGCC,Regulator of cell cycle RGCC,18806,96,0.97 [0.75-1.26],0.8444687816963383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,18501,97,0.80 [0.55-1.15],0.2255975286032495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMA,Repulsive guidance molecule A,21734,134,1.45 [0.90-2.33],0.1288315650536853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMB,RGM domain family member B,21734,134,1.46 [0.86-2.49],0.1590111915425399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS10,Regulator of G-protein signaling 10,18806,96,1.02 [0.73-1.42],0.9138702104905552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS8,Regulator of G-protein signaling 8,21136,129,0.69 [0.50-0.95],0.0246067264826266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RHOC,Rho-related GTP-binding protein RhoC,21243,132,1.07 [0.93-1.22],0.3589258521396544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RICTOR,Rapamycin-insensitive companion of mTOR,18284,95,0.96 [0.63-1.48],0.8620978098015826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,18442,92,0.91 [0.60-1.38],0.6610033812200502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILP,Rab-interacting lysosomal protein,21652,133,1.14 [0.88-1.47],0.3170500293187968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILPL2,RILP-like protein 2,18843,97,0.99 [0.81-1.21],0.9504269456654436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,18209,92,0.92 [0.67-1.27],0.624256821306689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN1,Prorelaxin H1,18806,96,0.91 [0.56-1.47],0.6955306558237064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN2,Prorelaxin H2,18404,91,1.00 [0.67-1.50],0.985653865701696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE1,Ribonuclease pancreatic,18856,97,1.37 [0.67-2.80],0.3921529098076414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE10,Inactive ribonuclease-like protein 10,18378,94,0.94 [0.62-1.43],0.773235548005361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE3,Eosinophil cationic protein,21457,132,1.05 [0.93-1.20],0.4202737236390658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE4,Ribonuclease 4,18219,95,1.77 [0.96-3.23],0.0653508556900162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,18728,97,1.54 [1.03-2.30],0.0362601679693605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASEH2A,Ribonuclease H2 subunit A,18806,96,0.88 [0.57-1.36],0.5623716088811104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,21736,133,2.18 [1.37-3.45],0.0009467407166955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF149,E3 ubiquitin-protein ligase RNF149,18378,94,1.56 [0.89-2.75],0.1211884308721812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF168,E3 ubiquitin-protein ligase RNF168,18284,95,0.75 [0.43-1.32],0.3157769148268025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF31,E3 ubiquitin-protein ligase RNF31,18284,95,0.78 [0.42-1.47],0.4476558788708068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF4,E3 ubiquitin-protein ligase RNF4,18501,97,0.94 [0.69-1.28],0.7145004492544618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF41,E3 ubiquitin-protein ligase NRDP1,21052,127,1.05 [0.83-1.34],0.665496273659385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF43,E3 ubiquitin-protein ligase RNF43,18501,97,0.84 [0.56-1.26],0.401549831285775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF5,E3 ubiquitin-protein ligase RNF5,18378,94,0.81 [0.63-1.06],0.1276079814291648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO1,Roundabout homolog 1,21582,130,1.65 [0.89-3.05],0.1120927038651764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO2,Roundabout homolog 2,21734,134,1.66 [0.87-3.18],0.1273355808478911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO4,Roundabout homolog 4,18378,94,1.04 [0.34-3.17],0.949724269921392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,21557,132,1.64 [1.02-2.62],0.0398367156954451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RP2,Protein XRP2,21446,131,1.21 [0.85-1.73],0.2939826347459554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPA2,Replication protein A 32 kDa subunit,18284,95,1.00 [0.52-1.91],0.9926530608080424
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPE,Ribulose-phosphate 3-epimerase,18501,97,0.88 [0.66-1.19],0.4082529124945959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPGR,X-linked retinitis pigmentosa GTPase regulator,18334,92,0.78 [0.46-1.32],0.3520640416366702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPL14,60S ribosomal protein L14,18378,94,1.02 [0.62-1.69],0.9310362220044645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPS10,40S ribosomal protein S10,18209,92,1.30 [0.88-1.92],0.192363323791482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRAS,Ras-related protein R-Ras,18334,92,0.93 [0.79-1.09],0.3525446245356614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2,Ribonucleoside-diphosphate reductase subunit M2,21052,127,1.23 [0.96-1.58],0.099745506356828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,21052,127,1.16 [0.91-1.46],0.223615002982174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRP15,RRP15-like protein,18213,94,0.95 [0.77-1.18],0.6716494389178316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,21365,132,1.74 [1.16-2.60],0.0074432692233178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,21724,133,2.82 [1.86-4.28],1.0880138892446838e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTBDN,Retbindin,21446,131,1.07 [0.65-1.78],0.7877862395045585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTKN2,Rhotekin-2,18209,92,1.24 [0.90-1.70],0.1826621889320761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",18806,96,0.99 [0.80-1.23],0.9464959997019508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4R,Reticulon-4 receptor,21724,133,1.72 [1.14-2.59],0.0091124735758972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RUVBL1,RuvB-like 1,21052,127,1.04 [0.90-1.20],0.6196707206355498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RWDD1,RWD domain-containing protein 1,21734,134,1.03 [0.81-1.32],0.7908421520049354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RYR1,Ryanodine receptor 1,18209,92,0.71 [0.36-1.40],0.3268530553599826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,21388,132,1.41 [1.10-1.80],0.0071794864934797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A12,Protein S100-A12,21240,131,1.18 [0.97-1.45],0.1011105613815758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,18284,95,1.59 [1.01-2.48],0.0432610403490411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A14,Protein S100-A14,18806,96,0.85 [0.58-1.24],0.3902983861847383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A16,Protein S100-A16,21028,131,0.85 [0.65-1.11],0.2203897687180218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A3,Protein S100-A3,18757,97,1.07 [0.72-1.61],0.7253141275038801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A4,Protein S100-A4,21637,130,1.02 [0.78-1.35],0.8692625175652414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100G,Protein S100-G,18806,96,1.00 [0.67-1.49],0.9812235873829682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100P,Protein S100-P,21144,129,1.20 [0.94-1.54],0.1395841617977297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,18873,98,1.54 [1.10-2.16],0.0123452633123292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAFB2,Scaffold attachment factor B2,18806,96,0.70 [0.32-1.52],0.3729314646024244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAG,S-arrestin,18213,94,1.01 [0.68-1.48],0.9708210378899012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAMD9L,Sterile alpha motif domain-containing protein 9-like,21505,131,1.10 [0.89-1.36],0.3908501658598211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAP18,Histone deacetylase complex subunit SAP18,18501,97,0.83 [0.61-1.13],0.2390063532213865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SARG,Specifically androgen-regulated gene protein,18763,97,1.00 [0.84-1.20],0.9628408340846312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SART1,U4/U6.U5 tri-snRNP-associated protein 1,18209,92,1.28 [0.84-1.94],0.2503845904299754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT1,Diamine acetyltransferase 1,18209,92,0.95 [0.63-1.45],0.8224359816488019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT2,Thialysine N-epsilon-acetyltransferase,18501,97,1.18 [0.91-1.54],0.2024843669772428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SATB1,DNA-binding protein SATB1,18806,96,1.02 [0.53-1.98],0.949016251356297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SBSN,Suprabasin,18816,99,0.74 [0.43-1.28],0.2812084800063866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCAMP3,Secretory carrier-associated membrane protein 3,21446,131,1.13 [0.94-1.35],0.2053150852779647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARA5,Scavenger receptor class A member 5,21734,134,1.76 [1.09-2.86],0.0215378624834262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB1,Scavenger receptor class B member 1,21055,131,1.00 [0.75-1.32],0.9883537632310296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,20959,131,1.93 [1.30-2.87],0.0012149888255796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF1,Scavenger receptor class F member 1,21821,134,1.26 [0.88-1.80],0.2164223076772403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,21734,134,2.53 [1.57-4.09],0.0001359143001829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG2,Secretogranin-2,21609,133,1.65 [1.06-2.57],0.0277015544164667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG3,Secretogranin-3,21582,130,1.09 [0.69-1.72],0.7151199970398223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB1A1,Uteroglobin,21562,129,0.88 [0.67-1.15],0.3452043858422328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB2A2,Mammaglobin-A,18209,92,1.13 [0.61-2.11],0.6900397982401809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A1,Secretoglobin family 3A member 1,18442,92,0.52 [0.24-1.13],0.098516136420459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A2,Secretoglobin family 3A member 2,21610,130,1.19 [1.02-1.38],0.0230080295790456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGN,Secretagogin,21136,129,1.15 [0.83-1.62],0.4011079525346464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCIN,Adseverin,18213,94,1.01 [0.77-1.32],0.9443378363215496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCLY,Selenocysteine lyase,21652,133,1.16 [0.84-1.60],0.376054836711543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2A,Sodium channel protein type 2 subunit alpha,18213,94,1.17 [0.82-1.67],0.3889780568086228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2B,Sodium channel subunit beta-2,18334,92,0.82 [0.39-1.73],0.6071786214712787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3A,Sodium channel protein type 3 subunit alpha,18334,92,0.93 [0.52-1.67],0.8096925649421581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3B,Sodium channel subunit beta-3,18213,94,0.79 [0.49-1.26],0.3141124065513624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN4B,Sodium channel subunit beta-4,18378,94,0.86 [0.54-1.37],0.5293145992912566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCP2,Non-specific lipid-transfer protein,21052,127,0.94 [0.74-1.18],0.5933663726851653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCPEP1,Retinoid-inducible serine carboxypeptidase,18303,94,1.05 [0.70-1.59],0.8016225579009326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRG1,Scrapie-responsive protein 1,18843,97,1.70 [0.90-3.21],0.0998845535416731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRIB,Protein scribble homolog,18378,94,0.93 [0.73-1.17],0.5274805481317133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRN1,Secernin-1,21505,131,1.08 [0.82-1.43],0.5845708427879874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCT,Secretin,18334,92,0.97 [0.65-1.46],0.902084892685144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC1,Syndecan-1,21557,132,1.07 [0.72-1.57],0.7493176625155846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC4,Syndecan-4,21557,132,0.82 [0.59-1.13],0.2267410222940527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDCCAG8,Serologically defined colon cancer antigen 8,18757,97,0.98 [0.82-1.16],0.7841650107013979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDHB,Succinate dehydrogenase,18745,97,1.00 [0.73-1.36],0.9965567255004328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDK2,Protein sidekick-2,18442,92,0.65 [0.38-1.13],0.1278131905613596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEC31A,Protein transport protein Sec31A,18378,94,0.96 [0.74-1.25],0.7753626051349731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEL1L,Protein sel-1 homolog 1,18378,94,1.07 [0.57-2.02],0.8345535896934909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELE,E-selectin,21821,134,1.03 [0.76-1.39],0.8604848739248946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELENOP,Selenoprotein P,18873,98,1.11 [0.49-2.55],0.7975422398940788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELL,L-selectin,18873,98,1.13 [0.49-2.59],0.7795011194317646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELP,P-selectin,21671,132,0.99 [0.75-1.31],0.962549109469354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELPLG,P-selectin glycoprotein ligand 1,21505,131,0.69 [0.42-1.14],0.1457695202694952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3F,Semaphorin-3F,21557,132,1.53 [0.86-2.71],0.1462758799144417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3G,Semaphorin-3G,18442,92,1.30 [0.85-1.99],0.2315714209746014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,21446,131,1.73 [1.17-2.54],0.0054702301510892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4D,Semaphorin-4D,21734,134,0.95 [0.57-1.58],0.8440457730791402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA6C,Semaphorin-6C,18284,95,1.42 [0.76-2.68],0.2721694736482413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA7A,Semaphorin-7A,21758,134,1.43 [0.88-2.32],0.1452824370246561
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN3,Neuronal-specific septin-3,18806,96,1.08 [0.84-1.39],0.5293507590120039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN7,Septin-7,18501,97,1.25 [0.94-1.65],0.1183884033915399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN8,Septin-8,18781,98,1.50 [0.86-2.62],0.1580014545206502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN9,Septin-9,21446,131,1.29 [0.78-2.12],0.3251671680524333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA1,Alpha-1-antitrypsin,18501,98,4.34 [0.75-25.05],0.1002776720057909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,21821,134,1.95 [1.33-2.85],0.0005960698103718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA12,Serpin A12,20897,128,1.09 [0.95-1.25],0.1963251167726726
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA3,Alpha-1-antichymotrypsin,18798,98,2.30 [0.82-6.46],0.1141304225971518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA4,Kallistatin,18526,96,2.11 [0.93-4.78],0.0751591880033991
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA5,Plasma serine protease inhibitor,18597,97,1.41 [0.81-2.46],0.2218598385709447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA6,Corticosteroid-binding globulin,18873,98,1.48 [0.43-5.06],0.5303268053549135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA7,Thyroxine-binding globulin,18873,98,0.90 [0.32-2.54],0.8424443329628155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA9,Serpin A9,21343,131,1.08 [0.87-1.34],0.4758223739297162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB1,Leukocyte elastase inhibitor,21507,131,1.17 [0.99-1.38],0.0665782008687448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB5,Serpin B5,21144,129,0.97 [0.71-1.34],0.8726181210993904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB6,Serpin B6,21664,134,1.12 [0.86-1.46],0.3972946885894678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB8,Serpin B8,21768,132,1.15 [0.91-1.44],0.2338952439560654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB9,Serpin B9,21365,132,1.41 [0.88-2.26],0.15534772604672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINC1,Antithrombin-III,18841,98,2.96 [0.83-10.58],0.0955609353485088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPIND1,Heparin cofactor 2,18841,98,1.72 [0.86-3.43],0.1228624849208917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE1,Plasminogen activator inhibitor 1,21821,134,0.98 [0.78-1.24],0.8881550690535092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE2,Glia-derived nexin,18843,97,0.88 [0.65-1.19],0.4110714710264654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF1,Pigment epithelium-derived factor,18575,98,1.34 [0.65-2.77],0.4240462658974908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF2,Alpha-2-antiplasmin,18510,97,3.88 [0.99-15.23],0.0523367082582431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPING1,Plasma protease C1 inhibitor,18841,98,2.98 [1.06-8.37],0.0387246795500368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINH1,Serpin H1,18501,97,0.98 [0.84-1.14],0.7491660122201116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI1,Neuroserpin,18414,92,0.76 [0.37-1.55],0.4546689370560807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI2,Serpin I2,18745,97,1.17 [0.84-1.64],0.3511063310029509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,21055,131,1.04 [0.81-1.32],0.7592750445038559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SETMAR,Histone-lysine N-methyltransferase SETMAR,21292,132,0.91 [0.53-1.54],0.7157744598445084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6,Seizure protein 6 homolog,18334,92,1.37 [0.73-2.57],0.3338137359751653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L,Seizure 6-like protein,21637,130,1.11 [0.63-1.93],0.7205787634505683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L2,Seizure 6-like protein 2,21446,131,1.57 [0.83-2.94],0.164251812179445
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SF3B4,Splicing factor 3B subunit 4,21446,131,1.02 [0.82-1.25],0.8848691338433263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,21302,132,1.90 [1.44-2.50],5.023002405314703e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP4,Secreted frizzled-related protein 4,18442,92,0.69 [0.42-1.14],0.1448203176440622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA1,Pulmonary surfactant-associated protein A1,21052,127,1.14 [0.89-1.47],0.3061745666425842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,21052,127,1.34 [1.02-1.76],0.0388242374685776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPD,Pulmonary surfactant-associated protein D,21557,132,0.91 [0.72-1.14],0.3911036336587009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SGSH,N-sulphoglucosamine sulphohydrolase,18504,97,1.05 [0.75-1.48],0.7631357067083702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2B3,SH2B adapter protein 3,21052,127,1.04 [0.89-1.22],0.6262365691068783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2D1A,SH2 domain-containing protein 1A,21505,131,0.95 [0.72-1.25],0.7274469941999582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,18213,94,1.16 [0.87-1.53],0.3079255452100148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BP1,SH3 domain-binding protein 1,18745,97,0.95 [0.63-1.43],0.7993558827728326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GL3,Endophilin-A3,18420,97,0.96 [0.77-1.21],0.7541415605435045
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GLB2,Endophilin-B2,18809,98,0.90 [0.67-1.19],0.4569804456661124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHBG,Sex hormone-binding globulin,18856,97,1.01 [0.67-1.52],0.9602235110940962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHC1,SHC-transforming protein 1,18165,95,1.12 [0.96-1.30],0.1487086194568488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHD,SH2 domain-containing adapter protein D,18164,92,0.99 [0.78-1.25],0.9115782413856656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHH,Sonic hedgehog protein,18284,95,0.84 [0.52-1.37],0.493359882349477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,18852,99,1.78 [1.10-2.89],0.0191878680964495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHMT1,"Serine hydroxymethyltransferase, cytosolic",21610,130,0.99 [0.82-1.19],0.8819842969563234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHPK,Sedoheptulokinase,18501,97,0.86 [0.51-1.45],0.5758194696147245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIAE,Sialate O-acetylesterase,21604,129,1.30 [0.93-1.81],0.1309449461536078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC1,Sialoadhesin,21644,130,1.28 [0.89-1.84],0.1815228154778774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC10,Sialic acid-binding Ig-like lectin 10,21505,131,0.96 [0.61-1.50],0.8411047172861644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC15,Sialic acid-binding Ig-like lectin 15,21055,131,0.78 [0.60-1.01],0.0576517197881432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC5,Sialic acid-binding Ig-like lectin 5,21578,131,1.11 [0.96-1.28],0.1758020471677819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC6,Sialic acid-binding Ig-like lectin 6,21724,133,1.25 [0.80-1.96],0.32185034509381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC7,Sialic acid-binding Ig-like lectin 7,21557,132,0.98 [0.56-1.73],0.9524507534173494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC8,Sialic acid-binding Ig-like lectin 8,18378,94,1.46 [0.95-2.24],0.0809679224738757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC9,Sialic acid-binding Ig-like lectin 9,21690,133,1.23 [0.73-2.07],0.4352385058445721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIL1,Nucleotide exchange factor SIL1,18378,94,1.09 [0.60-2.00],0.7760707299553249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,21618,134,1.38 [1.03-1.85],0.0286838044555046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPB1,Signal-regulatory protein beta-1,21520,130,1.23 [0.89-1.70],0.2054971225747688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT1,NAD-dependent protein deacetylase sirtuin-1,18284,95,0.84 [0.62-1.14],0.2668465157032147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT2,NAD-dependent protein deacetylase sirtuin-2,21446,131,1.13 [0.95-1.36],0.1668252127640175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",21055,131,0.87 [0.63-1.18],0.368275662614942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIT1,Signaling threshold-regulating transmembrane adapter 1,21136,129,1.13 [0.86-1.49],0.3770786516131711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP1,Src kinase-associated phosphoprotein 1,21332,132,0.98 [0.79-1.21],0.8385821405861922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP2,Src kinase-associated phosphoprotein 2,21644,130,1.00 [0.86-1.16],0.9864886331946928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKIV2L,Helicase SKI2W,18209,92,1.20 [0.76-1.90],0.4392241571155443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLA2,Src-like-adapter 2,18806,96,1.04 [0.86-1.25],0.7082238028688492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF1,Signaling lymphocytic activation molecule,21136,129,1.31 [1.01-1.72],0.0453532125784669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF6,SLAM family member 6,21052,127,1.03 [0.68-1.57],0.8887077516204025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF7,SLAM family member 7,21505,131,1.22 [0.94-1.57],0.1320972201860025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,21052,127,1.51 [1.12-2.03],0.0062227885785211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC12A2,Solute carrier family 12 member 2,18209,92,1.44 [0.90-2.31],0.1301944997823367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC13A1,Solute carrier family 13 member 1,18757,97,0.71 [0.45-1.12],0.142299883541954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC16A1,Monocarboxylate transporter 1,21055,131,1.09 [0.84-1.41],0.5287581194649349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC1A4,Neutral amino acid transporter A,18334,92,1.25 [0.89-1.75],0.1947266854336891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC27A4,Long-chain fatty acid transport protein 4,21055,131,1.17 [0.93-1.46],0.1717085345281639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC28A1,Sodium/nucleoside cotransporter 1,18165,95,1.05 [0.76-1.44],0.7829484552343206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC34A3,Sodium-dependent phosphate transport protein 2C,18165,95,0.83 [0.52-1.33],0.4416436312063864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A14,Zinc transporter ZIP14,21055,131,1.34 [0.88-2.02],0.1696266677948886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A5,Zinc transporter ZIP5,21505,131,1.16 [0.88-1.53],0.2964558631441368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC44A4,Choline transporter-like protein 4,18334,92,0.73 [0.50-1.07],0.1104984764397755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC4A1,Band 3 anion transport protein,18852,99,1.04 [0.69-1.56],0.8488256480433365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC51B,Organic solute transporter subunit beta,18209,92,0.97 [0.73-1.28],0.8237844716635908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,18442,92,1.03 [0.81-1.31],0.7909429568273796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,18745,97,1.12 [0.78-1.59],0.544058432310186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",18165,95,0.87 [0.59-1.27],0.4618045280856543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIT2,Slit homolog 2 protein,21055,131,0.93 [0.69-1.27],0.665974312142255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK1,SLIT and NTRK-like protein 1,18284,95,0.63 [0.34-1.16],0.136510142321499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK2,SLIT and NTRK-like protein 2,21724,133,1.05 [0.71-1.54],0.8058259303304356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK6,SLIT and NTRK-like protein 6,21144,129,1.02 [0.65-1.60],0.9172079566423266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLK,STE20-like serine/threonine-protein kinase,18501,97,1.03 [0.81-1.31],0.8245563051224798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLMAP,Sarcolemmal membrane-associated protein,18745,97,1.04 [0.82-1.31],0.7639096839821061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLURP1,Secreted Ly-6/uPAR-related protein 1,18713,98,1.27 [0.81-1.97],0.2970033140314442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD1,Mothers against decapentaplegic homolog 1,21052,127,1.07 [0.88-1.29],0.4998039393292312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD2,Mothers against decapentaplegic homolog 2,18757,97,0.94 [0.71-1.26],0.6940031288023466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD3,Mothers against decapentaplegic homolog 3,18757,97,0.92 [0.63-1.35],0.6769643499052931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD5,Mothers against decapentaplegic homolog 5,21446,131,1.05 [0.47-2.35],0.8969152619528149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMARCA2,Probable global transcription activator SNF2L2,21055,131,0.87 [0.69-1.10],0.2414891887810682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMC3,Structural maintenance of chromosomes protein 3,18165,95,0.81 [0.54-1.23],0.327883355408444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMNDC1,Survival of motor neuron-related-splicing factor 30,18745,97,1.14 [0.87-1.51],0.3404288309284535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,21724,133,1.98 [1.30-3.01],0.0015563404356323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,21644,130,1.67 [1.14-2.45],0.0083532370872517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD1,Sphingomyelin phosphodiesterase,21631,134,1.14 [0.84-1.54],0.3887674742637749
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD3,Sphingomyelin phosphodiesterase 3,18284,95,0.96 [0.65-1.41],0.8395322057852816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,21615,130,1.14 [0.90-1.45],0.2734061726650899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,18757,97,0.98 [0.76-1.27],0.8763600662142763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMS,Spermine synthase,18213,94,0.77 [0.53-1.12],0.1735802182139994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMTN,Smoothelin,18783,98,1.09 [0.89-1.35],0.4017331233348041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP23,Synaptosomal-associated protein 23,21557,132,0.97 [0.81-1.15],0.7246569540915713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP25,Synaptosomal-associated protein 25,18213,94,1.39 [0.92-2.08],0.1138393973293055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP29,Synaptosomal-associated protein 29,21637,130,1.03 [0.87-1.23],0.7209965559369037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAPIN,SNARE-associated protein Snapin,18806,96,0.70 [0.49-1.01],0.0557486278801504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCA,Alpha-synuclein,18442,92,0.91 [0.76-1.08],0.2861084538805821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,21365,132,1.67 [1.32-2.11],1.638271334815084e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",18378,94,1.29 [0.72-2.30],0.387887209720732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNRPB2,U2 small nuclear ribonucleoprotein B'',18809,98,1.13 [0.79-1.62],0.5055839699902873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNU13,NHP2-like protein 1,18209,92,0.72 [0.47-1.10],0.1295342381377556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX15,Sorting nexin-15,18442,92,0.88 [0.60-1.28],0.4985878843674713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX18,Sorting nexin-18,18745,97,1.23 [0.82-1.82],0.3168689475307099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX2,Sorting nexin-2,18757,97,0.93 [0.73-1.18],0.5557902638137545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX5,Sorting nexin-5,18378,94,0.82 [0.40-1.69],0.598214997006687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX9,Sorting nexin-9,21557,132,1.05 [0.83-1.32],0.6792861634710347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD1,Superoxide dismutase [Cu-Zn],21170,129,1.00 [0.72-1.38],0.9840899360858212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD2,"Superoxide dismutase [Mn], mitochondrial",21578,131,1.32 [0.90-1.93],0.1549957516705692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD3,Extracellular superoxide dismutase,18856,97,1.03 [0.76-1.41],0.8303077800180646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORBS1,Sorbin and SH3 domain-containing protein 1,18806,96,1.48 [1.07-2.04],0.0175257941461465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORCS2,VPS10 domain-containing receptor SorCS2,21052,127,1.36 [0.89-2.08],0.1601445429199275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORD,Sorbitol dehydrogenase,21623,132,0.96 [0.76-1.21],0.7156905282116177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORT1,Sortilin,21515,132,1.09 [0.72-1.65],0.6718471405065356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOST,Sclerostin,21515,132,0.97 [0.65-1.43],0.8745138846512469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,18334,92,0.94 [0.62-1.42],0.7628147256576947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX2,Transcription factor SOX-2,18763,96,0.61 [0.26-1.45],0.2646193361666099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX9,Transcription factor SOX-9,18334,92,1.83 [0.86-3.90],0.1172365895965974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,18806,96,0.89 [0.45-1.76],0.7441385669011066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPAG1,Sperm-associated antigen 1,18806,96,0.77 [0.52-1.13],0.1807306991727165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARC,SPARC,21637,130,0.99 [0.79-1.22],0.8974311756363373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARCL1,SPARC-like protein 1,21601,132,1.04 [0.60-1.80],0.8930897906074822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPART,Spartin,18442,92,0.90 [0.68-1.17],0.4242721116201463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPESP1,Sperm equatorial segment protein 1,18843,97,0.95 [0.53-1.72],0.8769820446005072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,21578,131,1.85 [1.38-2.49],4.450361915771212e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK2,Serine protease inhibitor Kazal-type 2,18442,92,1.63 [0.98-2.69],0.0576138796785087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,21505,131,1.30 [1.05-1.60],0.0151399341407677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK5,Serine protease inhibitor Kazal-type 5,21578,131,1.41 [0.91-2.18],0.1212708280899251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK6,Serine protease inhibitor Kazal-type 6,21724,133,1.43 [1.06-1.93],0.0203803682885876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK8,Serine protease inhibitor Kazal-type 8,18209,92,1.08 [0.63-1.83],0.7883686071654415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,21512,130,2.03 [1.18-3.52],0.011128757353622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT2,Kunitz-type protease inhibitor 2,21644,130,1.55 [1.05-2.30],0.0272359963574543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT3,Kunitz-type protease inhibitor 3,18745,97,1.02 [0.90-1.16],0.7789412624700432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPOCK1,Testican-1,21365,132,0.65 [0.36-1.18],0.1544129756986214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,21582,130,2.36 [1.77-3.14],4.8722722429186255e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,21452,131,1.88 [1.23-2.87],0.0037285523984859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,21795,134,1.39 [1.00-1.92],0.0487148084429809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",18284,95,0.71 [0.42-1.21],0.2095194155021831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRING1,SREBP regulating gene protein,18165,95,0.82 [0.55-1.23],0.3339220634324113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR1B,Cornifin-B,18501,97,0.85 [0.64-1.12],0.2465080120264842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR3,Small proline-rich protein 3,18809,98,1.14 [0.86-1.53],0.3568205182306977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRY2,Protein sprouty homolog 2,21136,129,0.99 [0.83-1.18],0.9069905121276846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",18213,94,0.74 [0.37-1.46],0.3849559263335091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTLC1,Serine palmitoyltransferase 1,18809,98,1.14 [0.71-1.82],0.590560263558071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRC,Proto-oncogene tyrosine-protein kinase Src,21600,130,1.04 [0.91-1.18],0.5717353141480963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRP14,Signal recognition particle 14 kDa protein,21446,131,1.22 [0.96-1.55],0.1082912456300705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPK2,SRSF protein kinase 2,21505,131,0.99 [0.82-1.20],0.90783606530232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,18843,97,2.01 [1.18-3.42],0.0102413783499892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSB,Lupus La protein,21055,131,1.00 [0.76-1.30],0.9738100652768444
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",18284,95,1.17 [0.69-1.99],0.5672400977949603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,21515,132,1.00 [0.87-1.13],0.9469289829003416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,21671,132,1.05 [0.73-1.51],0.7883766325457378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSH3,Protein phosphatase Slingshot homolog 3,18165,95,1.10 [0.56-2.16],0.7842131452997633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSNA1,Sjoegren syndrome nuclear autoantigen 1,18745,97,1.07 [0.73-1.55],0.7358470700877993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST13,Hsc70-interacting protein,18442,92,0.73 [0.51-1.04],0.0813958546717785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",21446,131,0.90 [0.61-1.33],0.6056536195196793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",21821,134,1.36 [0.84-2.20],0.2044003366270305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",18284,95,0.86 [0.54-1.37],0.5157378780160333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAB2,Stabilin-2,18852,99,1.73 [0.87-3.44],0.1175904962457768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAM,Signal transducing adapter molecule 1,18757,97,0.94 [0.54-1.63],0.8152268744118493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAMBP,STAM-binding protein,21332,132,1.03 [0.81-1.32],0.796814298298222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT2,Signal transducer and activator of transcription 2,18284,95,1.03 [0.79-1.34],0.8521509453421925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT5B,Signal transducer and activator of transcription 5B,21446,131,1.04 [0.93-1.16],0.5147485302107124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,18165,95,0.82 [0.58-1.16],0.2613026070506078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC1,Stanniocalcin-1,21734,134,1.39 [1.01-1.91],0.0448734980453869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC2,Stanniocalcin-2,21549,131,1.68 [0.88-3.23],0.1184581974592169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STEAP4,Metalloreductase STEAP4,18213,94,0.79 [0.56-1.11],0.1725482803920248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STIP1,Stress-induced-phosphoprotein 1,21544,131,1.09 [0.86-1.39],0.4647023290949028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK11,Serine/threonine-protein kinase STK11,21144,129,1.09 [0.88-1.35],0.4340176943450794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK24,Serine/threonine-protein kinase 24,21055,131,1.08 [0.84-1.39],0.558460255698657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK4,Serine/threonine-protein kinase 4,21557,132,1.00 [0.84-1.20],0.9928586182234712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STOML2,"Stomatin-like protein 2, mitochondrial",18165,95,1.03 [0.83-1.28],0.7843563401006506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX16,Syntaxin-16,21052,127,1.04 [0.79-1.38],0.7666755520311587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX1B,Syntaxin-1B,18334,92,1.13 [0.74-1.74],0.5624353094161944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX3,Syntaxin-3,18809,98,0.62 [0.33-1.18],0.1459104765662773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX4,Syntaxin-4,21446,131,1.21 [0.96-1.53],0.1111310080482219
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX5,Syntaxin-5,18284,95,1.13 [0.72-1.78],0.5876444032052783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX6,Syntaxin-6,21052,127,0.81 [0.61-1.07],0.1354859739034608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX7,Syntaxin-7,18284,95,0.94 [0.63-1.42],0.7820426384440182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX8,Syntaxin-8,21505,131,1.22 [0.89-1.67],0.2176384435227137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP1,Syntaxin-binding protein 1,18806,96,1.00 [0.78-1.29],0.9948301236701902
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP3,Syntaxin-binding protein 3,21052,127,1.27 [0.90-1.79],0.174178981040374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGP1,SURP and G-patch domain-containing protein 1,18745,97,0.91 [0.55-1.52],0.7303569522193201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGT1,Protein SGT1 homolog,21052,127,1.18 [0.96-1.44],0.1114814863189529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT1A1,Sulfotransferase 1A1,21734,134,1.07 [0.95-1.20],0.292269746694701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT2A1,Bile salt sulfotransferase,21505,131,1.19 [0.93-1.53],0.1610676516333131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF1,Formylglycine-generating enzyme,18284,95,1.16 [0.91-1.49],0.2378068658364744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,21734,134,1.12 [0.83-1.51],0.4583766232593085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUOX,"Sulfite oxidase, mitochondrial",18806,96,0.92 [0.66-1.27],0.5943652879729779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD1,Sushi domain-containing protein 1,21144,129,1.19 [0.86-1.64],0.2979905136305016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD2,Sushi domain-containing protein 2,21578,131,1.48 [0.88-2.49],0.1410424407584364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD4,Sushi domain-containing protein 4,18757,97,1.20 [0.77-1.87],0.4162878644750551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD5,Sushi domain-containing protein 5,18340,91,0.95 [0.53-1.72],0.8739928073642613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SV2A,Synaptic vesicle glycoprotein 2A,18334,92,0.85 [0.60-1.21],0.3775811360747434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SWAP70,Switch-associated protein 70,18745,97,1.03 [0.60-1.78],0.9009870387810452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYAP1,Synapse-associated protein 1,18442,92,0.80 [0.55-1.15],0.2281608998364995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,18213,94,1.01 [0.72-1.41],0.975155141118678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYT1,Synaptotagmin-1,18809,98,1.13 [0.74-1.74],0.5704890351450308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYTL4,Synaptotagmin-like protein 4,18843,97,0.96 [0.73-1.26],0.7535916799918679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,18501,97,0.90 [0.75-1.09],0.2929701237282774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACC3,Transforming acidic coiled-coil-containing protein 3,21446,131,1.08 [0.95-1.24],0.255572266463526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,19036,114,1.86 [1.27-2.74],0.001502747584509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TADA3,Transcriptional adapter 3,18757,97,0.95 [0.58-1.56],0.834649626114517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,21446,131,1.76 [1.21-2.58],0.003271564622769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAGLN3,Transgelin-3,18165,95,1.26 [0.96-1.67],0.1015293263878662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TALDO1,Transaldolase,18776,99,0.81 [0.51-1.28],0.3606788103103926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TANK,TRAF family member-associated NF-kappa-B activator,21136,129,0.98 [0.78-1.23],0.8413106587168373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAP1,Antigen peptide transporter 1,18501,97,1.00 [0.72-1.40],0.98107588223049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARBP2,RISC-loading complex subunit TARBP2,21055,131,1.02 [0.83-1.25],0.8378006798860425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",18334,92,0.87 [0.64-1.17],0.3495300282249591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",18757,97,0.77 [0.45-1.33],0.3461694533167176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAX1BP1,Tax1-binding protein 1,18809,98,0.97 [0.71-1.34],0.8765920543438418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D17,TBC1 domain family member 17,21055,131,0.91 [0.63-1.30],0.5882034044361303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D23,TBC1 domain family member 23,21446,131,1.02 [0.86-1.22],0.7942795746624421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D5,TBC1 domain family member 5,21505,131,1.05 [0.87-1.28],0.6099797045156893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCA,Tubulin-specific chaperone A,18442,92,0.89 [0.69-1.13],0.3298341491485042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCB,Tubulin-folding cofactor B,21365,132,1.09 [0.93-1.28],0.2809096101661513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCC,Tubulin-specific chaperone C,21365,132,1.10 [0.91-1.34],0.3285759838570587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBL1X,F-box-like/WD repeat-containing protein TBL1X,21052,127,1.11 [0.92-1.34],0.2655447984691293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBR1,T-box brain protein 1,18334,92,0.89 [0.57-1.39],0.6035562087674595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,21344,132,0.85 [0.73-0.99],0.034050372732805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1B,T-cell leukemia/lymphoma protein 1B,21144,129,0.96 [0.78-1.19],0.7271748646320586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN1,Transcobalamin-1,18480,96,1.28 [0.79-2.07],0.3102201697780787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,21795,134,1.63 [1.07-2.50],0.0240540845946658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCOF1,Treacle protein,18843,97,0.97 [0.52-1.81],0.9216889924499846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCP11,T-complex protein 11 homolog,18501,97,1.11 [0.82-1.49],0.4966090769830595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCTN3,Tectonic-3,18843,97,1.09 [0.57-2.08],0.7984885411212704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDGF1,Teratocarcinoma-derived growth factor 1,21055,131,0.99 [0.89-1.10],0.7952486772317748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDO2,"Tryptophan 2,3-dioxygenase",18334,92,0.94 [0.54-1.62],0.8159975759497387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDP1,Tyrosyl-DNA phosphodiesterase 1,18757,97,0.96 [0.72-1.28],0.7902080848430053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDRKH,Tudor and KH domain-containing protein,21055,131,1.10 [0.91-1.32],0.3113710117266261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEF,Thyrotroph embryonic factor,18209,92,0.96 [0.59-1.54],0.8514252233630744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEK,Angiopoietin-1 receptor,21637,130,1.73 [0.86-3.48],0.1229017559457173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TERF1,Telomeric repeat-binding factor 1,18284,95,0.95 [0.47-1.90],0.8756431639002014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TET2,Methylcytosine dioxygenase TET2,18458,97,1.05 [0.88-1.26],0.5784714387642427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX101,Testis-expressed protein 101,18334,92,0.63 [0.44-0.90],0.0120911365181955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX33,Testis-expressed protein 33,18501,97,0.96 [0.57-1.62],0.8698493002574622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TF,Serotransferrin,18873,98,0.91 [0.37-2.23],0.8399724004060598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFAP2A,Transcription factor AP-2-alpha,18213,94,0.97 [0.69-1.36],0.8635828647492924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,21471,130,1.28 [1.09-1.52],0.0035386321310694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,21610,130,1.59 [1.26-2.02],0.0001263969812629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,21553,132,1.58 [1.23-2.02],0.0003777631175548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI,Tissue factor pathway inhibitor,21526,132,0.92 [0.55-1.52],0.7330046721854637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI2,Tissue factor pathway inhibitor 2,21580,129,1.30 [0.99-1.73],0.0633115934025846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFRC,Transferrin receptor protein 1,21662,131,1.27 [0.85-1.88],0.2415445380189667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TG,Thyroglobulin,18757,97,1.10 [0.94-1.30],0.2417347289143005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,21505,131,1.46 [1.07-1.97],0.0156005634324945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB1,Transforming growth factor beta-1 proprotein,21736,131,1.37 [0.93-2.02],0.1119231409460319
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB2,Transforming growth factor beta-2 proprotein,18757,97,0.98 [0.68-1.43],0.9227378243090768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBI,Transforming growth factor-beta-induced protein ig-h3,21450,131,0.91 [0.52-1.62],0.7591743541060321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR1,TGF-beta receptor type-1,18284,95,1.42 [0.60-3.36],0.4213155020782686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,21637,130,1.76 [1.20-2.58],0.003604987210791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR3,Transforming growth factor beta receptor type 3,21821,134,1.52 [0.93-2.49],0.0951766299758384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGM2,Protein-glutamine gamma-glutamyltransferase 2,21527,132,1.12 [0.91-1.37],0.2825567579778678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGOLN2,Trans-Golgi network integral membrane protein 2,18856,97,1.08 [0.52-2.24],0.828614589638067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THAP12,52 kDa repressor of the inhibitor of the protein kinase,18138,95,0.96 [0.75-1.22],0.7274833628566135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBD,Thrombomodulin,21557,132,1.21 [0.72-2.02],0.470854110292448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,21578,131,1.68 [1.18-2.40],0.0040765014098812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,21589,132,1.53 [1.10-2.14],0.0118339825595682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THOP1,Thimet oligopeptidase,21441,132,0.83 [0.49-1.38],0.4636307099900308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THPO,Thrombopoietin,21144,129,1.18 [0.80-1.75],0.4039318776825222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THRAP3,Thyroid hormone receptor-associated protein 3,18209,92,1.13 [0.97-1.32],0.1260731068797951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THSD1,Thrombospondin type-1 domain-containing protein 1,18136,95,0.89 [0.49-1.63],0.7095457318635547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THTPA,Thiamine-triphosphatase,18730,97,0.88 [0.70-1.10],0.2680314437329635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THY1,Thy-1 membrane glycoprotein,21734,134,1.61 [0.97-2.66],0.0643957258698897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIA1,Nucleolysin TIA-1 isoform p40,20906,126,1.07 [0.94-1.22],0.3141544305499716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIE1,Tyrosine-protein kinase receptor Tie-1,21821,134,0.93 [0.65-1.32],0.6776645174536315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",21022,131,1.31 [0.96-1.78],0.088336796467096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,18501,97,0.71 [0.40-1.25],0.2349147296280495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,21671,132,1.35 [0.96-1.90],0.0883076531768277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,18843,97,0.90 [0.54-1.49],0.6832510164241009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,18809,98,0.95 [0.75-1.19],0.6325049152708757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,21353,131,1.99 [1.23-3.22],0.0053575881982391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP2,Metalloproteinase inhibitor 2,18843,97,1.30 [0.78-2.18],0.3135821484966316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP3,Metalloproteinase inhibitor 3,21644,130,1.05 [0.93-1.18],0.4116421330514307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP4,Metalloproteinase inhibitor 4,21578,131,1.36 [0.95-1.95],0.0890468559595672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TINAGL1,Tubulointerstitial nephritis antigen-like,21482,132,1.57 [0.78-3.14],0.2079327271963717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJAP1,Tight junction-associated protein 1,21637,130,0.97 [0.80-1.17],0.7505554489909767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJP3,Tight junction protein ZO-3,18213,94,0.73 [0.43-1.24],0.2459774215541561
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TK1,"Thymidine kinase, cytosolic",18501,97,0.81 [0.50-1.31],0.3930241291280516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR1,Toll-like receptor 1,18284,95,1.23 [0.60-2.52],0.5766805593842996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR2,Toll-like receptor 2,18501,97,1.06 [0.46-2.45],0.8929817546067516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR3,Toll-like receptor 3,21768,132,0.85 [0.67-1.09],0.194946361266441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR4,Toll-like receptor 4,18284,95,0.85 [0.42-1.73],0.6567814650377104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,18334,92,1.22 [0.88-1.70],0.2277973956677705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED1,Transmembrane emp24 domain-containing protein 1,18501,97,0.72 [0.48-1.08],0.1131191543199026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED10,Transmembrane emp24 domain-containing protein 10,18209,92,0.66 [0.35-1.25],0.20607448094005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED4,Transmembrane emp24 domain-containing protein 4,18209,92,1.11 [0.82-1.50],0.5146858974938826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED8,Protein TMED8,18745,97,0.97 [0.80-1.18],0.7678359438388325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM106A,Transmembrane protein 106A,18757,97,0.91 [0.69-1.21],0.5280420365361337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM132A,Transmembrane protein 132A,18378,94,1.14 [0.83-1.56],0.4105447798473089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM25,Transmembrane protein 25,18806,96,0.85 [0.54-1.34],0.485502743161574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMOD4,Tropomodulin-4,18165,95,1.02 [0.61-1.68],0.9533011809011628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11B,Transmembrane protease serine 11B,18213,94,1.17 [0.94-1.46],0.1686135712928501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11D,Transmembrane protease serine 11D,18781,98,1.41 [0.93-2.14],0.1094322956993925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS15,Enteropeptidase,21446,131,0.94 [0.79-1.12],0.5089285501248542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS5,Transmembrane protease serine 5,21275,132,0.92 [0.62-1.38],0.6911260294100929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,21578,131,1.34 [1.09-1.65],0.0055538580457793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,21671,132,1.46 [1.07-1.98],0.0163999817224048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNF,Tumor necrosis factor,21120,129,1.17 [0.81-1.70],0.4027527918925011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,18745,97,1.10 [0.73-1.63],0.6564741910599757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,21136,129,0.94 [0.61-1.43],0.7592821461088956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,18442,92,0.92 [0.66-1.28],0.6025893043479673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,21365,132,1.74 [1.25-2.43],0.0011270143954253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,21365,132,1.36 [1.12-1.66],0.0022607445900478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,21632,133,1.10 [0.80-1.51],0.5447953256313938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21768,132,1.60 [1.12-2.28],0.0089691297809125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,21549,130,3.13 [1.97-4.96],1.2704449741470276e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,21637,130,1.76 [1.18-2.63],0.0054374881191384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,21582,130,1.84 [1.39-2.43],1.6392490943957266e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,21136,129,0.83 [0.57-1.21],0.3281788785702956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,21582,130,1.98 [1.26-3.11],0.0030906162376051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,18442,92,1.23 [0.76-1.98],0.3964732067285931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,21724,133,2.06 [1.40-3.04],0.0002485639357448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,21578,131,2.17 [1.43-3.31],0.0003023559981863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,21578,131,1.45 [1.06-1.99],0.019208251115004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,21734,134,1.52 [0.90-2.57],0.1197772948447527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,21736,131,1.40 [0.96-2.05],0.0792170799566466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,21365,132,1.31 [1.03-1.67],0.0268978040021124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,21734,134,1.12 [0.80-1.57],0.51361896549403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,21365,132,1.23 [0.88-1.71],0.2212493103836252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,21768,132,0.43 [0.24-0.78],0.0051697988682742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF11,Tumor necrosis factor ligand superfamily member 11,21505,131,0.72 [0.56-0.94],0.0140468251843696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF12,Tumor necrosis factor ligand superfamily member 12,21768,132,1.16 [0.67-2.00],0.5875018151290681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13,Tumor necrosis factor ligand superfamily member 13,21644,130,1.52 [0.87-2.66],0.143266021570131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,21793,134,1.63 [1.00-2.66],0.0487638193326043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF14,Tumor necrosis factor ligand superfamily member 14,21365,132,1.22 [0.94-1.58],0.1312832018560953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF8,Tumor necrosis factor ligand superfamily member 8,18852,99,0.89 [0.52-1.52],0.6668901655006476
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNIP1,TNFAIP3-interacting protein 1,18809,98,0.97 [0.78-1.22],0.8193056538921201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNN,Tenascin-N,18852,99,1.01 [0.65-1.57],0.9760003656372318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNNI3,"Troponin I, cardiac muscle",21144,129,1.22 [1.00-1.48],0.0511780435149797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNPO1,Transportin-1,18501,97,0.77 [0.43-1.36],0.3670321808823604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNR,Tenascin-R,21365,132,0.77 [0.54-1.11],0.1669826413516482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNXB,Tenascin-X,21578,131,0.85 [0.46-1.55],0.5871996013577161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,18843,97,0.92 [0.71-1.19],0.5085763619530512
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1,DNA topoisomerase 1,18745,97,1.00 [0.85-1.19],0.990090061101283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1MT,"DNA topoisomerase I, mitochondrial",18165,95,1.17 [0.80-1.71],0.415567894242515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP2B,DNA topoisomerase 2-beta,18284,95,0.99 [0.77-1.28],0.9635798848939856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOR1AIP1,Torsin-1A-interacting protein 1,18378,94,0.98 [0.67-1.44],0.918941505035088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53,Cellular tumor antigen p53,21052,127,0.85 [0.58-1.23],0.3924116174350679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53BP1,TP53-binding protein 1,18284,95,1.03 [0.82-1.31],0.7830357759506499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53I3,Quinone oxidoreductase PIG3,18050,90,0.85 [0.57-1.26],0.4066651342756108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53INP1,Tumor protein p53-inducible nuclear protein 1,21144,129,1.06 [0.65-1.72],0.8283523928258818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP73,Tumor protein p73,18334,92,1.32 [0.74-2.37],0.3499307913295528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPBGL,Trophoblast glycoprotein-like,18334,92,0.79 [0.47-1.34],0.3830204081645096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPD52L2,Tumor protein D54,18442,92,0.99 [0.82-1.19],0.9253320070160947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPK1,Thiamin pyrophosphokinase 1,18843,97,0.55 [0.27-1.13],0.1053481092322416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPM3,Tropomyosin alpha-3 chain,18209,92,1.05 [0.68-1.63],0.8193762944787577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPMT,Thiopurine S-methyltransferase,21052,127,1.05 [0.84-1.30],0.6784287624164049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPP1,Tripeptidyl-peptidase 1,21408,129,1.35 [1.00-1.83],0.050160110554863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP2,Tubulin polymerization-promoting protein family member 2,18501,97,0.95 [0.73-1.23],0.6998629949625572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP3,Tubulin polymerization-promoting protein family member 3,21055,131,0.90 [0.59-1.38],0.6429103889952599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPR,Nucleoprotein TPR,18209,92,1.06 [0.72-1.56],0.7661800533633255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPRKB,EKC/KEOPS complex subunit TPRKB,18165,95,0.85 [0.60-1.21],0.3661674705382842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSAB1,Tryptase alpha/beta-1,21734,132,1.31 [0.97-1.77],0.0731677379798908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSD1,Tryptase delta,18806,96,1.23 [0.80-1.90],0.3500238120409654
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSG1,Tryptase gamma,18284,95,1.05 [0.50-2.21],0.8902387109936412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPT1,Translationally-controlled tumor protein,21136,129,1.09 [0.88-1.36],0.418554649435662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF2,TNF receptor-associated factor 2,21505,131,0.86 [0.68-1.08],0.1844327815180173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3,"TNF receptor-associated factor 3, Isoform 2",18284,95,0.79 [0.44-1.40],0.4171688942006624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,18209,92,1.06 [0.72-1.56],0.7713352666624418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,18501,97,1.03 [0.83-1.27],0.7924467697176065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREH,Trehalase,18852,99,1.10 [0.84-1.43],0.4926365131215496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREM2,Triggering receptor expressed on myeloid cells 2,21549,130,0.91 [0.68-1.22],0.5425435616340583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML1,Trem-like transcript 1 protein,18856,97,0.89 [0.61-1.30],0.5408317399525384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML2,Trem-like transcript 2 protein,21578,131,1.17 [0.75-1.82],0.4806581785701216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIAP1,TP53-regulated inhibitor of apoptosis 1,21724,133,1.33 [1.04-1.70],0.0212530067026405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM21,E3 ubiquitin-protein ligase TRIM21,21505,131,0.93 [0.76-1.13],0.4445926235046339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM24,Transcription intermediary factor 1-alpha,18472,97,1.00 [0.73-1.36],0.991394504577071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,18745,97,0.90 [0.75-1.08],0.2388036247179148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM26,Tripartite motif-containing protein 26,18165,95,0.77 [0.51-1.15],0.1994864603558244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM40,E3 ubiquitin ligase TRIM40,18334,92,1.00 [0.75-1.32],0.9834529862796056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM5,Tripartite motif-containing protein 5,21505,131,0.99 [0.82-1.19],0.9084405883409572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM58,E3 ubiquitin-protein ligase TRIM58,18757,97,0.96 [0.77-1.20],0.7107959761318129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRPV3,Transient receptor potential cation channel subfamily V member 3,18209,92,1.35 [1.01-1.81],0.0416005943679729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC1,Hamartin,18284,95,0.73 [0.50-1.06],0.0977575532511848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC22D1,TSC22 domain family protein 1,18806,96,0.97 [0.72-1.32],0.8639574780784197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSHB,Thyrotropin subunit beta,21557,132,0.87 [0.71-1.06],0.1729338105997013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSLP,Thymic stromal lymphopoietin,21144,129,0.94 [0.71-1.23],0.6310941620300672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSNAX,Translin-associated protein X,18209,92,0.82 [0.48-1.39],0.4554579595322318
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN1,Tetraspanin-1,21144,129,0.94 [0.76-1.15],0.5304356054669574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN15,Tetraspanin-15,18209,92,1.11 [0.79-1.55],0.5549374857225434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN7,Tetraspanin-7,18213,94,1.04 [0.85-1.28],0.6928240591324286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN8,Tetraspanin-8,18745,97,0.95 [0.78-1.16],0.598892363014953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPYL1,Testis-specific Y-encoded-like protein 1,18284,95,1.39 [0.87-2.20],0.1667727552821497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TST,Thiosulfate sulfurtransferase,21013,131,1.12 [0.91-1.38],0.2798531305395031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTF2,Transcription termination factor 2,18334,92,0.66 [0.43-1.03],0.0654543446876691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTN,Titin,18209,92,1.09 [0.81-1.46],0.5628820769860772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTR,Transthyretin,18676,97,0.69 [0.32-1.48],0.3387372350437722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TUBB3,Tubulin beta-3 chain,18213,94,1.22 [0.61-2.43],0.5700805694190685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TWF2,Twinfilin-2,18852,99,0.97 [0.77-1.22],0.7980260479459117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXK,Tyrosine-protein kinase TXK,18501,97,0.89 [0.66-1.19],0.4339691093082556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXLNA,Alpha-taxilin,21365,132,1.02 [0.85-1.22],0.8358946724192672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXN,Thioredoxin,18553,95,1.14 [0.75-1.72],0.5406344257266078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC15,Thioredoxin domain-containing protein 15,21637,130,1.25 [0.71-2.19],0.4388070401700238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC5,Thioredoxin domain-containing protein 5,21734,134,1.17 [0.94-1.47],0.1604232920980418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC9,Thioredoxin domain-containing protein 9,18809,98,1.01 [0.70-1.46],0.9563458524001206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNL1,Thioredoxin-like protein 1,18175,94,0.82 [0.63-1.05],0.1166679004748303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",21578,131,1.15 [0.82-1.61],0.4248255803795154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYMP,Thymidine phosphorylase,21410,131,1.10 [0.86-1.40],0.4414895008744463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRO3,Tyrosine-protein kinase receptor TYRO3,21557,132,1.22 [0.71-2.11],0.4776923567832534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",18284,95,1.14 [0.83-1.56],0.4166545276275297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBAC1,Ubiquitin-associated domain-containing protein 1,21446,131,1.02 [0.66-1.60],0.9155311948056364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2B,Ubiquitin-conjugating enzyme E2 B,18757,97,0.82 [0.41-1.65],0.5769685194286419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,18843,97,1.01 [0.73-1.39],0.9733749375851511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,18284,95,0.99 [0.69-1.40],0.9346198813140062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,18209,92,1.49 [1.19-1.88],0.000642769229538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBXN1,UBX domain-containing protein 1,18442,92,0.92 [0.68-1.24],0.5668689958425569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,18745,97,0.99 [0.86-1.14],0.8505361600195838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UGDH,UDP-glucose 6-dehydrogenase,18209,92,0.92 [0.72-1.16],0.4715069332237442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UHRF2,E3 ubiquitin-protein ligase UHRF2,18209,92,0.78 [0.40-1.52],0.4682192004285604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ULBP2,UL16-binding protein 2,21365,132,1.22 [0.83-1.80],0.3158439165717994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UMOD,Uromodulin,21761,134,0.90 [0.68-1.18],0.4461202915481516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC5D,Netrin receptor UNC5D,18284,95,0.95 [0.44-2.04],0.8937075149712222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC79,Protein unc-79 homolog,18165,95,0.94 [0.65-1.37],0.7637702551195202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNG,Uracil-DNA glycosylase,18757,97,0.83 [0.46-1.50],0.5427000345777455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPB1,Beta-ureidopropionase,18843,97,1.07 [0.86-1.33],0.5245925446254979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3A,Uroplakin-3a,18213,94,1.07 [0.73-1.58],0.7287751639265707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3BL1,Uroplakin-3b-like protein 1,18457,97,0.76 [0.48-1.22],0.2599807775417239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROD,Uroporphyrinogen decarboxylase,18442,92,0.81 [0.60-1.09],0.1598454737029635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROS,Uroporphyrinogen-III synthase,18334,92,0.78 [0.56-1.09],0.138945059896022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USO1,General vesicular transport factor p115,21446,131,1.09 [0.91-1.30],0.3398525259643887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP25,Ubiquitin carboxyl-terminal hydrolase 25,18757,97,0.98 [0.74-1.30],0.8992801682346756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP28,Ubiquitin carboxyl-terminal hydrolase 28,18809,98,1.56 [1.07-2.26],0.0197277172790274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP47,Ubiquitin carboxyl-terminal hydrolase 47,18209,92,0.96 [0.75-1.23],0.7422728998369958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP8,Ubiquitin carboxyl-terminal hydrolase 8,21144,129,1.04 [0.88-1.23],0.6711370969183004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UXS1,UDP-glucuronic acid decarboxylase 1,21052,127,0.91 [0.67-1.25],0.5670813675800448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP5,Vesicle-associated membrane protein 5,21144,129,1.13 [0.86-1.47],0.378053353957232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP8,Vesicle-associated membrane protein 8,18284,95,1.01 [0.80-1.27],0.938058860437564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASH1,Tubulinyl-Tyr carboxypeptidase 1,21505,131,1.14 [0.94-1.37],0.1822583721340855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASN,Vasorin,21229,128,1.25 [0.71-2.20],0.4370083114374922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASP,Vasodilator-stimulated phosphoprotein,18856,97,0.94 [0.71-1.23],0.6293850720416012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,21446,131,0.73 [0.33-1.62],0.4383062613694496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAV3,Guanine nucleotide exchange factor VAV3,18213,94,1.07 [0.87-1.31],0.5418390988852878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAM1,Vascular cell adhesion protein 1,21625,132,1.58 [0.92-2.70],0.098314218951755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAN,Versican core protein,21734,134,1.34 [0.81-2.21],0.2541696678755178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCPKMT,Protein-lysine methyltransferase METTL21D,18165,95,0.91 [0.70-1.18],0.4555918366914889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFA,Vascular endothelial growth factor A,21699,132,1.06 [0.81-1.37],0.6869508033963678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFB,Vascular endothelial growth factor B,18284,95,1.33 [0.68-2.62],0.4050545747647928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFC,Vascular endothelial growth factor C,21637,130,1.06 [0.81-1.40],0.6641236821373926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFD,Vascular endothelial growth factor D,21734,132,1.55 [1.02-2.36],0.0383127954420449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VGF,Neurosecretory protein VGF,18806,96,0.72 [0.37-1.38],0.3198005051210847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIM,Vimentin,21144,129,0.98 [0.86-1.12],0.741410848815911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIPR1,Vasoactive intestinal polypeptide receptor 1,18378,94,0.85 [0.35-2.06],0.723252737772835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIT,Vitrin,18843,97,1.25 [0.75-2.07],0.3962183925200011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VMO1,Vitelline membrane outer layer protein 1 homolog,21446,131,1.03 [0.82-1.29],0.7917384452040075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN1,Pantetheinase,18856,97,0.95 [0.73-1.24],0.7233294970600954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN2,Vascular non-inflammatory molecule 2,21446,131,1.32 [0.93-1.88],0.1172949816537908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS28,Vacuolar protein sorting-associated protein 28 homolog,18501,97,0.92 [0.67-1.25],0.5831873531631506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS37A,Vacuolar protein sorting-associated protein 37A,21446,131,1.00 [0.82-1.22],0.9766658432192484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS4B,Vacuolar protein sorting-associated protein 4B,18757,97,1.04 [0.84-1.28],0.7231169955171801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS53,Vacuolar protein sorting-associated protein 53 homolog,21446,131,1.04 [0.85-1.27],0.6956460870711532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10,V-set and immunoglobulin domain-containing protein 10,18757,97,1.16 [0.68-1.97],0.5837199958975496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,18209,92,1.27 [0.72-2.24],0.4109207302900645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,18757,97,1.50 [1.17-1.93],0.0013199949481844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,21549,131,1.56 [1.11-2.20],0.0108813687351509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,21519,132,1.11 [0.87-1.42],0.3845316732520359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSNL1,Visinin-like protein 1,18809,98,1.04 [0.63-1.73],0.8719209407439106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM1,V-set and transmembrane domain-containing protein 1,21055,131,1.10 [0.81-1.49],0.5485363747571865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2B,V-set and transmembrane domain-containing protein 2B,18501,97,0.81 [0.47-1.39],0.4502275201682573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,21144,129,0.78 [0.58-1.05],0.1015001034400544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,21734,134,1.07 [0.87-1.33],0.5118370194659994
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTCN1,V-set domain-containing T-cell activation inhibitor 1,21052,127,1.27 [0.77-2.09],0.3538476054508679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,18442,92,0.90 [0.62-1.30],0.5563888594771715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA1,von Willebrand factor A domain-containing protein 1,21686,133,1.03 [0.71-1.50],0.8695996293411197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA5A,von Willebrand factor A domain-containing protein 5A,18165,95,0.98 [0.76-1.28],0.9013387931507342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2,Brorin,21299,132,1.31 [0.90-1.91],0.1559420922429961
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2L,von Willebrand factor C domain-containing protein 2-like,18806,96,0.90 [0.56-1.44],0.6537100443521522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWF,von Willebrand factor,21821,134,1.10 [0.89-1.36],0.3647323974088898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WARS,"Tryptophan--tRNA ligase, cytoplasmic",21578,131,1.24 [0.83-1.86],0.2997804259449957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WAS,Wiskott-Aldrich syndrome protein,21136,129,0.97 [0.76-1.23],0.7977281411413883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF1,Wiskott-Aldrich syndrome protein family member 1,21144,129,1.03 [0.87-1.22],0.7032548080599046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF3,Wiskott-Aldrich syndrome protein family member 3,21055,131,1.10 [0.91-1.33],0.3011205746249848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASHC3,WASH complex subunit 3,18809,98,0.96 [0.73-1.25],0.7448368674173065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASL,Neural Wiskott-Aldrich syndrome protein,18284,95,0.84 [0.58-1.22],0.358782681593205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WDR46,WD repeat-containing protein 46,18757,97,1.08 [0.64-1.80],0.7797908780228292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC1,WAP four-disulfide core domain protein 1,18378,97,1.02 [0.72-1.45],0.9034380369891232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC12,WAP four-disulfide core domain protein 12,21693,133,1.13 [0.89-1.43],0.3091495935288548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,20482,122,2.04 [1.49-2.79],7.72561482780702e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",21292,132,0.77 [0.53-1.12],0.1728167336852669
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",21582,130,1.28 [0.81-2.02],0.2835362899005459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,21724,133,2.07 [1.34-3.21],0.0010254282681245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,21136,129,1.79 [1.13-2.84],0.0125871605194871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,21365,132,0.93 [0.70-1.25],0.6500170761439867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XCL1,Lymphotactin,21724,133,1.29 [1.00-1.65],0.046378358032198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,21730,134,1.94 [1.31-2.87],0.0009761517584009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XIAP,E3 ubiquitin-protein ligase XIAP,18284,95,0.88 [0.61-1.27],0.4987416800550091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,21637,130,0.83 [0.72-0.96],0.0137258783107073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XRCC4,DNA repair protein XRCC4,21055,131,0.87 [0.56-1.35],0.5335378458502136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,18809,98,3.52 [1.96-6.33],2.5828409165836088e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",18745,97,0.97 [0.85-1.11],0.6622627417067041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YES1,Tyrosine-protein kinase Yes,21446,131,1.02 [0.89-1.16],0.8277927435235455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YJU2,Splicing factor YJU2,18757,97,1.05 [0.57-1.91],0.879023615934423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YOD1,Ubiquitin thioesterase OTU1,18209,92,0.84 [0.61-1.17],0.3051221601942759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YTHDF3,YTH domain-containing family protein 3,21136,129,0.97 [0.81-1.17],0.7363880684848964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YWHAQ,14-3-3 protein theta,18442,92,0.88 [0.66-1.17],0.372506833208457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YY1,Transcriptional repressor protein YY1,18284,95,0.53 [0.25-1.13],0.100137440137889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBP1,Z-DNA-binding protein 1,18284,95,0.88 [0.51-1.52],0.6486991192534679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB16,Zinc finger and BTB domain-containing protein 16,21052,127,1.06 [0.85-1.32],0.6252109446559688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB17,Zinc finger and BTB domain-containing protein 17,21144,129,0.99 [0.68-1.45],0.9673228372472822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZCCHC8,Zinc finger CCHC domain-containing protein 8,18209,92,0.90 [0.63-1.29],0.5754039262527697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZFYVE19,Abscission/NoCut checkpoint regulator,18745,97,1.01 [0.81-1.26],0.9007599282105324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZHX2,Zinc fingers and homeoboxes protein 2,18809,98,0.99 [0.56-1.76],0.9851408243147004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF174,Zinc finger protein 174,18284,95,0.61 [0.31-1.22],0.1624412354871331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF75D,Zinc finger protein 75D,18501,97,0.88 [0.62-1.25],0.4689369565599326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF830,Zinc finger protein 830,18757,97,1.22 [0.99-1.51],0.0611995164134344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRD2,Protein ZNRD2,18745,97,1.08 [0.82-1.43],0.5897769745331268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,18757,97,1.24 [0.89-1.72],0.2003945935848892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP3,Zona pellucida sperm-binding protein 3,18378,94,1.02 [0.94-1.09],0.6850542790508634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP4,Zona pellucida sperm-binding protein 4,18165,95,0.76 [0.38-1.54],0.4492682964240965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZPR1,Zinc finger protein ZPR1,18213,94,0.99 [0.81-1.22],0.9504396910777552
